Bruner, DW Page 1 of 57 CURRICULUM VITAE

DEBORAH WATKINS BRUNER, RN, PhD, FAAN

BUSINESS ADDRESS Nell Hodgson Woodruff School of Nursing Emory University 1520 Clifton Road – Rm 232 Atlanta, Georgia 30322 Ph: 404.712.9695 Fax: 404/727-8514 dwbrune@emory.edu EDUCATION 1999 PHD University of Pennsylvania, Philadelphia, PA Major: Nursing [Outcomes Research] 1988 MSN Widener University, Chester, PA Major: Nursing [Administration]

1985 MSN Widener University, Chester, PA Major: Nursing [Oncology] 1978 BSN West Chester University, West Chester, PA Major: Nursing POSTGRADUATE TRAINING & FELLOWSHIP APPOINTMENTS 1991 Villanova University, Villanova, PA Post Graduate Certificate Major: Nursing [Administration] 7/99 - 7/01 Research Fellowship, Cancer Prevention and Control NCI R25 (CA57708) PROFESSIONAL EXPERIENCE and ACADEMIC POSITIONS Emory University, Atlanta, GA 1/12-present Robert W. Woodruff Chair in Nursing 9/11-present Professor of Nursing 9/11-12/15 Associate Director for Outcomes Research, Winship Cancer Institute 12/15-present Associate Director for Mentorship, Training and Education, Winship Cancer

Institute 7/13-present Director, Faculty Mentoring, School of Nursing University of Pennsylvania, School of Nursing, Philadelphia, PA (Primary Appointment) 11/10 – 8/31/11 Director, Biobehavioral Research Center, School of Nursing 5/09 – 7/1/10 Interim Associate Dean for Research 9/06 - 8/31/11 Independence Professor of Nursing Education 1/06 - 8/31/11 Professor of Nursing University of Pennsylvania, Philadelphia, PA

Bruner, DW Page 2 of 57 6/08 - 8/31/11 Co-Program Leader, Ca Prevention and Control Program, Abramson Cancer Center 4/08 - 8/31/11 Senior Fellow, Center for Public Health Initiatives 2/08 - 8/31/11 Professor of Radiation Oncology 1/06 – 6/09 Director, Recruitment, Retention & Outreach Core, Abramson Cancer Center Fox Chase Cancer Center, Philadelphia, PA 2/06 – 6/09 Adjunct Member, Population Science 12/02 - 1/06 Director, Developmental Recruitment, Retention and Outreach Core (RROC) Associate Member, Population Science and Radiation Oncology 9/02 - 1/06 Director, Symptoms and Outcomes Research Program 7/96 - 1/06 Director, Prostate Cancer Risk Assessment Program 7/99 - 9/02 Assistant Member, Population Science and Radiation Oncology 7/99 - 7/01 Research Fellowship, Cancer Prevention and Control NCI R25 (CA57708) 5/93 - 7/99 Clinical Nurse Specialists, Department of Radiation Oncology 8/89 - 5/93 Nurse Manager/Clinical Specialist, Department of Radiation Oncology Albert Einstein Medical Center, Philadelphia, PA 6/86 - 7/89 Gyn-Oncology Clinical Nurse Specialist/Program Coordinator Crozer-Chester Medical Center, Chester, PA 10/85 - 2/86 Research Nurse for Burns and Trauma 3/85 - 10/85 Critical Care PRN – Staff Nurse 11/83 - 3/85 Intensive Care - Staff Nurse 7/82 - 11/83 Oncology - Staff Nurse 7/78 - 12/79 Medical Surgical - Staff Nurse / Emory University Courses – Faculty of Record Spring 2015 NRSG 730 Measurement and Design in Clinical Research (8 doctoral students) Spring 2014 NRSG 730 Measurement and Design in Clinical Research (6 doctoral students) Spring 2013 NRSG 730 Measurement and Design in Clinical Research (6 doctoral students) Guest Lectures 4/7/17 NSG 412 “Cooperative Groups and Patient Outcomes Research” (10

undergraduates) 3/1/17 NRSG 730 Measurement and Design in Clinical Research (8 doctoral students; 6

video-connected from Addis Abba, Ethopia) “Experimental Design” 10/27/16 NSRG 710 Principles of Health Outcomes Research “Comparative Effectiveness

Research” 2/2/16 NRSG 730 Measurement and Design in Clinical Research (8 doctoral students; 3

video-connected from Addis Abba, Ethopia) “Experimental Design” 1/27/16 NRSG 730 Measurement and Design in Clinical Research (8 doctoral students; 3

video-connected from Addis Abba, Ethopia) “Human Subjects Recruitment and Retention”

10/20/14 RSPH EPI 504 “Fundamentals of Epidemiology” 9/18/14 NSRG 710 Principles of Health Outcomes Research “Comparative Effectiveness

Research” 3/3/14 NRSG 683 Human Sexuality in Health and Illness “Sexuality After Cancer

Therapy” 3/25/13 NRSG 371 Evidence Based Practice “Achieving Clinical Excellence through

Research and Evidence Based Practice”

Bruner, DW Page 3 of 57 3/18/13 NRSG 683 Human Sexuality in Health and Illness “Sexuality After Cancer

Therapy” 1/25/12 NRSG 730 Measurement and Design in Clinical Research, “Recruitment and

Retention” 2/8/12 NRSG 730 Measurement and Design in Clinical Research, “Experimental Design” 3/20/12 NRSG 683 Human Sexuality in Health and Illness “Sexuality After Cancer

Therapy” University of Pennsylvania Courses Spring 2011 N754 Qualitative Methods (16 doctoral students) Spring 2010 N754 Qualitative Methods (15 doctoral students) Spring 2009 N754 Qualitative Methods (14 doctoral students) Spring 2006 N753 Evolving Nursing Science: Concept Analysis (10 doctoral students) Guest Lectures 6/9/10 BE645, Research Methods in Cancer Etiology, Prevention, Treatment, and Control,

“Role of Patient Reported Outcomes (PROs): The Radiation Therapy Oncology Group Experience”

2/2/10 N666, Advanced Practice Oncology Nurse Program, “Sexuality and the Patient Treated for Cancer”

7/16/09 EP815, the CCEB Certificate in Clinical Research Program, “The Science of Recruiting and Retaining Human Subjects in Clinical Trials”

6/2/09 BE645, Research Methods in Cancer Etiology, Prevention, Treatment, and Control, “PRO Research in Cancer”

3/17/09 N666, Advanced Practice Oncology Nurse Program, “Sexuality and the Patient Treated for Cancer”

2/23/09 N823, Designing Interventions to Promote Health and Reduce Health Disparities, “Recruiting and Retaining Vulnerable Populations in Research”

7/9/08 EP815, the CCEB Certificate in Clinical Research Program, “The Science of Recruiting and Retaining Human Subjects in Clinical Trials”

5/20/08 Summer Nursing Research Institute, “Recruiting and Retaining Vulnerable Populations in Research”

3/24/08 N260, Undergraduate Research Methods, “Development a Conceptual Framework for the Study of Symptom Management and Quality of Life in Cancer Clinical Trials”

3/4/08 N666, Adult Oncology Nurse Practitioner Program, "Assessment and Management of Sexuality and Reproductive Issues in the Cancer Patient"

3/27/07 N666 Adult Oncology Nurse Practitioner Program, “Exploring Nursing Science in Cancer Clinical Trial Cooperative Groups”

3/20/07 N666 Adult Oncology Nurse Practitioner Program, “Quality of Life: Sexuality Issues for Cancer Patients”

3/15/07 ENVS 407- Prevention of Tobacco Addiction “PA Tobacco Settlement Funds: Use of Funding to Foster Public Health Interventions”

11/16/06 Bridges to the Doctorate, Joint Thomas Jefferson University/University of Pennsylvania Program, “Exploring Nursing Science in Cancer Clinical Trial Cooperative Groups”

4/18/06 Adult Oncology Nurse Practitioner Program, “Quality of Life: Sexuality Issues for Cancer Patients”

3/1/05 Adult Oncology Nurse Practitioner Program, “Managing Sexual Side-effects of Cancer Therapy”

11/94 Graduate Oncology Program, “Principles of Radiation Therapy” 11/93 Graduate Oncology Program, “Principles of Radiation Therapy”

Bruner, DW Page 4 of 57 Research Residency (University of Pennsylvania) Summer 2011 Justine Sefcik, Study of pain-sleep disturbance-fatigue-depression symptom cluster

in cancer Summer 2009 Lit Soo Ng, Study of factor analysis as a statistical method to evaluate psychometric

properties of patient self-report questionnaires using an RTOG data set Summer 2009 Canhua Xiao, Study of secondary data analysis methods of measures of utility using

an RTOG data set CLINICAL & ADMINISTRATIVE POSITIONS 7/1/04 - 7/1/05 Clinical Adjunct Instructor, Temple University School of Medicine Spring 2000 Research Preceptor, LaSalle University Spring 1996 Clinical Preceptor, Thomas Jefferson University Spring 1991 Clinical Preceptor, LaSalle University Spring 1989 Clinical Preceptor, Gwynedd Mercy College Fall 1987/Spring 1988 Clinical Adjunct Instructor, Widener University Summer 1988 Clinical Preceptor, University of Pennsylvania Fall 1987 & 1988 Instructor Oncology Course, Albert Einstein Medical Center Fall 1983 Instructor, Oncology Component, Advanced Clinical Nursing Course, Crozer-Chester Medical Center CERTIFICATION/LICENSURE PA License #: RN-229486-L GA License # RN-219292 (Active) HONORS/AWARDS/MEMBERSHIPS IN HONORARY SOCIETIES 2017 Elected to Sun Valley High School, Aston, PA Hall of Fame 2016 Elected to National Academy of Medicine (former Institute of Medicine) 2016 Nurses Abstract Award for “NRG Oncology/RTOG 0415, Phase III Non-Inferiority

Study Comparing 2 Fractionation Schedules in Patients with Low-Risk Prostate Cancer: Prostate Specific Quality of Life Results.” ASTRO Annual Meeting, Boston MA, September 25-28, 2016.

2016 Awarded among the first “class” of Emory Distinguished Faculty 2016 Induction, International Nurse Researcher Hall of Fame, Sigma Theta Tau

International Honor Society of Nursing, Cape Town, South Africa 2015-2020 U. S. Presidential appointment to the National Cancer Advisory Board, NCI 2015 Distinguished Researcher Award, Oncology Nursing Society 2014 100 Inspiring Nursing Professors to Watch in 2014 online LPN to RN http://onlinelpntorn.org/inspiring-nursing-professors/ 2013 Inducted into Honor Society of Nursing, Sigma Theta Tau International 2013 Outstanding Faculty Mentorship Award, School of Nursing, Emory University 2012 Top 100 Nursing Professors in 2012 in BSNtoMSN.org 2012 Emory University, Academic Leadership Program 2011 Senior Faculty Research Award, Biobehavioral Department, School of Nursing University of Pennsylvania 2007 Fellow, American Academy of Nursing 2004 Excellence in Radiation Oncology, Oncology Nursing Society/Varian Nursing Award 2003 - 2005 Re-Elected to Board of Directors, American Cancer Society, Southeast Region, PA 2001 - 2003 Elected to Board of Directors, American Cancer Society, Southeast Region, PA 2001 - 2003 Elected to Executive Board, American Society of Preventive Oncology 2000 Best New Investigator, International Society for Pharmacoeconomics & Outcomes

Research, Poster Presentation

Bruner, DW Page 5 of 57 2000 Linda Hunter Quality of Life Lecture, Society of Gynecologic Nurse Oncologists 1998 - 2000 Research Award, Oncology Nursing Foundation/Amgen Inc. 1988 - 1999 Who's Who in American Nursing 1996, 2000, 2002 Who’s Who in Medicine and Healthcare (‘96-1st edition) 1995 Doctoral Scholarship, Oncology Nursing Society 1995 - 1998 Doctoral Scholarship, American Cancer Society 1995 President’s Award, Philadelphia Area Chapter, ONS RESEARCH Doctoral Dissertation Bruner, D.W. (1999). Determination of Preferences and Utilities for the Treatment of Prostate Cancer,

Dissertation, University of Pennsylvania, Volume 6007B of UMI Dissertation Abstracts, Ann Arbor, MI.

Past/Present Funded Research Grants as Principal Investigator ($94,716,534) Principal Investigator, “Developing Modern Radiotherapy in Low Income Countries: An Ethiopian

Tailored Radiation Therapy Medical Physics Quality Assurance Training Credentialing and Scholarship Program,” Funded through Emory University Office of Global Strategy and Initiatives and the Winship Cancer Institute (5/1/17-4/30/18) $40,000

Principal Investigator, “The Vaginal Microbiome and Cervical Cancer.” Funded through Winship Invests Pilot Project Grant (2/1/16-1/31/16) $50,000

Principal Investigator, NRG Oncology NCORP Research Base, Funded through NIH 1UG1CA189867-01 (8/1/14-7/31/19) $52,672,772

Principal Investigator, Pilot Testing of Computerized Neurocognitive Testing in an RTOG Brain Tumor Trial, Funded through NIH U10 CA37422 (Yr 23 Supplement 8/1/10-5/31/11) $161,647 total

Principal Investigator, Radiation Therapy Oncology Group (RTOG) Community Clinical Oncology Program Research Base, Funded through NIH U10 CA37422 (Yrs 23-28 6/1/10-5/31/15) $18,346,306 direct; $22,611,690 total

Principal Investigator, Radiation Therapy Oncology Group (RTOG) Community Clinical Oncology Program Research Base, Funded through NIH U10 CA37422 (Yr 22 Supplement 6/1/09-5/31/10) $1,446,400 total

Principal Investigator, Feasibility of Biospecimen Sampling for Assessment of Vaginal Stenosis, Funded through the University of Pennsylvania University Research Foundation (URF) Penn IRB# 811152 (3/1/10 to 2/29/11) $25,000

Principal Investigator, Randomized Feasibility Study of Dilator Use and an Educational Program to Increase Compliance after Vaginal Brachytherapy for Endometrial Cancer Funded through the National Institutes of Health, 1R21CA140766-01 Penn IRB# 809892; Emory IRB# 00052986 (9/1/09 - 8/31/13) $209,379

Principal Investigator, Assessment of Methods to Increase Latino Enrollment into Cancer Clinical Trials, Funded through the Radiation Therapy Oncology Group/Pennsylvania Commonwealth Universal Research Enhancement (C.U.R.E.) Program ME-02-149 Penn IRB# 813844 (1/1/09 - 12/31/13) $85,000 Use of Cartographic Modeling Techniques to Increase Latino and African American Enrollment into Cancer Clinical Trials Emory U IRB# 00057364 Cultural Competency Training Program on the Recruitment to Cancer Clinical Trials Enrollment Emory U IRB# 00059171

Principal Investigator, Identifying Interventions for Cancer Patients at High Risk for Poor Outcomes, Funded through the Radiation Therapy Oncology Group/Pennsylvania Commonwealth Universal Research Enhancement (C.U.R.E.) Program ME-02-149 Penn IRB# 806873 (1/1/07 - 12/31/09) $102,000

Principal Investigator, Identification of Barriers and Facilitators to Oncology Clinical Trial Recruitment, Funded through the Abramson Cancer Center Pennsylvania Commonwealth Universal Research Enhancement (C.U.R.E.) Program ME-02-149 (5/1/06 - 12/31/09) $170,000 Principal Investigator, Identification of Barriers and Facilitators to RTOG Clinical Trials Recruitment,

Bruner, DW Page 6 of 57

Funded through the Radiation Therapy Oncology Group/Pennsylvania Commonwealth Universal Research Enhancement (C.U.R.E.) Program ME-02-149 (1/1/06 - 12/31/09) $359,380

Principal Investigator, Ethnic Differences in Media Response & Recruitment R01, Funded through the National Institutes of Health, R01CA114321-01A1, FCCC IRB#06-801 Emory U IRB#00056687 (12/1/05 - 6/30/10) $958,751

Principal Investigator, Preference Shift & Spousal Utility for Cancer Treatments, Funded through the National Institutes of Health, R21CA112155-01A1, FCCC IRB#05-829 (9/1/05 - 8/31/07) $319,694 Principal Investigator, Assessment of Clinical, Genetic and Behavioral Factors in Men at Increased Risk for Prostate Cancer, Funded through Fox Chase Cancer Center/PA Department of Health Tobacco Settlement Formula Research Funds, FCCC IRB# 96-091 (1/1/05 - 6/30/06) $234,086 Principal Investigator, RTOG Outcomes Associated with Cancer Therapy in Special Populations and Ethnic Minorities at High-Risk for Poor Outcomes, Funded through the Radiation Therapy Oncology Group/Pennsylvania Commonwealth Universal Research Enhancement (C.U.R.E.) Program ME-02-149 (1/1/03 - 12/31/06) $105,018 Principal Investigator, Improving Recruitment of Special Populations and Ethnic Minorities in High- Risk Cancer Screening and Prevention Trials, Funded through the Fox Chase Cancer Center/PA Department of Health Tobacco Settlement Formula Funds, FCCC IRB#02-845 (1/03 - 12/04) $453,810 Principal Investigator, Preferences and Utilities for Prostate Cancer Screening & Treatment: Assessment of the Underlying Decision Making Process, Funded through the Department of Defense DAMD17-02-1-0055 Army New Investigator, FCCC IRB#01-026 (1/1/02 - 12/31/05) $394,740 Principal Investigator, RTOG 0215 Treatment of Erectile Dysfunction in Patients Treated on RTOG 99-

10 for Prostate Cancer: Impact on Patient and Partner QOL, Funded through the National Institutes of Nursing Research, R01 NR07971-01, FCCC IRB#01-844 (9/29/01 - 9/28/05) $824,501

Principal Investigator, Improving the Time Trade-Off for Utility Analyses of Prostate Cancer Therapies, Funded through the American Cancer Society, ACS RPG-00-208-01-CCE, FCCC IRB# 00-829 (7/00 to 6/04) $438,000 Principal Investigator, Determination of Preferences and Utilities for the Treatment of Prostate Cancer, Funded through the Oncology Nursing Foundation/ Amgen Inc, FCCC IRB#97-827 (5/98 to 5/00) $10,000 Co- Principal Investigator, RTOG Community Clinical Oncology Program Research Base (PI, Walter Curran, MD), Funded through NIH U10 CA37422 (Yrs 20-22 6/1/07-5/31/10) ~$9,000,000 Co- Principal Investigator, Fox Chase Cancer Center CCOP-Research Base Program (PI, Paul Engstrom MD), Funded through NIH U10 CA101178 (10/1/03 – 5/31/09) $3,844,666 Co- Principal Investigator, Research Recruitment, HPV, and Cervical Cancer Prevention in Asian

American Women (PI: Giang Nguyen, MD), Funded through the Abramson Cancer Center’s Strategic Planning Pilot Project and the Pennsylvania Commonwealth Universal Research Enhancement (C.U.R.E.) Program ME-02-149 (1/1/08 - 12/31/10) $200,000

Past/Present Funded Research Grants as Co-Investigator ($86,642,987) Co-Investigator, Epigenetic Mechanisms of Inflammation and Fatigue in Head and Neck Cancer.

(PI Canhua Xiao, PhD) Funded through 1R01NR015783-01, (04/01/2016 – 03/31/2019) Co-Investigator and Mentor, “The relationship between the human microbiome and patient symptom

experience in women undergoing combined modality therapy for breast cancer.” (PI, Pretesh Patel, MD) Funded through Winship Invests Pilot Project Grant (2/1/16-1/31/16) $50,000

Co-investigator and co-Mentor, “Exploring the Anal Microbiome and Anal Cancer Risk in HIV-Infected and Uninfected Women” (PI, Jessica Wells) Funded through Winship Cancer Institute, American Cancer Society Institutional Research Grant, (1/1/16 to 12/31/16) $30,000

Co-investigator, “Winship Health Literacy Core: Optimizing Cancer Research and Treatment Trials” (PI, Drenna Waldrop-Valverde) Funded through Winship Cancer Institute Cancer and the Brain Strategic Initiative., (3/1/16-2/28/19) $77, 787

Bruner, DW Page 7 of 57 Co-Investigator and Primary Mentor, “African American Caregivers’ Influence on Adherence to

Cancer Pain Treatment” (PI, Kate Yeager, PhD) Funded through Winship American Cancer Society Institutional Research Pilot Grant Program (6/1/15 to 5/31/16) $30,000

Co-Investigator, “Increasing Enrollment in Breast Cancer Clinical Trials Using Video Education” (PI, Kate Yeager, PhD) Funded through V Foundation for Cancer Research ( Grant ID #: 02015-012) (7/1/15 to 7/1/16) $65,000

Co-Investigator, MRI and Ultrasonic Imaging for Predicting and Reducing Erectile Dsyfunction from Prostate Cancer Radiotherapy (PI, Tian Liu, PhD) Funded through the Emory Department of Radiation Oncology Pilot Grant Program (10/15/14-10/14/15) $40,000

Co-Investigator, Vaginal Toxicities, Microbiome and Quality-of-Life Outcomes in GYN Cancer Radiotherapy (PI, Tian Liu, PhD) Funded through the Winship Basic/Translational Pilot Grant (2/15/14-2/15/15) $50,000

Co-Investigator, Fatigue and NF-kB Related Inflammatory Mediators in Patients with Head and Neck Cancer (PI, Canhua Xiao, PhD, RN) Funded through the Oncology Nursing Society (1/15/13 – 1/15/15) $25,000

Co-Investigator, A Community-based, Coach-assisted Exercise Program for Breast Cancer Survivors (PI, Carla Berg, PhD) Funded through the Winship Cancer Institute Glenn Family Pilot Program Emory IRB# 00056815 (3/1/12 – 2/29/13) $35,400 total

Co-Investigator, Ultrasound Imaging and Ultrasonic Tissue Characterization for Measurement of Radiation-Induced Vaginal Toxicity (PI, Tian Liu, PhD) Funded through Radiation Therapy Oncology Group (RTOG) Community Clinical Oncology Program Research Base, NIH U10 CA37422 pilot program Emory U IRB# 00038342 (3/1/12 – 2/29/13) $40,000 total

Co-Investigator, RTOG preliminary analysis of normal tissue reactions found in the high dose arm of RTOG 0126: A Phase III Randomized Study of High Dose 3D-CRT/IMRT Vs Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer (PI, Walter Curran, MD), Funded through the Radiation Oncology Institute, American Society for Radiation Oncology Penn IRB# 812758 (7/1/10 – 6/30/11) $139,170 total

Co-Investigator, Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) (PI, Ethan Basch MD), Funded through N02-PC-2010-00063

(9/30/10 – 9/15) $8,616,882 total Co-Investigator, Validating and Extending the PROMIS Sexual Function Measure for Clinical Research

(PI Kevin Weinfurt, Duke Univ) U01 AR057965-01 (9/1/09 – 9/30/13) $3,455,474 total Co-Investigator, A Novel Approach to Elucidate Mechanisms for Disparity in Cancer Pain Outcomes

(PI, Salimah Meghani, PhD), Funded through ARRA Challenge Grant 1RC1NR011591-01 (9/1/09 – 9/30/11) $845,947

Co-Investigator, Development of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) (PI, Ethan Basch MD), Funded through N02-PC-85002-29 (9/30/08 – 9/10) $1,830,006

Co-Investigator, Respondent Burden and Retention in Cancer Clinical Trials, (PI, Connie Ulrich RN, PhD), Funded through the NIH/National Institutes Nursing Research R21 NR10259-01A1 (1/15/08 – 1/14/10) $196,875

Co-Investigator, Penn Resource Center for Minority Aging Research (RCMAR) Core-C, (PI, Jerry Johnson, MD), Funded through the NIH/NIA P30-AG031043-04 (9/30/2007-6/30/2012) $392,594

Co-Investigator, Factors Associated with Retention in Radiation Therapy Oncology Trials: A 20-year review, (PI, Connie Ulrich RN, PhD), Funded through the Radiation Therapy Oncology Group/Pennsylvania Health Research Formula Funds Research Grant (1/1/07 - 12/31/08) $30,000

Co-Investigator, Nurse Practitioners’ Attitudes, Knowledge, and Practices Related to Cancer Clinical Trials, (PI, Connie Ulrich RN, PhD), Funded through the Oncology Nursing Society/Pennsylvania Health Research Formula Funds Research Grant (1/1/07 - 12/31/08) $25,000

Co-Investigator, Assessing the Value Added of Patient Reported Outcomes (PROs) in Cooperative Group Oncology Clinical Trials (PI, Jeff Sloan PhD), Funded through the Radiation Therapy

Bruner, DW Page 8 of 57

Oncology Group/Pennsylvania Commonwealth Universal Research Enhancement (C.U.R.E.) Program ME-02-149 (1/1/06 - 12/31/08)

Co-Investigator, Missing Quality of Life Assessments in Radiation Therapy Oncology Group Studies (PI, Suzanne Swann PhD), Funded through the Radiation Therapy Oncology Group/Pennsylvania Commonwealth Universal Research Enhancement (C.U.R.E.) Program ME-02-149 (1/1/06 - 12/31/07)

Co-Investigator, Mechanisms Linking Dairy to Higher, Prostate Cancer Risk (PI, Marilyn Tseng PhD), Funded through NIH R03 CA110892-01A2 (9/29/05-1/31/06) $100,000 Co-Investigator, Evaluation of a Culturally Targeted, Personalized Mail-Home Brochure Directed To Partners of At-Risk Men to Facilitate Prostate Cancer Risk Assessment (PI, Suzanne Miller PhD), Funded through the Department of Defense PC050583 FCCC (11/1/05 - 9/30/08) $374,746 Co-Investigator, Economic and Quality-Adjusted Survival Analyses of Radiation Therapy Oncology Group (RTOG) clinical trials involving patients with tobacco related cancers (PI, Konski), Funded through the Radiation Therapy Oncology Group/Pennsylvania Commonwealth Universal Research Enhancement (C.U.R.E.) Program (1/1/04 - 12/31/07) $69,355 Co-Investigator, Radiation, Hormones & Antisense Prostate Cancer Therapy (PI, Alan Pollack MD), Funded through NIH R01 CA101984 (10/1/03 - 9/30/07) $2,450,605 Co-Investigator, Radiation Therapy Oncology Group (RTOG) Core Grant, Chair of the Outcomes

Committee Overseeing the Quality of Life, Economic Impact, Epidemiology and Special Populations Subcommittees,(PI, Walter Curran MD), Funded through the NIH U10 CA21661 28 (1/1/02 - 12/31/07) $66,000,000

Co-Investigator, Promoting Cancer Screening Through Family Involvement, (PI, Michael Diefenbach PhD), Funded through NIH/NCI 5P30 CA06927-37 Supplement #4 (9/27/99-12/13/00) $84,587 Co-Investigator, Fox Chase Cancer Center (FCCC) Establishment of the Fox Chase Network Prostate Cancer Registry (PI, Mary Daly MD), Funded through the PA Department of Health Grant # 98- PADOH-ME-98155 (10/98 - 6/03) $774,030 Co-Investigator, QOL & LENT in Survivors of Head and Neck/Prostate Cancer, (PI, Charles Scott PhD), Funded through NIH/NCI R01 CA79034-01 (7/98 - 6/01) $142,529 Co-Investigator, Facilitating Participation in a Prostate Cancer Family Risk Assessment Program, (PI, Suzanne Miller PhD), Funded through the American Cancer Society PBP 89318 FCCC IRB#97-871 (7/98-12/00) $672,000 National Clinical Trials Cooperative Group (RTOG/GOG) Protocols: Principal Investigator, RTOG 0831 Phase III Trial to Evaluate the Effectiveness of a Phosphodiesterase

5 Inhibitor, Tadalafil, In Prevention of Erectile Dysfunction in Patients Treated with Radiotherapy for Prostate Cancer, Funded through the RTOG-CCOP Emory U IRB#00048915 (9/09 – 2014)

Principal Investigator, GOG 147, A Quality of Life Companion Study to GOG #122 - Whole Abdominal Radiotherapy vs. combination Doxurabicin - Cisplatin Chemotherapy in Advanced

Endometrial Carcinoma, (PI, Marcus Randall, MD), Funded through GOG/NCI (6/92 - 6/02) Principal Investigator, RTOG 9116, Quality of Life Study – Companion to 89-03 A Phase III Bladder Cancer Protocol (PI, William Shipley, MD), Funded through RTOG/NCI (3/91 to 7/94) Co-Investigator (Outcomes), RTOG 1115 Phase III Trial of Dose Escalated Radiation Therapy and

Standard Androgen Deprivation Therapy (ADT) With a GNRH Agonist vs. Dose Escalated Radiation Therapy and Enhanced ADT With a GNRH Agonist and TAK-700 for Men with High Risk Prostate Cancer (PI, M. Dror Michaelson, MD, PhD) Funded through RTOG/NCI (8/12 - present)

Co-Investigator (Outcomes/Utilities), RTOG 0924 Androgen Deprivation Therapy And High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial (PI, Mack Roach, MD) Funded through RTOG/NCI (7/11 - present)

Bruner, DW Page 9 of 57 Co-Investigator (Outcomes), RTOG 0938, A Randomized Phase II Trial of Hypofractionated

Radiotherapy for Favorable Risk Prostate Cancer, (PI, Himu Lukka, MD) Funded through RTOG/NCI (1/11 - present)

Co-Investigator (Outcomes), RTOG 0815, A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer (PI, Alvaro A. Martinez, MD) Funded through RTOG/NCI (9/09 - present)

Co-Investigator (Outcomes), RTOG 0841, Efficiency of Screening for Depression in Cancer Patients Receiving Radiotherapy (PI, Lynne Wagner, PhD) Funded through RTOG/NCI (9/09 – 9/11)

Co-Investigator (Outcomes), Pilot Project to Reduce Missing RTOG Quality of Life Data via Electronic Web-based Form Collection: a companion study for RTOG 0415 (PI, Benjamin

Movsas, MD), Funded through RTOG/VisionTree Software, Inc. (1/08 – 3/11) Co-Investigator (Outcomes), RTOG 0534, A Phase III Trial of Prostate Bed Radiotherapy (PBRT)

Only, PBRT Plus Short Term Androgen Deprivation (STAD), and Pelvic Lymph Node Radiotherapy (PLNRT) plus STAD in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy (PI, Alan Pollack MD), Funded through RTOG/NCI (1/07 - present)

Co-Investigator (Outcomes), RTOG 0415, A Phase III Randomized Study of Hypofractionated 3D- CRT/IMRT versus Conventionally Fractionated 3D-CRT/IMRT in Patients Treated For Favorable-Risk Prostate Cancer, Funded through RTOG/NCI (PI, Robert Lee MD) (1/06 – present) Co-Investigator (Outcomes), RTOG 0232, A Phase III Study Comparing Combined External Beam

Radiation And Transperineal Interstitial Permanent Brachytherapy with Brachytherapy Alone for Selected Patients with Intermediate Risk Prostatic Carcinoma, Funded through RTOG/NCI (PI, William Prestidge MD) (3/03 - present)

Co-Investigator (Outcomes), RTOG 0126, A Phase III Randomized Study of High Dose 3D-CRT Vs Standard Dose 3D-CRT in Patients Treated for Localized Prostate Cancer, Funded through RTOG/CCOP/NCI (PI, Jeff Michalski MD) (1/02 - 2011) Co-Investigator (Utilities), RTOG 9714, Randomized Trial of Palliative Radiation Therapy for Osseous Metastases: A Study of Palliation of Symptoms, Quality of Life, and Cost-effectiveness, Funded through RTOG/CCOP/NCI (PI, William Hartsell MD) (11/97 - 1/03) Co-Investigator (QOL), RTOG 9408, A Phase III Trial of the Study of Endocrine Therapy Used as a Cytoreductive and Cytostatic Agent Prior to Radiation Therapy in Good Prognosis Locally Confined Adenocarcinoma of the Prostate, Funded through RTOG/NCI (PI, McGowan) (6/94 – 2011) Co-Investigator, RTOG 9020, A Phase II Trial of External Beam Radiation with Etanidazole (SR 2508) for the Treatment of Locally Advanced Prostate Cancer, Funded through RTOG/NCI (PI, Norman Coleman MD) (5/91 - 7/94) Emory University Clinical Protocols (supported through Winship Cancer Institute): Co-Investigator Emory U IRB# 00033272 Extracorporeal Detection of Circulating Cancer cells in Head

and Neck Cancer Patients Using Pegylated Surface-Enhanced Raman scattering (SERs) Gold Nanoparticles and Laser Excitation (PI, Jonathan Beitler) (4/12-present)

Co-Investigator Emory U IRB# 00038342 Quantitative Ultrasound Evaluation of Vaginal Fibrosis after Radiation Treatment of Gynecologic Malignancies (PI, Peter Rossi) (4/12-present)

FCCC Clinical Protocols (supported through Fox Chase Cancer Center): Principal Investigator, FCCC IRB# 96-091, Prostate Risk Assessment Program (2/01 - 1/06) Co-Investigator (Outcomes), FCCC IRB# 03-605, Phase II Trial Comparing Intensity Modulated

Radiotherapy Using Hypofractionation Vs 3-Dimensional Conformal Radiotherapy Plus A High-Dose Rate Brachytherapy Boost for Treatment of Endometrial Cancer (PI, Penny Andersen MD) (7/03 – 1/06)

Co-Investigator (Outcomes), FCCC IRB# 02-602, A Phase III Intensity Modulated Radiotherapy Dose

Bruner, DW Page 10 of 57 Escalation Trial for Prostate Cancer Using Hypofractionation (PI, Alan Pollack MD) (1/02 –1/06) Co-Investigator (Outcomes), FCCC IRB# 03-606, Phase I Study of Preoperative Intensity Modulated Radiation Therapy (IMRT) with Incorporated Boost and Oral Capecitabine in Locally Advanced Rectal Cancer (PI, Gary Freedman MD) (9/03 - 1/06) Co-Investigator (Outcomes), FCCC IRB# 03-026, Phase II Study of Hypofractionated Intensity

Modulated Radiation Therapy (IMRT) with Incorporated Boost in Early Stage Breast Cancer (PI, Gary Freedman MD) (9/03 - 1/06)

Co-Investigator, FCCC IRB# 95-068 A Phase II Trial of Oral Sucralfate versus Placebo for the Prophylaxis of Acute and Chronic Bowel Dysfunction after Pelvic Irradiation (PI, Benjamin Movsas MD), (6/95 - 6/00)

Co-Investigator, FCCC IRB# 93-024 Phase II and Pharmacokinetic Study of Taxol and Carboplatin on Previously Untreated Patients with Stage IIIB & IV Non-Small Cell Lung Cancer (PI, Corey Langer MD), (6/93 - 6/95)

Past/Present Funded Program Grants (Educational or Practice) Principal Investigator, Educational Grant 2009-10, Integrated, Multi-disciplinary Translational Research

Across a Disease Spectrum Using the NCI TRWG Pathways Model Funded by the School of Medicine, University of Pennsylvania, $5,000

Principal Investigator, Educational Grant 2007, Connecting the Dots: Diversity and Outreach Efforts Across Campus Funded jointly by the Schools of Nursing and Medicine, University of Pennsylvania, $8,000

Journals Articles (154) (*refereed publications, +data based publications, #invited publications, ^Dr. Bruner’s mentee) *+Hanlon A, Small Jr, W, Strauss J, Lin LL, Hanisch L, Huang L, Bai J, ^ Wells J,^ Bruner DW.

Dilator Use following Vaginal Brachytherapy for Endometrial Cancer: A Randomized Feasibility and Adherence Study. Cancer Nursing 2017 Apr 21. [Epub ahead of print] PMID:28437283

*+Basch E, Pugh S, Dueck A, Mitchell S, Berk L, Fogh S, Rogak L, Gatewood M, Reeve B, Mendoza T, O’Mara A, Denicoff A, Minasian L, Bennett A, Setser A, Schrag D, Roof K, Moore J, Gergel T, Stephans K, Rimner A, DeNittis A, Bruner DW. Feasibility of Patient Reporting of Symptomatic Adverse Events via the PRO-CTCAE in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial. International Journal of Radiation Oncology, Biology, Physics (In Press)

*+ Fogh S, Deshmukh S, Berk L, Dueck AC, Roof K, Yacoub S, Gergel T, Stephans K, Rimner A, DeNittis A, Pablo J, Rineer J, Williams TM, Bruner D. A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012. International Journal of Radiation Oncology, Biology, Physics 2017 Mar 15;97(4):786-796. Epub 2016 Nov 23. PMID: 28244415

*+ Xiao C^, Zhang Q, Nguyen-Tân PF, List M, Weber RS, Ang K, Rosenthal D, Filion EJ, Kim H, Silverman C, Raben A, Galloway T, Fortin A, Gore E, Winquist E, Jones CU, Robinson W, Raben D, Le QT, Bruner D. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129. International Journal of Radiation Oncology, Biology, Physics. 2017 Mar 15;97(4):667-677. Epub 2016 Jul 25. PMID:27727063

*+Kachnic L, Bruner DW, Qureshi M, Russo G. Perceptions and practices regarding women’s vaginal health following radiation therapy: a survey of radiation oncologists practicing in the United States, Practical Radiation Oncology 2017 pii: S1879-8500(17)30046-2. [Epub ahead of print] PMID: 28377136 (#150)

*+Pugh SL, Wyatt G, Wong RK, Sagar SM, Yueh B, Singh AK, Yao M, Nguyen-Tan PF, Yom SS, Cardinale FS, Sultanem K, Hodson DI, Krempl GA, Chavez A, Yeh AM, Bruner DW. Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life

Bruner, DW Page 11 of 57

Questionnaire-RTOG Modification. J Pain Symptom Manage. 2017 Jan;53(1):139-145.e2. PMID:27899312

*+Wagner, L., Pugh, S., Small B., Kirshner, J.J., Sidhu, K., Bury, M., DeNittis, A., Alpert, T., Tran, B., Bloom, B., Mai, J., Yeh, A., Sarma, K., Becker, M., James, J., Bruner, D.W. Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools on NRG Oncology RTOG Trial 0841. Cancer, 2016 123(3):485-493. Nov 10. [Epub ahead of print] PMID:27861753

*+Flynn KE, Lin L, Bruner DW, Cyranowski JM, Hahn EA, Jeffery DD, Reese JB, Reeve BB, Shelby RA, Weinfurt KP. Sexual Satisfaction and the Importance of Sexual Health to Quality of Life Throughout the Life Course of U.S. Adults. J Sex Med. 2016 Nov;13(11):1642-1650. PMID:27671968

*+Truong MT, Zhang Q, Rosenthal DI, List M, Axelrod R, Sherman E, Weber R, Nguyen-Tân PF, El- Naggar A, Konski A, Galvin J, Schwartz D, Trotti A, Silverman C, Singh A, Godette K, Bonner JA, Jones CU, Garden AS, Shenouda G, Matthiesen C, Le QT, Bruner D. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522.Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):687-699. Epub 2016 Aug 12.PMID:27727066

*+Wells JS^, Pugh S, Boparai K, Rearden J, Yeager KA^, Bruner DW. Cultural Competency Training to Increase Minority Enrollment into Radiation Therapy Clinical Trials-an NRG Oncology RTOG Study. J Cancer Educ. 2016 May 21. [Epub ahead of print]PMID: 27209044 (#145)

*+Bruner, DW, Dunbar, S, Higgins, M, Martyn, K. Benchmarking and gap analysis of faculty mentorship priorities and how well they are met. Nursing Outlook 2016 Mar 9. pii: S0029-6554(16)30003-3. [Epub ahead of print] PMID: 27105829

*+Lee WR, Dignam JJ, Amin MB, Bruner DW, Low D, Swanson GP, Shah AB, D'Souza DP, Michalski JM, Dayes IS, Seaward SA, Hall WA, Nguyen PL, Pisansky TM, Faria SL, Chen Y, Koontz BF, Paulus R, Sandler HM. A Randomized Phase III Non-Inferiority Study Comparing Two Radiation Therapy Fractionation Schedules in Patients with Low-Risk Prostate Cancer. Journal of Clinical Oncology: 2016. 34(20):2325-32; Apr 4. [Epub ahead of print] PMID:27044935

*+Xiao C,^ Beitler JJ, Higgins KA, Conneely K, Dwivedi B, Felger J, Wommack EC, Shin DM, Saba NF, Ong LY, Kowalski J, Bruner DW, Miller AH. Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy. Brain Behav Immun. 2015. pii: S0889-1591(15)30042-8. [Epub ahead of print] PMID: 26515035

*+Weinfurt KP, Lin L, Bruner DW, Cyranowski JM, Dombeck CB, Hahn EA, Jeffery DD, Luecht RM, Magasi S, Porter LS, Reese JB, Reeve BB, Shelby RA, Smith AW, Willse JT, Flynn KE. Development and Initial Validation of the PROMIS(®) Sexual Function and Satisfaction Measures Version 2.0. J Sex Med. 2015 Sep;12(9):1961-74. Epub 2015 Sep 7. PMID: 26346418

*+Mao JJ,^ Bowman MA Xie SX, Bruner DW, DeMichele A, Farrar J. Electro-Acupuncture vs. Gabapentin for Hot Flashes among Breast Cancer Survivors: A Randomized Placebo-Controlled Trial. Journal of Clinical Oncology 2015 Aug 24. [Epub ahead of print] PMID:26304905 (#140)

*+Dueck, AC, Mendoza T, Mitchell SA, Reeve B, Castro K, Rogak L, Atkinson T, Bennett A, Denicoff A, O'Mara A, Li Y, Clauser S, Bryant D, Bearden J, Gillis T, Harness J, Siegel R, Paul DB, Cleeland C, Schrag D, Sloan J, Abernethy A, Bruner DW, Minasian L, Basch E, on behalf of the National Cancer Institute PRO-CTCAE Study Group. Validity and Reliability of the U.S. National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncology 2015 Aug 13 [Epub ahead of print] PMID:26270597

*+ Bruner, DW, Pugh, S, Yeager, K,^ Bruner, J, Curran,W. Cartographic Mapping and Travel Burden to Assess and Develop Strategies to Improve Minority Access to National Cancer Clinical Trials. International Journal of Radiation Oncology, Biology, Physics 2015 Jul 10. [Epub ahead of print] PMID: 26281827

Bruner, DW Page 12 of 57 *+Meghani SH,^ Thompson AM, Chittams J, Bruner DW, Riegel B. Adherence to analgesics for cancer

pain: A comparative study of African Americans and Whites using an electronic monitoring device. J Pain. 2015 Jun 12. [Epub ahead of print] PMID: 26080042

*+Atherton PJ, Watkins-Bruner D, Gotay C, Moinpour C, Satele D, Winter K, Schaefer P, Movsas B, Sloan J. The Complementary Nature of Patient-Reported Outcomes (PROs) and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591). J Pain Symptom Manage. 2015: S0885-3924(15)00238-9. [Epub ahead of print]

*+Bruner DW, Hunt D, Michalski J, Bosch W, Galvin J, Amin M, Xiao C,^ Bahary JP, Patel M, Chafe S, Rodrigues G, Lau H, Duclo M, Baikadi M, Deshmukh S, Sandler H. Preliminary Patient Reported Outcomes Analysis of 3DCRT versus IMRT on the High Dose Arm of the Radiation Therapy Oncology Group (RTOG) 0126 Prostate Cancer Trial. Cancer 2015;121(14):2422-30. Apr 2. [Epub ahead of print] PMID:25847819 (#135)

*+Mao JJ,^ DeMichele A, Xie SX, Farrar J, Stricker C, Bowman,M, Bruner DW. A Randomized Trial of Electro-acupuncture for Arthralgia related to Aromatase Inhibitor Use. European Journal of Cancer 2014 Jan;50(2):267-76. Epub 2013 Oct 24. PMID:24210070

*+Bauml J, Xie SX, Farrar JT, Bowman MA, Li SQ, Bruner D, DeMichele A, Mao JJ^. Expectancy in real and sham electroacupuncture: does believing make it so? J Natl Cancer Inst Monogr. 2014 Nov;2014(50):302-7. PMID:25749596

*+Mao JJ^, Farrar J, Bruner DW, Zee J, Bowman M, Seluzicki C, DeMichele A, Xie SX. Electro-acupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: A randomized trial.” Cancer Jul 30. [Epub ahead of print] 2014 Dec 1;120(23):3744-51. PMID: 25077452

*+Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O'Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, Rogak L, Barz A, Paul DB, Schrag D. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014;106(9). PMID:25265940

*# Badger TA, Heitkemper M, Lee KA, Bruner DW. An experience with the Patient-Reported Outcomes Measurement Information System: Pros and cons and unanswered questions. Nurs Outlook. 2014 Sep-Oct;62(5):332-8. Epub 2014 Jul 10. PMID: 25218082 (#130)

*+Wilmoth, M, Hanlon, A., Ng, L, Bruner, DW. Factor Analysis of the Modified Sexual Adjustment Questonnaire-Male J Nurs Meas. 2014;22(2):241-54. PMID: 25255676

#Pisansky TM, Bruner DW, Greenberg RE. Tadalafil for erectile dysfunction prevention after radiotherapy for prostate cancer--reply. JAMA. 2014 Aug 20;312(7):748-9.

#Siddiqui, F, Liu, AK, Watkins-Bruner, D, Movsas, B. Patient Reported Outcomes (PROs) and Survivorship in Radiation Oncology: Overcoming the “Cons.” Journal of Clinical Oncology. 2014. Sep 10;32(26):2920-2927. Epub 2014 Aug 11.PMID:25113760

*+Yang X, Tridandapani S, Beitler JJ, Yu DS, Chen Z, Kim S, Bruner DW, Curran WJ, Liu T. Diagnostic Accuracy of Ultrasonic Histogram Features to Evaluate Radiation Toxicity of the Parotid Glands: A Clinical Study of Xerostomia Following Head-and-Neck Cancer Radiotherapy. Acad Radiol. 2014 pii: S1076-6332(14)00222-0 [Epub ahead of print] PMID:25088832

*Reeve B, Mitchell S, Dueck A, Basch E, Cella D, Reilly C^, Minasian L, Denicoff A, O'Mara A, Fisch M, Chauhan C, Aaronson N, Coens C, and Bruner DW. Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials. Journal of the National Cancer Institute 2014;106(7). PMID:25006191(#125)

* Chen R, Chang P, Vetter R, Lukka H, Stokes W, Sanda M, Watkins-Bruner D, Reeve B, Sandler H. Recommended Patient-Reported Core Set of Symptoms to Measure in Prostate Cancer Treatment Trials. Journal of the National Cancer Institute 2014;106(7). PMID:25006192

*Donovan K, Donovan H, Cella D, Gaines M, Penson R, Plaxe S, von Gruenigen V, Watkins-Bruner DW, Reeve B, Wenzel L. Recommended Patient-Reported Core Set of Symptoms to Measure in Ovarian Cancer Treatment Trials. Journal of the National Cancer Institute 2014;106(7). PMID:25006190

Bruner, DW Page 13 of 57 * Chera B, Eisbruch A, Murphy B, Ridge J, Gavin P, Reeve B, Watkins-Bruner D, Movsas B.

Recommended Patient-reported Core Set of Symptoms to Measure in Head and Neck Cancer Treatment Trials. Journal of the National Cancer Institute 2014;106(7). PMID:25006189

*+ Wells, J.^, Holstad, M., Thomas, T., Bruner, D.W. An Integrative Review of Guidelines for Anal Cancer Screening in HIV-Infected Persons" AIDS Patient Care and STDs 2014;28(7):350-7. Epub 2014 Jun 17. PMID: 24936878

*+Movsas B, Hunt D, Watkins-Bruner D, Lee WR, Tharpe H, Goldstein D, Moore J, Dayes IS, Parise S, Sandler H. Can electronic web-based technology improve quality of life data collection? Analysis of Radiation Therapy Oncology Group 0828. Pract Radiat Oncol. 2014;4(3):187-91. Epub 2013 Sep 16.PMID: 24766686 (#120)

*+ Pisansky, T., Pugh, S., Greenberg, R., Pervez, N., Reed, D., Rosenthal, S., Mowat, R., Raben, A., Buyyounouski, M., Kachnic, L. Bruner, D.W. Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer – the Radiation Therapy Oncology Group [0831] randomized clinical trial. Journal of the American Medical Association (JAMA). 2014;311(13):1300-7. PMID:24691606

#Bruner DW, O'Mara A. Nurse scientists in cancer cooperative groups. Semin Oncol Nurs. 2014 Feb;30(1):4-10. Epub 2013 Dec 18. PMID:24559774

*+Hoffman KE, Pugh SL, James JL, Scarantino C, Movsas B, Valicenti RK, Fortin A, Pollock J, Kim H, Brachman DG, Berk LB, Bruner DW, Kachnic LA. The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial. Qual Life Res. 2014 Feb 4. [Epub ahead of print] PMID:24492945

*+ Yang X, Tridandapani S, Beitler JJ, Yu DS, Wu N, Wang Y, Bruner DW, Curran WJ, Liu T. Ultrasonic Nakagami-parameter characterization of parotid-gland injury following head-and-neck radiotherapy: A feasibility study of late toxicity. Med Phys. 2014 Feb;41(2):022903. PMID:24506650

*+ Mao JJ^, Tan T, Li SQ, Meghani SH, Glanz K, Bruner DW. Attitudes and Barriers towards Participation in an Acupuncture Trial among Breast Cancer Patients: A Survey Study. BMC Complementary and Alternative Medicine 2014, 14:7 (#115)

*+ Xiao C^, Bruner DW, Jennings BM, Hanlon AL. Methods for examining cancer symptom clusters over time. Res Nurs Health. 2014 Feb;37(1):65-74. PMID:24414939

*+ Xiao C^, Hanlon A, Zhang Q, Movsas B, Ang K, Rosenthal D, Nguyen-Tan PF, Kim H, Le Q, Bruner DW. Risk Factors for Clinician-Reported Symptom Clusters in Patients with Advanced Head and Neck Cancer in a Phase III Randomized Clinical Trial: RTOG 0129. Cancer. 2013 [Epub ahead of print] PMID:24338990

*+ Michalski JM, Yan Y, Watkins-Bruner D, Bosch WR, Winter K, Galvin JM, Bahary JP, Morton GC, Parliament MB, Sandler HM. Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the radiation therapy oncology group 0126 prostate cancer trial. Int J Radiat Oncol Biol Phys. 2013;87(5):932-8. Epub 2013 Oct 8. PMID:24113055

*+ Brown PD, Pugh S, Laack NN, Wefel JS, Khuntia D, Meyers C, Choucair A, Fox S, Suh JH, Roberge D, Kavadi V, Bentzen SM, Mehta MP, Watkins-Bruner D; Radiation Therapy Oncology Group (RTOG). Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol. 2013 Oct;15(10):1429-37. Epub 2013 Aug 16. PMID:23956241

*+Wang Y, Liu T, Rossi PJ, Watkins-Bruner D, Hsiao W, Cooper S, Yang X, Jani AB. Influence of Vascular Comorbidities and Race on Erectile Dysfunction after Prostate Cancer Radiotherapy. J Sex Med. 2013. 10(8):2108-14. Jun 6. [Epub ahead of print] PMID: 23742221(#110)

*+Gondi V, Paulus R, Bruner DW, Meyers CA, Gore EM, Wolfson A, Werner-Wasik M, Sun AY, Choy H, Movsas B. Decline in Tested and Self-Reported Cognitive Functioning After Prophylactic Cranial Irradiation for Lung Cancer: Pooled Secondary Analysis of Radiation Therapy Oncology Group Randomized Trials 0212 and 0214. Int J Radiat Oncol Biol Phys. 2013. 86(4):656-64. Apr 15. [Epub ahead of print] PMID: 23597420

Bruner, DW Page 14 of 57 *+Flynn KE, Lin L, Cyranowski JM, Reeve BB, Reese JB, Jeffery DD, Smith AW, Porter LS, Dombeck

CB, Bruner DW, Keefe FJ, Weinfurt KP. Development of the NIH PROMIS ® Sexual Function and Satisfaction measures in patients with cancer. J Sex Med. 2013;10 Suppl 1:43-52. PMID: 23387911

*+Flynn KE, Reeve BB, Lin L, Cyranowski JM, Bruner DW, Weinfurt KP. Construct validity of the PROMIS® sexual function and satisfaction measures in patients with cancer. Health Qual Life Outcomes. 2013; 11:40. PMID: 23497200

*+Yang X, Rossi P, Bruner DW, Tridandapani S, Shelton J, Liu T. Noninvasive evaluation of vaginal fibrosis following radiotherapy for gynecologic malignancies: A feasibility study with ultrasound B-mode and Nakagami parameter imaging. Med Phys. 2013;40(2):022901. PMID: 23387772

*+Reilly CM^, Bruner DW, Mitchell SA, Minasian LM, Basch E, Dueck AC, Cella D, Reeve BB. (2013). A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Support Care Cancer. 2013;21(6):1525-50. Epub 2013 Jan 12. Review. PMID: 23314601 (#105)

*+Xiao C^, Hanlon A, Zhang Q, Ang K, Rosenthal DI, Nguyen-Tan PF, Kim H, Movsas B, Bruner DW. (2013). Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy. Oral Oncol. 2012 Nov 2. S1368-8375(12)00323-5. [Epub ahead of print]PMID:23168337

*+Bauml, J., Penn, C., Xie,S., Desai, K., Dong, K., Watkins-Bruner D, Vapiwala, N., Mao, J^. (2012). A Pragmatic Evaluation of the National Cancer Institute Physician Data Query (PDQ)®-Based Brief Counseling on Cancer-Related Fatigue among Patients Undergoing Radiation Therapy. J Palliative Care Med 2:125.

# Currow, D., Bruner, D.W., Abernethy, A. (2012).Editorial: death to the fiefdoms. Current Opinions in Supportive Palliative Care. 6(4):457-8. PMID: 23123819

*+Meghani, S.^, Bruner, D.W. (2011) A Pilot Study to Identify Correlates of Intentional Versus Unintentional Nonadherence to Analgesic Treatment for Cancer Pain. Pain Management Nursing. 2013 Jun; 14(2):e22-30. Epub 2011 May 6. PMID: 23688368

*+Xiao C^, Polomano R, Bruner DW. (2012) Comparison between Patient-Reported and Clinician-Observed Symptoms in Oncology. Cancer Nurs. Oct 5. [Epub ahead of print] PMID: 23047799 (#100)

*+Keller LM, Buyyounouski MK, Sopka D, Ruth K, Klayton T, Pollack A, Watkins-Bruner D, Greenberg R, Price R, Horwitz EM. (2012). Stamp Test Delivers Message on Erectile Dysfunction After High-dose Intensity-modulated Radiotherapy for Prostate Cancer. Urology. 80(2):337-42. [Epub ahead of print] PMID: 22749428

*+Liu T, Yang X, Bruner DW, Tridandapani S, Chen H, Henry S, Rossi P. (2012) WE-C-BRA-10: Ultrasound Nakagami Imaging for Noninvasive Evaluation of Vaginal Fibrosis Following Radiotherapy for Gynecologic Malignancies. Med Phys.;39(6):3948-9 PMID: 22757200

*+Freedman, G, Anderson, P., Bleicher, R., Litwin, S., Li, T., Swaby, R., Ma, C., Li, J., Sigurdson, E., Watkins-Bruner, D., Morrow, M., Goldstein, L. (2012). Five-year Local Control on a Phase II Study of Hypofractionated Intensity Modulated Radiation Therapy with an Incorporated Boost for Early Stage Breast Cancer. International Journal of Radiation Oncology, Biology, Physics 2012 May 12. [Epub ahead of print] PMID: 22580118

*+Bekelman JE, Deye JA, Vikram B, Bentzen SM, Bruner DW, Curran WJ Jr, Dignam J, Efstathiou JA, Fitzgerald TJ, Hurkmans C, Ibbott GS, Lee JJ, Merchant TE, Michalski J, Palta JR, Simon R, Ten Haken RK, Timmerman R, Tunis S, Coleman CN, Purdy J.(2012). Redesigning Radiotherapy Quality Assurance: Opportunities to Develop an Efficient, Evidence-Based System to Support Clinical Trials-Report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance. International Journal of Radiation Oncology, Biology, Physics 83(3):782-90. [Epub ahead of print] PMID:22425219(#95)

*+Shah A, Efstathiou JA, Paly JJ, Halpern SD, Bruner DW, Christodouleas JP, Coen JJ, Deville C Jr, Vapiwala N, Shipley WU, Zietman AL, Hahn SM, Bekelman JE. (2012). Prospective Preference Assessment of Patients' Willingness to Participate in a Randomized Controlled Trial of Intensity-Modulated Radiotherapy Versus Proton Therapy for Localized Prostate Cancer. International

Bruner, DW Page 15 of 57

Journal of Radiation Oncology, Biology, Physics . 83(1):e13-9. [Epub ahead of print] PMID:22381899

*+Hanisch, L.^, Bryan, C.^, James, J., Pisansky, T., Corbett M, T., Parliament, M., Stewart,C., Hartford, A., Sandler H.,Berk, L., Kachnic, L., Bruner, D.W. (2012) Impact of sildenafil on marital and sexual adjustment in patients and their spouses after radiotherapy and short-term androgen suppression for prostate cancer: Analysis of RTOG 0215. Supportive Care in Cancer Feb 22. [Epub ahead of print] PMID:22354624

*+ Bruner, D.W., Hanisch, L.^, Trotti, A., Reeve, B., Schrag, D, Sit, L., Minasian, L, O'Mara, A., Denicoff, A., Rowland, J., Montello, M., Geoghegan, C., Abernethy, A., Clauser, S., Castro, K., Mitchell, S., Burke, L., Trentacosti, A.M,. Mendoza, T.,Basch, E. Stakeholder Perspectives on Implementing the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), (2011) Translational Behavioral Medicine: Practice, Policy and Research. 1(1):110-122.

*+Ulrich CM^, Zhou Q, Ratcliffe SJ, Ye L, Grady C, Watkins-Bruner D. (2012). Nurse Practitioners' attitudes about cancer clinical trials and willingness to recommend research participation. Contemp Clin Trials. 33(1):76-84. [Epub 2011 Sep 29] PMID: 21983623

*+Chow, E., James, J., Hartsell, W., Scarantino, C., Ivker, R., Roach, M., Suh, J.H. Demas, W., Konski, A., Bruner, D.W. (2011) Validation of a Predictive Model for Survival in Patients With Advanced Cancer: Secondary Analysis of RTOG 9714. World Journal of Oncology. 2(4):181-190.

*+Nguyen J, Cramarossa G, Bruner D, Chen E, Khan L, Leung A, Lutz S, Chow E.(2011), A literature review of symptom clusters in patients with breast cancer. Expert Reviews in Pharmacoeconomic Outcomes Research; 11(5):533-9. PMID: 21958098 (#90)

*+Basch EM, Reeve BB, Mitchell SA, Clauser SB, Minasian L, Sit L, Chilukuri R, Baumgartner P, Rogak L, Blauel E, Abernethy AP, Bruner, D.W. (2011). Electronic Toxicity Monitoring and Patient-Reported Outcomes. Cancer Journal; 17(4):231-4. PMID: 21799330

*+Jones, C., Hunt, D., McGowan, D., Amin, M., Chetner, M., Bruner,. D.W., Leibenhaut, M., Husain, S., Rotman, M., Souhami, L., Sandler, H., Shipley, W. (2011). Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer. New England Journal of Medicine 365(2):107-18. PMID: 21751904

*+ Du, K., Bae, K., Movsas, B., Yan, Y., Bryan, C.^, Bruner, D.W. (2011). Impact of Marital Status and Race on Outcomes of Patients Enrolled in Radiation Therapy Oncology Group Prostate Cancer Trials. Supportive Care in Cancer Jul 1. [Epub ahead of print] PMID: 21720747

*+ Bae, K., Bruner, D.W., Baek, S., Movsas, B., Corn, B, .Dignam, J. (2011). Patterns of missing mini mental status exam (MMSE) in radiation therapy oncology group (RTOG) brain cancer trials. Journal Neurooncology. May 21. [Epub ahead of print] PMID: 21603964

*+ Dilling, T., Bae, K., Paulus, R., Watkins-Bruner, D., Ang, K., Forastiere, A., Garden, A., Movsas, B. (2011). The Impact of Gender, Partner Status, and Race on Locoregional Failure and Overall Survival in Head and Neck Cancer Patients in Three Radiation Therapy Oncology Group (RTOG) Trials. International Journal of Radiation Oncology, Biology, Physics May 5. [Epub ahead of print] PMID: 21549515 (#85)

*+ Giarelli, E., Bruner, D.W., Nguyen, E., Basham, B., Marathe, P., Dao, D., Huynh, T.N., Cappella, J., Nguyen, G.^ (2011). Research Participation among Asian American Women at Risk for Cervical Cancer: Exploratory Pilot of Barriers and Enhancers. Journal of Immigrant and Minority Health Apr 22. [Epub ahead of print] PMID: 21512747

*+ Bahng, A., Dagan, A., Bruner, D.W., Lin, L.L. (2011). Determination of Prognostic Factors for Vaginal Mucosal Toxicity Associated with Intravaginal High-Dose Rate Brachytherapy in patients with Endometrial Cancer. International Journal of Radiation Oncology, Biology, Physics 82(2):667-73. Feb 5. [Epub ahead of print] PMID: 21300451

*+ Lutz, S., Berk, L., Chang, E., Chow, E., Hahn, C., Hoskin, P., Howell, D., Konski ,A., Kachnic, L., Lo, S., Sahgal, A., Silverman, L., von Gunten, C., Mendel, E., Vassil, A., Watkins Bruner, D., Hartsell, W. (2011). Palliative Radiotherapy for Bone Metastases: An ASTRO Evidence-

Bruner, DW Page 16 of 57

Based Guideline. International Journal of Radiation Oncology, Biology, Physics 79(4):965-76 PMID: 21277118

*+ Watkins Bruner, D, James, J, Bryan, C^, Pisansky, T, Rotman, M, Corbett, T, Speight, J, Byhardt, R, Sandler, H, Bentzen, S, Kachnic, L, Berk, L. (2011). Randomized, Double-Blinded, Placebo-Controlled Crossover Trial of Treating Erectile Dysfunction with Sildenafil after Radiotherapy and Short-Term Androgen Deprivation Therapy: Results of RTOG 0215, Journal of Sexual Medicine 8(4):1228-1238. PMID: 21235716

*+ Siddiqui, F., Bae, K., Langer, C., Coyne, J., Gamerman,V., Komaki, R., Choy, H., Curran, W., Watkins-Bruner, D., Movsas, B. (2010). The Influence of Gender, Race, and Marital Status on Survival in Lung Cancer Patients: Analysis of Radiation Therapy Oncology Group Trials, Journal of Thoracic Oncology, 5(5):631-9. PMID: 20432520 (#80)

*+Konski, A., Bhargavan, M., Owen, J., Paulus, R., Cooper, J., Forastiere, A., Ang, K., Bruner, D.W. (2010). Feasibility of economic analysis of Radiation Therapy Oncology Group (RTOG) 91-11 using Medicare Data. International Journal of Radiation Oncology, Biology, Physics 79(2):436-42.PMID: 20472371

*+Ulrich, C.^, James, J., Walker, E., Stine, S.H., Gore, E., Prestidge, B., Michalski, J., Gwede, C., Chamberlain, R., Bruner, D.W. (2010). RTOG physician and research associate attitudes, beliefs and practices regarding clinical trials: Implications for improving patient recruitment. Contemp Clin Trials. 31(3):221-8. PMID: 20215046

*+Chow E, James J, Barsevick A, Hartsell W, Ratcliffe S, Scarantino C, Ivker R, Suh J, Petersen I, Konski A, Demas W, Bruner D. (2010). Confirmatory factor analysis of brief pain inventory (BPI) functional interference clusters in patients with bone metastases. Journal Pain Management,3(3):247-253. PMID:21686033

*+Meghani, S.H.^, Lee, C.S., Hanlon, A.L., Bruner, D.W. (2009). Latent class cluster analysis to understand heterogeneity in prostate cancer treatment utilities. BMC Med Inform Decis Mak.;9(1):47. PMID: 19941668

*+Movsas, B., Moughan, J., Sarna, L., Langer, C., Werner-Wasik, M., Nicolaou, N., Komaki, R., Machtay, M., Wasserman, T., Bruner, D.W. (2009). Quality of Life Supercedes the Classic Prognosticators for Long Term Survival in Locally Advanced Non-Small Cell Lung Cancer (NSCLC): An Analysis of Radiation Therapy Oncology Group (RTOG) 9801. Journal of Clinical Oncology 27(34):5816-22. PMID: 19858383 (#75)

*+Giri, V.N., Coups, E.J., Ruth, K., Goplerud, J., Raysor, S., Kim, T.Y., Bagden, L., Mastalski, K., Zakrzewski, D.., Leimkuhler, S., Watkins-Bruner, D. (2009). Prostate Cancer Early Detection Program Recruitment Methods and Show Rates in Men at High Risk. The Journal of Urology, 182(5):2212-7. PMID: 19758657

*+Chow, E., James, J., Barsevick, A., Hartsell, A., Ratcliffe, S., Scarantino, C., Ivker, R., Roach, M., Suh, J., Petersen, I., Konski, A., Demas, W., Bruner, D. (2010; Epub 2009). Functional Interference Clusters in Cancer Patients with Bone Metastases: A Secondary Analysis of RTOG 9714. International Journal of Radiation Oncology, Biology, Physics, 76(5):1507-11. PMID: 19632065

*+Mao, J.J.^, Bruner, D., Stricker, C.T., Farrar, J.T., Xie, S.X., Bowman, M.A., Pucci, D., Han, X., DeMichele, A. (2009). Feasibility Trial of Electro-Acupuncture for Aromatase Inhibitor Related Arthralgia in Breast Cancer Survivors. Integrative Cancer Therapies, 8(2):123-9. PMID: 19679620

*+Mao, J.J.^, Stricker, C.T., Bruner, D., Xie, S.X., Bowman, M.A., Farrar, J.T., Greene, B.T., DeMichele, A. (2009). Patterns and Risk Factors Associated with Aromatase Inhibitor Related Arthralgia among Breast Cancer Survivors, Cancer, 115(16):3631-9 PMID: 19517460

*+Konski, A., James, J., Hartsell, W., Leibenhaut, M.H., Janjan, N., Curran, W., Roach, M., Watkins-Bruner, D. (2009). Economic Analysis of Radiation Therapy Oncology Group 97-14: Multiple Versus Single Fraction Radiation Treatment of Patients With Bone Metastases. Am J Clin Oncol. 32(4):423-8. PMID:19546803

*+Tseng, M., Giri, V., Watkins-Bruner, D., Giovannucci E. (2009). Dairy intake and 1,25-dihydroxyvitamin D levels in men at high risk for prostate cancer. Cancer Causes Control. 20:1947–1954. PMID: 19578936

Bruner, DW Page 17 of 57 *+Tseng, M., Giri, V., Bruner, D.W., Giovannucci E. (2009). Prevalence and correlates of vitamin D

status in African American men. BMC Public Health. 18;9(1):191. PMID: 19534831 *+Konski, A., Bhargavan, M., Owen, J., Paulus, R., Cooper, J., Fu, K., Ang, K., Bruner, D.W. (2008).

Feasibility of Using Administrative Claims Data for Cost-Effectiveness Analysis of a Clinical Trial. Journal of Medical Economics, 11: 611–623, PMID: 19450071.

*+Coyne J.C., Pajak T.F., Watkins Bruner, D. (2008). Reply to Emotional Well-Being Does Not Predict Survival in Head and Neck Cancer Patients: A Radiation Therapy Oncology Group Study. Cancer. 112(10):2327-2328.

*+Siddiqui, F., Kohl, R., Swann, S., Watkins-Bruner, D., Movsas, B. (2008). Gender Differences in Pretreatment Quality of Life in a Prospective Lung Cancer Trial. Journal of Supportive Oncology 6(1):33-39, PMID: 18257399 (#65)

*+Bryan, C.^, Wetmore-Arkader, L., Calvano, T., Deatrick, J., Giri, V.^, Bruner, D. W. (2008) Using Focus Groups to Adapt Ethnically-Appropriate, Information-Seeking and Recruitment Messages for a Prostate Cancer Screening Program for Men at High Risk, Journal of the National Medical Association, 100(6):674-82, PMID: 18595569.

*+Siddiqui, F., Pajak, T.F., Watkins-Bruner, D., Konski, A.A., Coyne J.C., Gwede C.K., Garden, A.S., Spencer, S.A., Jones, C., Movsas, B. (2008). Pretreatment Quality of Life Predicts for Locoregional Control in Head and Neck Cancer Patients: A Radiation Therapy Oncology Group Analysis International Journal of Radiation Oncology, Biology, Physics, 70(2):353-360, PMID: 17889449.

*+Hartsell, W., DeSlivo, M., Bruner, D.W., Scarantino, C., Ivker, R., Roach, M., Suh, J., Demas, W., Movsas, B., Petersen, I., Konski, A. (2008) Can physicians Accurately Predict Survival Time in Patients with Metastatic Cancer? Journal of Palliative Medicine, 11:723-728, PMID: 18588404.

# Bruner, D.W., (2007). Should Patient-reported Outcomes Be Mandatory for Toxicity Reporting in Cancer Clinical Trials? (Editorial) Journal of Clinical Oncology. 25(34):5345-5347. PMID: 18048812.

*+Coyne, J.C., Pajak, T.F., Harris, J. Konski, A, Movsas, B., Ang, K., Watkins Bruner, D. (2007). Emotional Well-Being Does Not Predict Survival in Head and Neck Cancer Patients: A Radiation Therapy Oncology Group Study, Cancer. 110(11):2568-2575, PMID: 17955501. (#60)

*+# Bruner, D.W., Bryan, C.^, Aaronson, N., Blackmore, C., Brundage, M., Cella, D., Ganz, P., Gotay, G., Hinds, P., Kornblith, A., Movsas, B., Sloan, J., Wenzel, L., Whalen, G. (2007) Issues and Challenges with Integrating PROs in Clinical Trials Supported by the NCI-sponsored Clinical Trials Networks, Journal of Clinical Oncology 25(32):5051-5057, PMID: 17991920.

*+# Moinpour, C., Denicoff, A., Bruner, D.W., Kornblith, A., Land, S., O'Mara, A., Trimble. T. (2007) Funding Patient-Reported Outcomes (PROs) in Cancer Clinical Trials, Journal of Clinical Oncology 25(32):5100-5105, PMID: 17991928.

*# Lipscomb, J., Reeve, B., Clauser, S., Abrams, J., Bruner, D.W., Burke, L., Denicoff, A., Ganz, P., Gondek, K., Minasian L., O’Mara, A., Revicki, D., Rock, E., Rowland, J., Sgambati, M., Trimble, E. (2007) Patient-Reported Outcomes Assessment in Cancer Trials: Taking Stock, Moving Forward, Journal of Clinical Oncology 25(32):5133-5140, PMID: 17991933.

# Bruner, D.W. and Calvano, T. (2007) The Sexual Impact of Cancer and Cancer Treatments in Men. Nursing Clinics of North America. 42:555-580, PMID: 17996755.

*+ Giri, V.^, Beebe-Dimmer, J., Buyyounouski, M., Konski, A., Feigenberg, S., Uzzo, R., Hanks, G., Godwin, A., Chen, D., Gordon, R., Cescon, T., Raysor, S., Watkins Bruner, D. (2007). Prostate Cancer Risk Assessment Program - A Ten-Year Update of Cancer Detection. Journal of Urology, 178:1920-1924. PMID: 17868726. (#55)

#Bruner, D.W. (2007) Outcomes Research in Cancer Symptom Management Trials: The Radiation Therapy Oncology Group (RTOG) Conceptual Model, JNCI Monographs, 37:12-15, PMID: 17951225 .

*+Trotti, A., Pajak, P., Gwede, C., Paulus, R., Cooper, J., Forastiere, A., Ridge, J., Watkins-Bruner, D., Garden, A., Ang, K., and Curran, C. (2007). TAME: Development of a New Method for

Bruner, DW Page 18 of 57

Summarizing the Adverse Events of Cancer Treatment by the Radiation Therapy Oncology Group. Lancet Oncology 8(7):613-624, PMID: 17543584.

*+Roach, M., 3rd, De Silvio, M., Rebbeck, T., Grignon, D., Rotman, M., Wolkov, H., Fisher, B., Hanks, G., Shipley, W.U., Pollack, A., Sandler, H., Watkins-Bruner, D. (2007). Racial Differences in CYP3A4 Genotype and Survival Among Men Treated on Radiation Therapy Oncology Group (RTOG) 9202: A Phase III Randomized Trial. International Journal of Radiation Oncology, Biology, Physics, 69(1):79-87, PMID: 17498886.

*+Freedman, G.M., Anderson, P.R., Goldstein, L.J., Ma, C.M., Li, J., Swaby, R.F., Litwin, S., Watkins-Bruner, D., Sigurdson, E.R., Morrow, M. (2007). Four-Week Course of Radiation for Breast Cancer Using Hypofractionated Intensity Modulated Radiation Therapy with an Incorporated Boost. International Journal of Radiation Oncology, Biology, Physics, 68(2):347-53, PMID: 17379430.

*+ Freedman, G.M., Meropol, N.J., Sigurdson, E.R., Hoffman, J., Callahan, E., Price, R., Cheng, J., Cohen, S., Lewis, N., Watkins-Bruner, D., Rogatko, A., Konski, A. (2007). Phase I Trial of Preoperative Hypofractionated Intensity Modulated Radiation Therapy (IMRT) with Incorporated Boost and Oral Capecitabine in Locally Advanced Rectal Cancer. International Journal of Radiation Oncology, Biology, Physics, 67: 1389-93, PMID: 17394942. (#50)

*+Bruner, D.W., Barsevick, A., Tian, C., Randall, M., Mannel, R., Cohn, D., Sorosky, J., Spirtos, N. (2007). Randomized Trial Results of Quality of Life Comparing Whole Abdominal Irradiation And Combination Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study. Quality of Life Research, 16(1):89-100, PMID: 17033909.

*+Bruner, D.W., Nolte SA, Shahin MS, Huang HQ, Sobel E, Gallup D, Cella D; Gynecologic Oncology Group. (2006). Measurement of Vaginal Length: Reliability of the Vaginal Sound--a Gynecologic Oncology Group Study. International Journal of Gynecological Cancer, 16(5):1749-1755. PMID:17009966

*+Konski, A, Watkins-Bruner, D., Feigenberg, S., Hanlon, A., Kulkarni S.^, Beck, J.R., Horwitz, E., Pollack, A. (2006). Using Decision Analysis to Determine the Cost-Effectiveness of Intensity Modulated Radiation Therapy in the Treatment of Intermediate Risk Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics, 66(2):408-415.

*+Konski, A., DeSilvio, M., Hartsell, W., Watkins-Bruner, D., Coyne, J., Scarantino, C., JanJan, N. (2006). Continuing Evidence for Poorer Treatment Outcomes for Single Male Patients: Re-Treatment Data From RTOG 97-14 International Journal of Radiation Oncology, Biology, Physics, 66(1) 229-233.

*+Konski, A., Pajak, T., Movsas, B., Coyne, J., Harris, J., Gwede, C., Garden, A., Spencer, S., Jones, C., Watkins-Bruner, D. (2006). Disadvantage of Men Living Alone Participating in Radiation Therapy Oncology Group Head and Neck Trials. Journal of Clinical Oncology, 24(25): 4177-4183.

*+Movsas, B, Scott, C., Watkins Bruner, D. (2006). Pre-Treatment Factors Significantly Influence Quality of Life in Cancer Patients: A Radiation Therapy Oncology Group (RTOG) Analysis. International Journal of Radiation Oncology, Biology, Physics, 65(3):830-835.

*+#Bruner, D.W., Jones, M., Buchanan, D., Russo, J. (2006). Reducing Cancer Disparities For Minorities: A Multidisciplinary Research Agenda To Improve Patient Access To Health Systems, Clinical Trials, And Effective Cancer Therapy. Journal of Clinical Oncology, 24(14):2209-2215.

*+Konski, A., Watkins-Bruner, D., Brereton, H., Feigenberg, S., Hanks, G. (2006). Long-Term Hormone Therapy and Radiation is Cost-Effective for Patients with Locally Advanced Prostate Cancer. Cancer, 106(1):51-57.

*+Konski, A., Sherman, E., Krahn, M. Bremner, K., Beck, J.R., Watkins-Bruner, D., Pilepich, M. (2005). Economic analysis of a Phase III Clinical Trial evaluating the addition of Total Androgen Suppression (TAS) to Radiation Versus Radiation Alone for Locally Advanced Prostate Cancer (RTOG 86-10) International Journal of Radiation Oncology, Biology, Physics, 63(3):788-794.

*+Feigenberg, S., Lee, W.R., DeSilvio, M., Winter, K., Pisansky, T., Bruner, D.W., Lawton, C., Morton, G., Baikadi, M., Sandler, H. (2005). Health-Related Quality of Life in Men Receiving Prostate

Bruner, DW Page 19 of 57

Brachytherapy on RTOG 98-05. International Journal of Radiation Oncology, Physics, Biology, 62(4):956-964.

*+Hartsell, W.F., Scott, C.B., Bruner, D.W., Scarantino, C.W., Ivker, R.A., Roach, M., Suh, J.H., Demas, W.F., Movsas, B., Petersen, I.A., Konski, A., Cleeland, C., Janjan, N.A. (2005). Randomized Trial of Short- Versus Long-Course Radiotherapy for Palliation of Painful Bone Metastases. Journal of the National Cancer Institute, 97(11):798-804.

*+Watkins Bruner D., Linton, S, Konski, A, Uzzo, R, Greenberg, R, Pollack, A, Gordon, R, Cescon, T, Daly, M, Young, W, Goplerud, J, Tofani SH, Engstrom, P. (2004). Successful Strategies for African American Recruitment to Prostate Cancer Research. International Journal Cancer Prevention, 1(4): 295-306.

*+O’Brien, T.G., Guo, Y., Visvanathan, K., Sciulli, J., McLaine, M., Helzlsouer, K., Watkins-Bruner, D. (2004). Differences in Ornithine Decarboxylase and Androgen Receptor Allele Frequencies among Ethnic Groups. Molecular Carcinogenesis, 41(2):120-123.

*+Uzzo, R.G., Brown, J.G., Horwitz, E.M., Hanlon, A., Mazzoni, S.^, Konski, A., Greenberg, R.E., Pollack, A., Kolenko, V., Watkins-Bruner, D. (2004). Prevalence and patterns of self-initiated nutritional supplementation in men at high risk for prostate cancer. British Journal of Urology, 93:955-960.

*Konski, A., Watkins-Bruner, D. (2004). The RTOG Outcomes Model: Economic Endpoints and Measures, Expert Opinion on Pharmacotherapy, 5(3):513-519.

*+Bruner, D.W., Movsas, B., Konski, A., Roach, M., Bondy, M., Scarintino, C., Scott, C., Curran W. (2004). Outcomes Research in Cancer Clinical Trial Cooperative Groups: The RTOG Model. Quality of Life Research, 13(6):1025-1041.

*+Watkins Bruner, D., Hanlon A, Mazzoni S^, Raysor, S, Konski, A, Hanks G, Pollack, A. (2004). Predictors of Preferences, Utilities And Quality Of Life In Men Treated With 3DCRT For Prostate Cancer. International Journal of Radiation Oncology, Physics, Biology, 58(1):34-42.

*+Bruner, D.W., Moore, D, Parlanti, A^, Dorgan, J, Engstrom, P. (2003). Relative Risk of Prostate Cancer for Men with Affected Relatives: Systematic Review and Meta-analysis. International Journal of Cancer, 107(5):797-803.

*+Uzzo, R.G., Pinover, W.H., Horwitz, E., Parlanti, A.^, Mazzoni, S.^, Raysor, S., Mirchandani, I., Greenberg, R.E., Pollack, A., Hanks, G. E., and Bruner, D.W. (2003). Free PSA improves prostate cancer detection in a high-risk population of men with a normal total PSA and digital rectal examination. Urology, 61(4):754-759.

*+Moore-Higgs, G.J., Watkins-Bruner, D., Balmer, L., Johnson-Doneski, J., Komarny, P., Mautner, B., Velji, K. (2003). The Role of Licensed Nursing Personnel in Radiation Oncology: Part B: Integrating The Ambulatory Care Nursing Conceptual Framework. Oncology Nursing Forum, 30(1):59-64.

*+Moore-Higgs, G.J., Watkins-Bruner, D., Balmer, L., Johnson-Doneski, J., Komarny, P., Mautner, B., Velji, K. (2003). The Role of Licensed Nursing Personnel in Radiation Oncology: Part A: Results of a Descriptive Study. Oncology Nursing Forum, 30(1):51-58.

#Wilmoth, M. C. & Bruner, D.W. (2002). Integrating Sexuality Into Cancer Nursing Practice. Oncol Nurs Patient Treat Support, 9(1):1-14. *Watkins-Bruner, D., Berk, L., Bondy, M., Kachnic, L., Konski, A., Layne, E., Lee,W.R., Choucair,

A., Movsas, B., Okunieff, P., Roach, M., Scott, C., Vijayakumar, S., Wenzel, L. (2001). Outcomes Committee: RTOG Core Grant. International Journal of Radiation Oncology, Physics, Biology, 51(3), Supp. 2:66-74.

*Sandler, H., Shipley, W., Gomella, L., Pienta, K., Bard, R., Bruner, D.W., Clark, R., DeSilvio, M., Gaspar, L., Gillin, M., Grignon, D., Hammond, E., Hanks, G., Heydon, K., Kaufman,

D., Lee, W.R., Michalski, J., Mydlo, J., Pisansky,T., Pollack, A., Porterfield, H., Rifkin,M., Roach, M., Sanda, M., True, L.,Vijayakumar, S., Winter, K., Zietman, A. (2001). Genitourinary Cancer Committee: RTOG Core Grant. International Journal of Radiation Oncology, Physics, Biology, 51(3), Supp. 2:28-38.

*Okunieff, P., Hammond, M.E., Grignon, D., Langer, C., Pajak, TD., Ang, K., Bruner, D.W., Travis, E., Greven, K., Guha, A., Moulder, J., Pollack, A., Scarantino, C., Sneige, N., Watson, J., Amin, M..,

Bruner, DW Page 20 of 57

Bondy, M., Chakravarti, A., Chapman, J.D. (2001) Translational Research Program Committee: RTOG Core Grant. International Journal of Radiation Oncology, Physics, Biology, 51(3), Supp. 2:75-87.

*+Winter, D.L., Hanlon, A.L., Raysor, S.L., Watkins-Bruner, D., Pinover, W.N., Hanks, G.E., & Tricoli, J.V. (2001). Plasma Levels of IGF-1, IGF-2 and IGFBP-3 in White and African American Men at Increased Risk for Prostate Cancer. Urology, 58(4):614-8.

*+Miller, S.M., Diefenbach, M.A., Kruus L.K., Watkins-Bruner, D., Hanks, G.E., Engstrom, P.F. (2001). Psychological and Screening Profiles of First-Degree Relatives of Prostate Cancer Patients. Journal of Behavioral Medicine, 24(3):247-58.

*+Hanlon, A., Watkins-Bruner, D., Peter, R., Hanks, G. (2001). Quality-of-Life Study in Prostate Cancer Patients Treated with Three-Dimensional Conformal Radiation Therapy: Comparing Late Bowel and Bladder Quality-of-Life Symptoms to that of the Normal Population. International Journal of Radiation Oncology, Physics, Biology, 49(1): 51-59.

*Campbell-Grumet, S.^, Bruner, D.W., (2000). The Identification and Screening of Men at High Risk to Develop Prostate Cancer. Urologic Nursing, 20(1): 15-24.

*Pickett, M., Bruner, D.W., Joseph, A., Burggraf, V. (2000). Prostate Cancer Elder Alert (Part II): Living with the Treatment Choices and Outcomes. Journal of Gerontologic Nursing, 26(2): 22-34.

*Bruner, D.W., Pickett, M., Joseph, A., Burggraf, V. (2000). Prostate Cancer Elder Alert (Part I): Epidemiology, Screening and Early Detection. Journal of Gerontologic Nursing, 26(1): 6-15. (#20)

*+Bruner, D.W., Boyd, C. (1999). Assessing Women’s Sexuality after Cancer Therapy: Checking Assumptions with the Focus Group Technique. Cancer Nursing, 22(6): 438-447.

#Bruner, D.W., James, J.S. (1999). Genetics and Prostate Cancer: Giving New Meaning to the Family Tree. Family Urology, 4(3):9-10.

*+Tricoli, J.V., Winter, D.L., Hanlon, A.L., Raysor, S.L., Watkins-Bruner, D., Pinover, W.N. & Hanks, G.E. (1999). Racial Differences in Insulin-Like Growth Factor Binding Protein 3 in Men at Increased Risk for Prostate Cancer. Urology, 54 (1): 178-182.

*+Bruner, D.W., Baffoe-Bonnie, A., Miller, S., Diefenbach, M., Tricoli, J.V., Daly, M., Pinover, W., Campbell-Grumet, S., Stofey, J., Ross, E., Raysor, S., Balshem, A., Malick, J., Mirchandani, I., Engstrom, P., Hanks, G.E. (1999). Prostate Cancer Risk Assessment Program: A Model for Early Detection of Prostate Cancer. Oncology, 13(3): 325-334.

*#Bruner, D.W. (1998). Cost-Effectiveness and Palliative Care. Seminars in Oncology Nursing, 14(2): 164-167.

*Bruner, D.W. (1996). Managing a Managed-Care Contract in Radiation Oncology. Oncology Nursing Forum, 23(3): 451-455.

#Bruner D.W. (1996). Demystifying radiation oncology. Nursing Spectrum (Wash DC). 4;6(23):15. *Wasserman, T., Bruner, D.W., Scott, C. (1996). Radiation Therapy Oncology Group (RTOG).

Journal of the National Cancer Institute Monographs, (20), 81-82. *+Watkins-Bruner, D., Scott, C., Lawton, C., DelRowe, J., Rotman, M., Buswell, L., Beard, C., Cella,

D. (1995). RTOG’s First Quality-of-Life Study - RTOG 9020: A Phase III Trial of External Beam Radiation Therapy with Etanidazole for Locally Advanced Prostate Cancer. International Journal of Radiation Oncology Biology Physics, 33(4): 901-906.

*+Grigsby, P.W., Russell, A., Bruner, D.W., et. al. (1995). Late Injury of Cancer Therapy on the Female Reproductive Tract. International Journal of Radiation Oncology, Biology, Physics, 31(5): 1281-1299. (#10)

*Bruner, D. W., Wasserman, T. (1995). The Impact on Quality of Life by Radiation Late Effects. International Journal of Radiation Oncology, Biology, Physics, 31(5):1353-1355.

*Bruner, D.W. (1995). In Search of the “Quality” in Quality-of-Life Research (editorial). International Journal of Radiation Oncology, Biology, Physics, 31(1):191-192.

*Scott, C., Stetz, J., Bruner, D.W., Wasserman, T. (1994). Radiation Therapy Oncology Group Quality-of-Life Assessment: Design, Analysis and Data Management Issues. Quality of Life Research, 3(3): 199-206.

Bruner, DW Page 21 of 57 *+Bruner D.W. Lanciano, R., Keegan, M., Corn, B., Martin, E., and Hanks, G. (1993). Vaginal Stenosis

and Sexual Functioning Following Intracavitary Radiation for the Treatment of Cervical and Endometrial Carcinoma. International Journal of Radiation Oncology, Biology, Physics, 27 (4): 725-830.

*Bruner D. W. (1993). The Nurse in Radiation Oncology: Staffing Patterns and Role Development. Oncology Nursing Forum, 20(4): 651-659. #Bruner D.W., McGinn-Byer, M. (1993). Ostomy Care During or as a Result of Radiation Therapy.

Progressions, 5(3): 18-23. *Bruner D.W. (1990). Model Quality Assurance Program. In Radiation Oncology Nursing. Cancer

Nursing, 13 (6), 335-338. *Bruner D.W. (1990) Report of the Radiation Oncology Nursing Subcommittee of the American College

of Radiology Task Force on Standards Development. Oncology, 4 (8):80-81. *Watkins-Bruner, D., (1987). Quality Assurance Monitor - Review of Symptom Management. Hospice

Journal, 3(1):47-57.

Abstracts (^Dr. Bruner’s mentee) Published Abstracts (135) Yeager, K.A.,^ Williams, B., Meghani, S., Cooper, H., Quest, T., Bruner, D.W. Opiate Adherence in

African Americans being Treated for Cancer Pain. Accepted as Podium Presentation at the session "Best of ONS Abstracts" of the Oncology Nursing Society 42nd Annual Congress, May 4, 2017, Denver Colorado. (#135)

Thomas R^, Winfrey C, Daniel G^, Bai J^, Wells J^, Patel P, Sheldon J, Liu T, Hu Y, Shaw K, Mule J, Bruner DW. Quality Assurance of the Vaginal Microbiome Collection Protocol in Women with Gynecologic Cancers. Poster Presentation at the Southern Nursing Research Society 31st Annual Conference, Dallas, TX, February 22-25, 2017

Kweon J, Margolis L, Gogineni K, Waldrop-Valverde D, Bruner DW, Yeager K. Development, Acceptability and Feasibility of a Patient Education Video on Cancer Clinical Trials for Breast Cancer Patients, Poster Presentation (Top Student Posters Session) at the Southern Nursing Research Society 31st Annual Conference, February 22-25, 2017, Dallas, TX.

Bruner, DW, Pugh, S, Lee, WR, Dignam, J, Low, D, Swanson, G, Shah, A, David P D'Souza, D, Michalski, J, Dayes, I, Seaward, S, Nguyen, P, Hall, W, Pisansky, T, Chen, Y, Sandler, H, Movsas, B. NRG Oncology/RTOG 0415, Phase III Non-Inferiority Study Comparing 2 Fractionation Schedules in Patients with Low-Risk Prostate Cancer: Prostate Specific Quality of Life Results. Plenary Presentation at American Society for Radiation Oncology (ASTRO) 58th Annual Meeting, Boston MA, September 25-28, 2016. Winner of the Nurses Abstract Award. International Journal of Radiation Oncology • Biology • Physics, Vol. 96, Issue 2, S2-3.

Klopp, A., Yeung, A., Deshmukh, S., Gil, K., Wenzel, L., Westin, S., Gifford, K., Gaffney, D., Small, W., Thompson, S., Doncals, D., Cantuaria, G., Yaremko, B., Chang, A., Kundapur, V., Mohan, D., Haas, M., Kim, Y.B., Ferguson, C., Bruner, D.W. A Randomized Phase III Study Of Standard vs. IMRT Pelvic Radiation For Post-Operative Treatment Of Endometrial And Cervical Cancer (TIME-C). Plenary Presentation at American Society for Radiation Oncology (ASTRO) 58th Annual Meeting, Boston MA, September 25-28, 2016. International Journal of Radiation Oncology • Biology • Physics, Vol. 96, Issue 2, S3.

Kachnic L, Moughan J, Suntharalingam M, Ilson D, Konski A, Burrows W, Anker C, Bar-Ad V, Thakrar H, Hayes J, Gore E, Kavadi V, Komaki R, Raben A, Giguere J, Pollack J, Greenberger J, Videtic G, Roof K, Bruner, D.W. Patient-reported Outcomes (PROs) in NRG Oncology/RTOG 0436: A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Esophageal Cancer Treated without Surgery Oral Abstract Presentation at American Society for Radiation Oncology (ASTRO) 58th Annual Meeting, Boston MA, September 25-28, 2016. International Journal of Radiation Oncology • Biology • Physics, Vol. 96, Issue 2, S31. (#130)

Ferris, M., Zhong, J., Switchenko, J., Higgins, K., McDonald, M., Eaton, B., Miller, A, Bruner, D.W., Xiao, C., Bietler, J.CNS Dose Is Not Associated With Treatment-Related Fatigue in Patients Undergoing Radiation Therapy for Head and Neck Cancer. Poster Abstract Presentation at

Bruner, DW Page 22 of 57

American Society for Radiation Oncology (ASTRO) 58th Annual Meeting, Boston MA, September 25-28, 2016. International Journal of Radiation Oncology • Biology • Physics, Vol. 96, Issue 2, E357.

Xiao, C., Beitler, J., Higgins, K., Glazer, T., Wommack, E., Shin, D.M., Saba, N.F., Bruner, D.W., etal

Persistent Fatigue Is Associated With Persistent Peripheral Inflammation in Patients With Squamous Cell Carcinoma of the Head and Neck Cancer up to 3 Months Post-Intensity Modulated Radiation Therapy Poster Abstract Presentation at American Society for Radiation Oncology (ASTRO) 58th Annual Meeting, Boston MA, September 25-28, 2016. International Journal of Radiation Oncology • Biology • Physics, Vol. 96, Issue 2, E348

Garcia, R.^, Hanlon, A., Small, W., Wells, J.^, Bruner, D.W. Exploring the Relationship Between Pre-Treatment BMI and Post-Treatment Sexual Function in Women with Endometrial Cancer treated with Vaginal Brachytherapy, Oral podium presentation at 41st Annual Oncology Nursing Society Congress, San Antonio, TX, April 28–May 1, 2016.

Lemen, J.^, Bruner, D.W. Characterizing the Vaginal Microbiome of Gynecologic Cancer Patients: An Integrative Review. ePoster Abstract Presented at 41st Annual Oncology Nursing Society Congress, San Antonio, TX, April 28–May 1, 2016.

Okwan-Duodu,D. Atif,F., Yu, D.S., Yousuf, S., Bruner,D.W., Curran,W., Stein, D.G. Progesterone to Improve Neurocognitive Outcomes Following Cranial Irradiation, Poster Presented at the 2016 Cancer Survivorship Symposium: Advancing Care and Research, San Francisco, CA, January 15-16, 2016. J Clin Oncol 34, 2016 (suppl 3S; abstr 128) (#125)

Lukka H, Pugh S, Bruner DW, Bahary J, Lawton C, Efstathiou J, Kudchadker R, Ponsky L, Seaward S, Dayes I, Gopaul D, Michalski J, Delouya G, Kaplan I, Horwitz E, Roach M, Pinover W, Beyer D, Sandler H, Kachnic L. NRG Oncology/RTOG 0938, evaluating two ultrahypofractionated regimens (UHR) for prostate cancer (CaP). Oral Abstract Presented at American Society of Clinical Oncology Genitourinary Cancers Symposium, San Francisco, CA, January 7-9, 2016. J Clin Oncol 34, 2016 (suppl 2S; abstr 27)

Lee WR, Dignam J, Amin M, Bruner DW, Low D, Swanson G, Shah A, D'Souza D, Michalski J, Dayes I, Seaward S, Hall W, Nguyen P, Pisansky T, Faria S, Chen Y, Koontz B, Paulus R, Sandler H. NRG Oncology RTOG 0415: A Randomized Phase III Non-Inferiority Study Comparing Two Fractionation Schedules in Patients with Low-Risk Prostate Cancer. Oral Abstract Presented at American Society of Clinical Oncology Genitourinary Cancers Symposium, San Francisco, CA, January 7-9, 2016. J Clin Oncol 34, 2016 (suppl 2S; abstr 27)

Bruner DW, Deshmukh S, Michalski J, Purdy J, Bosch W, Bahary JP, Patel M, Parliament M, Lock M, Lau HY, Hamstra D, Fisher S, Souhami L, Kwok Y, Seider M, Vigneault E, Gay H, Rosenthal S, Sandler H, Movsas B. Bowel and Bladder Function of Men on a Phase III Randomized Study of High Vs Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer. ePoster Discussion Abstract Presented at American Society for Radiation Oncology (ASTRO) 57th Annual Meeting, San Antonio, TX October 18-21, 2015.

Lee WR, Dignam J, Amin M, Bruner DW, Low D, Swanson G, Shah A, D'Souza D, Michalski J, Dayes I, Seaward S, Hall W, Nguyen P, Pisansky T, Faria S, Chen Y, Koontz B, Paulus R, Sandler H. “NRG Oncology RTOG 0415: A Randomized Phase III Non-Inferiority Study Comparing 2 Fractionation Schedules in Patients with Low-Risk Prostate Cancer” Late Breaking Oral Abstract Presented at American Society for Radiation Oncology (ASTRO) 57th Annual Meeting, San Antonio, TX October 18-21, 2015.

Lukka H, Pugh S, Bruner DW, Bahary J, Lawton C, Efstathiou J, Kudchadker R, Ponsky L, Seaward S, Dayes I, Gopaul D, Michalski J, Delouya G, Kaplan I, Horwitz E, Roach M, Pinover W, Beyer D, Sandler H, Kachnic L. “A randomized phase II trial of hypofractionated radiotherapy for favorable risk prostate cancer: primary results of NRG Oncology/RTOG 0938” Late Breaking Oral Abstract Presented at American Society for Radiation Oncology (ASTRO) 57th Annual Meeting, San Antonio, TX October 18-21, 2015. (#120)

Konski A, Buyyounouski M, Stoyanova R, Movsas B, Uzzo R, Horwitz E, Kwon D, Bruner DW, Pollack A. “Quality Adjusted Survival Comparing Standard Vs Hypofractionated Radiation

Bruner, DW Page 23 of 57

Therapy in the Treatment of Prostate Cancer.” Oral Abstract Presented at American Society for Radiation Oncology (ASTRO) 57th Annual Meeting, San Antonio, TX October 18-21, 2015.

Bruner DW, Deshmukh S, Michalski J, Purdy J, Bosch W, Bahary JP, Patel M, Parliament M, Lock M, Lau HY, Hamstra D, Suntharalingam M, Fisher S, Souhami L, Vigneault E, Seider M, Gay H, Rosenthal S, Sandler H, Movsas B. “Sexual Function of Men on a Phase III Randomized Study of High vs Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer,” Oral abstract presentation at Controlling Cancer Summit, London. May 12-14, 2015.

Basch, E., Pugh, S., Dueck, A., Mitchell, S., Berk, B., Rogak, L., Gatewood, M., Reeve, B., Mendoza, T., O’Mara, A., Denicoff, A., Minasian, L., Fogh, S., Roof, K., Moore, J., Gergel, T., Stephans, K., Rimner, A., DeNittis, A., Bruner. D.W. Feasibility of Patient Reporting of Symptomatic Adverse Events via the PRO-CTCAE in a Radiation Therapy Oncology Group (RTOG) Cooperative Group Clinical Trial, Poster presentation, ISoQoL, Berlin, Germany, October15 - 18, 2014.

Bauml J, Xie S, Farrar J, Bowman M, Li S, Bruner DW, DeMichel A, Mao, J. Baseline Response Expectancy: A Potential Tool for Personalized Acupuncture Therapy. Oral presentation under the "Best of SIO," 11th Annual International Conference, Society of Integrative Oncology, Houston, TX, October 26-28, 2014

Bruner D, Flynn KE, Lin L, Reese JB, Weinfurt KP, & the PROMIS Sexual Function Domain Group: PROMIS-SA. “Preliminary validation of a new measure of oral discomfort with sexual activity: PROMIS-SA.” Oral presentation at the World Meeting on Sexual Medicine; Sao Paolo, Brazil; October 11, 2014. (#115)

Weinfurt KP, Flynn KE, Bruner DW, Cyranowski JM, Dombeck CB, Hahn EA, Jeffery DD, Lin L, Luecht RM, Magasi S, Porter LS, Reese JB, Reeve BB, Shelby RA, Willse JT. “Development and preliminary validation of the PROMIS SexFS Version 2.0.” Oral presentation at the World Meeting on Sexual Medicine; Sao Paolo, Brazil; October 11, 2014.

Berk, L, Deshmukh, S, Fogh, S, Roof, K, Yacoub, S, Gergel, T, Stephans, K, Rimner, A, DeNittis, A, John Pablo, J, Rineer, J, Chakravarti, A, Bruner, DW. Randomized Phase II Trial of Best Supportive Care, Manuka Honey Liquid and Manuka Honey Lozenges for Prevention of Radiation Esophagitis during Chemotherapy and Radiotherapy for Lung Cancer, Oral Abstract Presented at American Society for Radiation Oncology (ASTRO) 56th Annual Meeting, San Francisco, September 14 - 17, 2014

Giblin, J, Berg, B, Stratton, E, Bruner, DW, Annesi, J, McEwen, K, Miller, A, Gary, R. Changes in Physical Activity Among Breast Cancer Patients Enrolled in a YMCA Coach-Assisted Program, Oral Abstract presentation at 5th Annual Academy of Oncology Nurse and Patient Navigators, September 18-21, 2014, Orlando, Fl, Journal of Oncology Navigation and Survivorship, Aug 2014:5(4), pg6.

Small W, Jr, Pugh S, Wagner L, Kirshner J, Sidhu K, Bury M, DeNittis A, Alpert T, Tran B, Bruner DW. RTOG 0841: Two Item Questionnaire Effectively Screens for Depression in Cancer Patients Receiving Radiotherapy. Plenary Session, Presented at American Society for Radiation Oncology (ASTRO) 55th Annual Meeting, Atlanta, GA, September 22 - 25, 2013

Liu T, Yu D, Beitler J Tridandapani S, Bruner D, Curran W, Yang X. Ultrasonic Tissue Characterization of Parotid-Gland Injury Following Head-And-Neck Radiotherapy Using Nakagami-Parameter Imaging: A Feasibility Study. Oral presentation at the 55th Annual Meeting of the American Association of Physicists in Medicine, Indiana, IN, August 4 - 8, 2013. (#110)

Bruner, D.W, Pugh, S., Pisansky, T., Greenberg, R., Pervez, N., Reed, D., Rosenthal, S., Mowat, R., Raben, A., Buyyounouski, M., Kachnic, L. Preliminary results of RTOG 0831, randomized, double-blinded, placebo-controlled trial of tadalafil in prevention of erectile dysfunction in patients treated with radiotherapy for prostate cancer. Poster Discussion Session Presented at ASCO, Chicago, IL, June 3 – 7, 2011 May 31 – June 4, 2013

Mao, J.J.^, Xie, S., Farrar, J.T., Stricker, C., Bowman, M., Bruner, D.W., DeMichele, A. Electro-acupuncture for joint pain related to aromatase inhibitors among breast cancer survivors: A randomized placebo-controlled trial. Poster Abstract Presented at ASCO, Chicago, IL, June 3 – 7, 2011 May 31 – June 4, 2013

Bruner, DW Page 24 of 57 Wagner, L., Pugh, S., Small B., Kirshner, J.J., Sidhu, K., Bury, M., DeNittis, A., Alpert, T., Tran, B.,

Bloom, B., Mai, J., Bruner, D.W. Screening for depression in community-based radiation oncology settings: Results from RTOG 0841. Poster Discussion Session Presented at ASCO, Chicago, IL, June 3 – 7, 2011 May 31 – June 4, 2013

Wefel, J., Shook, S., Brown, P., Laack, N.; Choucair, A., Suh, J., Roberge, D., Kavadi, V., Mehta, M., Watkins-Bruner, D. Memantine for the Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiotherapy (WBRT): First Report of RTOG 0614, a Placebo-Controlled, Double-Blind, Randomized Trial. Oral Abstract Podium Presentation at Society of NeuroOncology, Washington DC, Nov 15-18, 2012.

Xiao C^, Hanlon A, Zhang Q, Ang K, Rosenthal DI, Nguyen-Tan PF, Kim H, Movsas B, Burner DW. Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy. Oral Abstract Podium Presentation, at ONS Connections: Advancing Care Through Science Conference, Phoenix, AZ, Nov 16-18, 2012(#105)

Brown, P. Shook, S., Laack, N.; Wefel, J., Choucair, A., Suh, J., Shouhami, L., Kavadi, V., Mehta, M., Watkins-Bruner, D. Memantine for the Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiotherapy (WBRT): First Report of RTOG 0614, a Placebo-Controlled, Double-Blind, Randomized Trial. Oral Abstract Plenary Presentation at American Society for Radiation Oncology (ASTRO), Boston, MA, October 28-31, 2012.

Bruner, D.W., Hunt, D., Michalski, J., Bosch, W., Yan, Y., Galvin, J., Bahary, J., Morton, G., Parliament, M., Sandler, H. Value Added of Patient-Reported Data to Clinician Reported Toxicity Data: Preliminary Analysis of 3DCRT vs IMRT on RTOG 0126 Prostate Cancer Trial High Dose Arm. Oral Abstract Presentation at 19th Annual Meeting of the International Society for Quality of Life Research (ISOQOL), Budapest, Hungry, October 24-27, 2012.

Xiao C^, Hanlon A, Burner DW. Comparison of Missing Data Imputation Techniques in Factor Analysis. Poster Abstract Presentation at National State of the Science Congress on Nursing Research. Washington, DC,15, Sept 13-2012

Bruner, DW; Lin, L; Strauss, J; Gatewood, Ml; Small, W. Standard vs Enhanced Education To Improve Vaginal Dilator Adherence After Vaginal Brachytherapy For Endometrial Cancer Oral Abstract Presented at the World Meeting on Sexual Medicine, Chicago, Il, Aug 26-30, 2012

Small, W; Lin, L; Strauss, J; Xiao, C^; Bruner, DW. Vaginal Length After Vaginal. Brachytherapy For Endometrial Cancer Oral Abstract Presented at the World Meeting on Sexual Medicine, Chicago, Il, Aug 26-30, 2012(#100)

Weinfurt, K.; Flynn, K.; Moore, A.; Lin, L.; Bruner, D.; Reese, J.; Smith, A.; Reeve, B. Reasons For Sexual Inactivity: Results From A National Survey. Moderated Poster Abstract Presented at the World Meeting on Sexual Medicine, Chicago, Il, Aug 26-30, 2012

Flynn, K.; Reese, J.; Bruner , D.; Dombeck, C.; Keefe, F.; Czajkowski , S.; Reeve, B.; Shelby, R.; Weinfurt, K. Patients' Understanding Of Interest, Desire, And Arousal Moderated Poster Abstract Presented at the World Meeting on Sexual Medicine, Chicago, Il, Aug 26-30, 2012

Weinfurt, K.; Flynn, K.; Lin, L.; Bruner, D.; Dombeck, C.; Cyranowski, J.; Jeffery, D.; Keefe, F.; Luecht, R.; Porter, L.; Reese, J.; Reeve, B.; Smith , A.; Willse, J. Development and Validation of The PROMIS Sexual Function Measure, Moderated Poster Abstract Presented at The World Meeting On Sexual Medicine, Chicago, Il, Aug 26-30, 2012

Liu, T., Yang, X., Bruner, D.W., Tridandapani ,S., Chen, H., Henry, S., Rossi, P. Ultrasound Nakagami Imaging for Noninvasive Evaluation of Vaginal Fibrosis Following Radiotherapy for Gynecologic Malignancies. Oral Abstract Presentation at American Association of Physicists in Medicine (AAPM) 54th Annual Meeting, Charlotte, NC, July 29-Aug 2, 2012. Won the 2012 John Laughlin Science Council Research Symposium Award.

Meghani, S.H.^, Hanlon, A., Bubanj, J., Riegel, B., & Bruner, D.W. African Americans are more likely to receive an analgesic with toxic metabolite despite clinical risks. Oral Abstract Presentation at American Pain Society's 31st Annual Scientific Meeting, Honolulu, HI. May 16-18, 2012.

Meghani, S.H.^, Hanlon, A., Bubanj, J., Riegel, B., & Bruner, D. (2012). African Americans are more likely to receive an analgesic with toxic metabolite despite clinical risks. Journal of Pain, 13(4), S37. (#95)

Bruner, DW Page 25 of 57 Flynn KE, Lin L, Dombeck C, Fawzy M, Abernethy AP, Bruner DW, Reese JB, Reeve BB, Smith AW,

Weinfurt KP. Validating the PROMIS Sexual Function Brief Profile Measure. Oral Abstract Presentation International Society of Quality of Life (ISOQOL) Research, Denver, CO, October 26-29, 2011.

Bruner, D.W., Hunt, D., Michalski, J., Bosch, W., Yan, Y., Galvin, J., Bahary, J.P., ; Morton, G., Parliament, M., Sandler, H. Preliminary Analysis of 3DCRT vs IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial: Patient Reported Outcomes. Oral Abstract Presentation at American Society for Radiation Oncology (ASTRO), Miami, Florida, October 2-6, 2011.

Michalski JM, Yan Y, Bruner D.W., Bosch W, Winter K, Galvin JM, Bahary JP, Morton GC, Parliament MB, Sandler H. Preliminary analysis of RTOG 0126 high dose arm prostate patients receiving 3DCRT or IMRT: Toxicity Report. Plenary Presentation at American Society for Radiation Oncology (ASTRO), Miami, Florida, October 2-6, 2011.

Xiao, C.^, Hanlon, A., Zhang, Q., Ang, K., Rosenthal, D.I., Nguyen-Tan, P.F., Kim H., Movsas, B., Bruner, D.W. Predictors on Longitudinal Changes of Clinician Reported Symptom Clusters Identified in Patients with Head and Neck Cancer Treated on RTOG Trials. Poster Abstract Presentation at American Society for Radiation Oncology (ASTRO), Miami, Florida, October 2-6, 2011.

Movsas, B., Hunt, D., Watkins-Burner, D., Lee, W. R., Tharpe, H., Goldstein, D., Moore, J., Dayes, I., Parise, S., Sandler, H. Electronic Web-Based Technology Significantly Improves Quality of Life (QOL) Data Collection: Analysis of RTOG 0828. Oral Abstract Presentation at American Society for Radiation Oncology (ASTRO), Miami, Florida, October 2-6, 2011. (#90)

Gondi, V., Paulus, R., Bruner, D.W., Meyers, C.A, Gore, E.M., Wolfson, A., Werner-Wasik, M., Choy, H., Movsas, B. Decline in tested and patient-reported cognitive functioning following prophylactic cranial irradiation for lung cancer: Secondary analysis of RTOG 0212 and 0214. Oral Abstract Presentation at American Society for Radiation Oncology (ASTRO), Miami, Florida, October 2-6, 2011.

Lee WR, Dignam J, Bruner, D.W., Efstathiou J, Yan Y, Hanks G, Roach M, Pilepich MV, Sandler H. Does Enrollment Setting Influence Patient Attributes and Outcomes in RTOG Prostate Cancer Studies? Poster Abstract Presentation at ASCO, Chicago, IL, June 3 – 7, 2011

Gondi, V., Paulus, R., Bruner, D.W., Meyers, C., Gore, E., Wolfson, A., Werner-Wasik, M., Choy, H., Movsas, B. Prognostic significance of QOL deterioration during early lung cancer survivorship: Secondary analysis of RTOG 0212 and 0214. Poster Abstract Presentation at ASCO, Chicago, IL, June 3 – 7, 2011

Meghani, S.^, Bruner, D.W., Hanlon, A., Riegel, B. Do Subjective Measures of Adherence Predict Actual Analgesic Taking Behavior for Cancer Pain? Poster Abstract Presentation at the American Pain Society's 30th Annual Scientific Meeting, May 19-21, 2011, Austin, TX. Journal of Pain (In Press)

Berk, L., Fogh, S.^, Bae, K., Bruner, D.W. Development and Implementation of a Randomized Trial of Manuka Honey for Radiation Esophagitis. Oral Abstract Presentation at the 7th International Conference of the Society for Integrative Oncology, New York, NY, November 11-13, 2010 (#85)

Turaka, A., Zhu, F., Buyyounouski, M., Horwitz, E., Watkins-Bruner, D., Konski, A., Pollack, A. Conventional versus Hypofractionated IMRT: Results of Late GI and GU Toxicity and Quality of Life from a Phase III Trial. Oral Abstract Presentation at American Society for Radiation Oncology (ASTRO), San Diego, CA. October 31 – November 4, 2010

Basch, E., Reeve, B., Cleeland, C., Sloan, J., Schrag, D., Atkinson, T., Mendoza, T., Hay, J, Abernethy, A., Minasian, L., Kwitkowski, V., Trentacosti, A., Burke, L., Sit, L., Bruner, D. W. Development of the Patient-Reported Version of the Common Terminology Criteria For Adverse Events (PRO-CTCAE). Poster Presentation at the 13th Annual ISPOR European Congress, Prague, Czech Republic, November 6-9, 2010

Bruner, D.W., Hanisch, L., Reeve, B., Minasian, L., Rowland, J., O’Mara. A., Sit, L., Sloan, J., Cleeland, C., Denicoff, A., Trimble, E., St. Germain, D. Clauser, S., Geoghegan, C., Paul, D., Abernethy, A., Schrag, D., Basch, E. Perceived Barriers To Implementing The Patient-Reported Outcomes-Common Toxicity Criteria Adverse Event (PRO-CTCAE) System In Cancer Clinical

Bruner, DW Page 26 of 57

Trials. Oral Abstract Presentation at 17th Annual Meeting of the International Society for Quality of Life Research (ISOQOL), London, England, October 27-30

Basch, E., Reeve, B., Cleeland, C., Sloan, J., Mendoz, T., Abernethy, A., Bruner, D.W., Hay. J., Atkinson, T., Sit., L., Minasian, L., O'Mara, A., Burke, L., Schrag, D. Development of the Patient-Reported Version of The Common Terminology Criteria For Adverse Events (PRO-CTCAE). Poster at the 17th Annual Meeting of the International Society for Quality of Life Research (ISOQOL), London, England, October 27-30, 2010

Dueck, A., Mendoza, T., Reeve, B., Sloan, J., Cleeland, C., Hay, J., Li, Y., O'Mara, A., Denicoff, A., Bruner, D.W., Basch, E. Validation Study of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Poster at ISPOR 15th Annual International Meeting, Atlanta, GA, May 15-19, 2010 (#80)

Ulrich, C.^, Bruner, D.W. Barriers to Nurse Practitioners Recommending Clinical Trials. Oral Abstract Presentation at the 22nd Eastern Nursing Research Society, Providence, RI, March 24-26, 2010

Bruner, D.W., Bae, K., Siddiqui, F., Langer, C., Coyne, J., Gamerman,V., Komaki, R., Choy, H., Curran, W., Movsas, B. The Influence of Gender, Race and Marital Status on Survival in Lung Cancer Patients: Meta-Analysis of Radiation Therapy Oncology Group (RTOG) Trials. Poster Discussion Session at the 51st American Society of Therapeutic Radiologists & Oncologists (ASTRO), Chicago, IL, November 2009, International Journal of Radiation Oncology, Physics, Biology

Du, K.L.^, Bae, K., Movsas, B., Gamerman, V., Coyne, J., Bryan, C.^, Watkins-Bruner, D. The Impact of Marital Status and Race in Patients Enrolled in Radiation Therapy Oncology Group (RTOG) Prostate Cancer Trials. Poster at the 51st American Society of Therapeutic Radiologists & Oncologists (ASTRO), Chicago, IL, November 2009, International Journal of Radiation Oncology, Physics, Biology

Ulrich, C.M.^, James J, Grady C, Bryan C^, Hanlon A, Watkins-Bruner D, Curran, W. Factors Associated with Attrition in RTOG Clinical Trials Oral Abstract Presentation at the 51st American Society of Therapeutic Radiologists & Oncologists (ASTRO), Chicago, IL, November 2009, International Journal of Radiation Oncology, Physics, Biology

Freedman, G., Anderson, P., Litwin, S., Swaby, R., Nicolaou, N., Sigurdson, E., Ma, C., Watkins-Bruner, D., Morrow, M., Goldstein, L. 5-year Results of a Phase II Study of Hypofractionated IMRT with an Incorporated Boost for Breast Cancer Oral Abstract Presentation at the 51st American Society of Therapeutic Radiologists & Oncologists (ASTRO), Chicago, IL, November 2009, International Journal of Radiation Oncology, Physics, Biology (#75)

Siddiqui, F., Bae, K., Langer, C., Coyne, J., Gamerman,V., Komaki, R., Choy, H., Curran, W., Watkins-Bruner, D., Movsas, B. Gender Differences in Survival Among Lung Cancer Patients Treated in Radiation Therapy Oncology Group (RTOG) Trials, Poster Discussion Session, 13th World Conference on Lung Cancer, San Francisco, CA July 31- August 4, 2009.

Desai, K., DeMichele, A., Bruner, D.W., Vapiwala, N., Halbert. C.H., Stricker. C., Mao,J.J.^ Factors associated with willingness to participate in an acupuncture clinical trial for arthralgia among breast cancer patients. Poster Abstract Presentation at American Society of Clinical Oncology, Orlando, Fl, May 29 – June 2, 2009.

Donovan, H.S., Nolte, S., Pipe, T., Ulrich, C., Hooke, C., Lillington, L., Hinds, P., Barton, D., Homan, S., Smith, E.M.L., Bruner, D.W., Mallory, G. ONS Foundation Multi-site Research Training Program: Lessons Learned Two Years Out. Poster Abstract Presentation. Oncology Nursing Society, 34th Annual Congress San Antonio, TX, April 30-May 3, 2009.

Bruner, D.W., Gotay, C., Moinpour, C., Atherton, P., Johnson, V., Winter, K., Schaefer, P., Movsas, B., Sloan, J. Value-Added of Patient-Reported Outcomes (PRO) in Cooperative Group Oncology Clinical Trials: A Pooled Analysis. Oral Abstract Presentation at the 15th Annual Meeting of the International Society for Quality of Life Research. Montevideo, Uruguay October 22-25, 2008. Quality of Life Research,

Bae, K., Bruner, D.W., Yan, Y., Coyne, C., Movsas, B. Patterns of Missing Mini Mental Status Exam Data in Radiation Therapy Oncology Group (RTOG) Brain Tumor Trials. Poster Discussion Session at the 50th American Society of Therapeutic Radiologists & Oncologists (ASTRO),

Bruner, DW Page 27 of 57

Boston, MA, September 2008, International Journal of Radiation Oncology, Physics, Biology 72(1): Supp 1; 2008: S498, 2736. (#70)

Chow, E., James, J., Hartsell, W., Barsevick, A., Scarantino, C., Ivker, R., Roach, M., Suh, J., Petersen, I., Bruner, D.W. Functional Interference Clusters In Cancer Patients With Bone Metastases: An Analysis Of RTOG 9714 Poster Presentation at the 50th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Boston, MA, September 2008, International Journal of Radiation Oncology, Physics, Biology, 72, (1): Supp 1; 2008: S141, 1062.

Buyyounouski, M., Li, T., Konski, A., Watkins-Bruner, D., Horwitz, E., Pollack A. Relationship Between Urinary Toxicity And Global Health Related Quality Of Life Following Radiotherapy For Prostate Cancer. Presentation at the American Radium Society, Dana Point, CA, May 3-7, 2008.

Bryan, C.^, James, J., Pisansky, T., Corbett, T., Jha, N., Swanson, R., Hartford, A., Sandler, H., Berk, L., Kachnic, L., Bruner, D.W. Impact of Sildenafil on Marital and Sexual Adjustment in Patients and Their Partners After Radiotherapy and Short-Term Androgen Suppression for Prostate Cancer: Analysis of RTOG 0215. Presentation at the 13th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Toronto, Canada, May 2008

Giri, V., Ruth, K., Raysor, S., Kim, T., Calvano, T., Bagden, L., Zakrzewski, D,. Watkins-Bruner, D. Recruitment Efforts to a Prostate Cancer Screening Program for High-Risk Men - Challenges Faced and Lessons Learned Over 10 Years. Poster Presentation at the ASCO/ASTRO/SUO Genitourany Cancers Symposium, San Francisco, CA, Febuary 14-16, 2008.

Bruner, D.W., James, J., Pisansky, T., Rotman, M., Corbett, T., Speight, J., Byhardt, R., Sandler, H., Berk, L. RTOG 0215 Treatment of Erectile Dysfunction (ED) in Patients Treated with Neoadjuvant and Concurrent Androgen Deprivation (AD) and Radiotherapy (RT) for Prostate Cancer (PC). Oral Abstract Presentation at the 49th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Los Angeles, CA, October 2007, International Journal of Radiation Oncology, Physics, Biology, 69(3); Supp 2007; S30. (#65)

Buyyounouski, M., Li, T., Watkins-Bruner, D., Horwitz, E., Pollack, A. A Comparison Of Sexual Function Outcome Following Radiotherapy For Prostate Cancer: Results Of A Prospective, Randomized Trial Of Hypofractionated Intensity Modulated Radiotherapy. Oral Abstract Presentation at the 49th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Los Angeles, CA, October 2007, International Journal of Radiation Oncology, Physics, Biology, 69(3): Supp 1; 2007:S7-8, 13.

Nicolaou, N.^, Moughan, J., Sarna, L., Langer, C., Werner-Wasik, M., Komaki, R., Machtay, M., Wasserman, T., Bruner, D.W., Movsas, B. Quality of Life (Qol) Supercedes The Classic Predictors Of Survival In Locally Advanced Non-Small Cell Lung Cancer (NSCLC): An Analysis Of Radiation Therapy Oncology Group (RTOG) 9801. Oral Abstract Presentation at the 49th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Los Angeles, CA, October 2007, International Journal of Radiation Oncology, Physics, Biology, 69(3): Supp 1; 2007:S58-S59, 103.

Kwok, Y., Won, M., Regine, W., Mehta, M., Schmitt, F., Patchell, R., Bruner, D.W. Neurocognitive impact of whole brain radiation of patients with brain metastasis: Secondary analysis of RTOG BR-0018. Oral Abstract Presentation at the 49th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Los Angeles, CA, October 2007, International Journal of Radiation Oncology, Physics, Biology, 69(3): Supp 1; 2007:S103, 184.

Bruner, D.W., Hanlon, A., Trotta, R., Konski, K., Horwitz, E., Kulkarni, S^, Giri, V. Preferences for Prostate Cancer Screening & Treatment: Assessment of Message Framing and Theoretical Underpinnings. Oral Abstract Presentation at the Department of Defense (DOD) Prostate Cancer Research Program (PCRP) Innovative Minds in Prostate Cancer Today (IMPaCT) meeting September 5-8, 2007, Atlanta, Georgia.

Bruner, D.W., Moughan, J., Movsas, B., Konski, A., Hanks, G., Cox, J., Roach, M. Predictors of Late Toxicities and Symptom Clusters in Radiation Therapy Oncology Group (RTOG) Prostate Cancer Trials of High Risk Patients: A Meta-analysis of Physician Rated Toxicities. Oral

Bruner, DW Page 28 of 57

Abstract Presentation at the 48th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Philadelphia, PA, November 2006, International Journal of Radiation Oncology, Physics, Biology, 66(3): Supp; 2006: S68, 119. (#60)

Roach, M., Moughan, J., Movsas, B., Konski, A., Hanks, G., Cox, J., Watkins-Bruner, D. Socio-demographic Predictors of Biochemical Failure and Survival Among High Risk Patients Treated on Radiation Therapy Oncology Group (RTOG) Prostate Cancer Trials: A Meta-analysis. Oral Abstract Presentation at the 48th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Philadelphia, PA, November 2006, International Journal of Radiation Oncology, Physics, Biology. 66(3): Supp; 2006: S204, 1127.

Movsas, B., Moughan, J., Swann, S., Coyne, J., Konski, A., Komaki, R., Bradley, J., Langer, C., Choy, H. and Watkins Bruner, D. Sociodemographic Factors are Significant Predictors of Toxicity in RTOG Non-Operative NSCLC Trials. Oral Abstract Presentation at the 48th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Philadelphia, PA, November 2006, International Journal of Radiation Oncology, Physics, Biology, 66(3): Supp; 2006: S62, 109.

Konski, A., Bhargavan, M., Owen, J., Paulus, R., Cooper, J., Forastiere, A., Geopfert, H., Ang, K., Bruner, D.W. The Addition of Chemotherapy to Radiation is Cost-Effective in the Treatment of Patients with Locally Advanced Laryngeal Cancer: An Economic Analysis of Radiation Therapy Oncology Group (RTOG) 91-11. Oral Abstract Presentation at the 48th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Philadelphia, PA, November 2006, International Journal of Radiation Oncology, Physics, Biology, 66(3): Supp; 2006: S66, 115.

Walker, E.M.^, James, J., Stine, S.H., Gore, E. Prestidge, B., Michalski, J., Maguire, P., Chamberlain, R., Gwede, C., Torres-Roca, J., Simon, T., Bruner D.W. RTOG Participating Physician and Research Associates Attitudes Regarding Clinical Trials: Implications for Improving Recruitment. Oral Abstract Presentation at the 48th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Philadelphia, PA, November 2006, International Journal of Radiation Oncology, Physics, Biology, 66(3): Supp; 2006: S94, 167.

Kohl, R., Swann, S., Watkins-Bruner, D., Kaiser, L., Sause, W., Choy, H., Movsas, B. Pretreatment Quality of Life in a Prospective Lung Cancer Trial: Should Gender Differences be Stratified by Performance Status? Poster Abstract Presentation at the 48th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Philadelphia, PA, November 2006, International Journal of Radiation Oncology, Physics, Biology, 66(3): Supp; 2006: S542, 2597.

Freedman, G., Anderson, P., Goldstein, L., Litwin, S., Li, J., Watkins-Bruner, D., Nicolaou, N., Swaby, R., Sigurdson, E., Morrow, M. A Phase II Study of Four-Week Radiation For Breast Cancer Using Hypofractionated Intensity Modulated Radiation Therapy (IMRT) With An Incorporated Boost Poster Discussion Abstract Presentation at the 48th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Philadelphia, PA, November 2006, International Journal of Radiation Oncology, Physics, Biology, 66(3): Supp; 2006: S176, 1080.

Bruner, D.W., James, J., Hartsell, W., Konski, A., Curran, W., Roach, M, Doncals, D., Movas, B., Movsas, B., Lee, D., Scarantino, C. Patient Reported Outcomes (PROs) Support Change In Practice In U.S. Palliative Radiation Therapy For Osseous Metastases (RTOG 9714). 13th Annual Conference of the International Society for Quality of Life Research October 10 - 14, 2006 Lisbon Portugal Quality of Life Research, A-43, Abstract #1566.

Konski, A., Bhargavan, M., Owen, J., Paulus, R., Cooper, J., Fu, K., Ang, K., Bruner, D. W. Altered Fractionated Radiotherapy is Cost-Effective in the Treatment of Locally Advanced Head and Neck Cancer: An Economic Analysis of Radiation Therapy Oncology Group (RTOG) 90-03. Oral Abstract Presentation at 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO), Atlanta, GA, June 2-6, 2006; Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I, 24(18S) (June 20 Supp), 2006:6007

Konski, A., DeSilvio, M., Hartsell, W., Watkins-Bruner, D., Coyne, J., Scarantino, C., Janjan, N. Continuing Evidence for Poorer Treatment Outcomes for Single Male Patients: Re-treatment Data from RTOG 97-14. Poster Abstract Presentation at the 47th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Denver, CO, October 2005, International Journal of Radiation Oncology, Physics, Biology, 63(2): Supp; 2005:S192, 1079.

Bruner, DW Page 29 of 57 Movsas, B., Moughan, J., Swann, S., Coyne, J., Konski, A., Komaki, R., Bradley, J., Langer, C., Choy,

H., Watkins-Bruner, D. Back to B.E.D……Predictors of Outcome in RTOG Non-Operative Non-Small Cell Lung Cancer (NSCLC) Trials, Poster Discussion at the 47th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Denver, CO, October 2005, International Journal of Radiation Oncology, Physics, Biology, 63 (2): 1139 Supp; 2005: S230-S231. (#50)

Konski, A., Feigenberg, S., Bower, A., Raysor, S., Eisenberg, D., Mirchandani, I., Uzzo, R., Greenberg, R., Horowitz, E., Pollack, A., Hanks, G., Watkins-Bruner, D. Twenty-Five Percent Positive Biopsy Rate in a High-Risk Prostate Cancer Screening Program with a PSA < 2.5 ng/ml. Poster Presentation at 42th Annual Meeting of the American Society of Clinical Oncology (ASCO), Orlando, FL, May 14-17, 2005; Journal of Clinical Oncology, 23(16S) Supp; 2005:392.

Hartsell, W., Winter, K., Watkins-Bruner, D., Scarantino, C., Ivker, R., Roach III, M., Suh, J., Demas, W., Movsas, B., Petersen, I. and Konski, A.: Breast Cancer Patients have Better Outcomes than Prostate Cancer Patients for Palliation of Painful Bone Metastases: Results of RTOG 97-14. Poster Presentation at 42th Annual Meeting of the American Society of Clinical Oncology (ASCO), Orlando, FL, May 14-17, 2005; Journal of Clinical Oncology, 23(16S) Supp; 2005: 607.

Bruner, D.W., Konski, K., Feigenberg, S., Dewberry-Moore, N., Goplerud, J. Benchmarking African-American Recruitment to Cancer Control Trials with Social Marketing and Direct Response Radio. Poster Abstract Presentation at 8th National Conference on Cancer Nursing Research, Ft. Lauderdale, FL, February 3-5, 2005. Oncology Nursing Forum, 32(1); 2005:180.

Bruner, D.W., Winter, K., Hartsell, W., Konski, A., Curran, W., Roach, M, Doncals, D., Movas, B., Lee, D., Scarantino, C. Prospective Health-Related Quality of Life Valuations (utilities) of 8 Gy in 1 Fraction vs 30 Gy in 10 Fractions for Palliation of Painful Bone Metastases: Preliminary Results of RTOG 97-14. Oral Abstract Presentation at the 46th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Atlanta, GA,, October 4, 2004, International Journal of Radiation Oncology, Physics, Biology, 60(1) Supp; 2004: S142.

Hartsell, W.F., DeSilvio, M., Bruner, D.W., Scarantino, C., Ivker, R., Roach, M., Suh, J., Demas,W., Movsas, B., Petersen, I., Konski, A. Can physicians accurately predict survival time in patients with metastatic cancer? Analysis of RTOG 9714. Oral Abstract Presentation at the 46th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Atlanta, GA,, October 4, 2004, International Journal of Radiation Oncology, Physics, Biology, 60(1) Supp; 2004: S143.

Konski, A., Watkins-Bruner, D., Feigenberg, S., Hanlon, A., Kulkarni, S.^, Beck, R., Pollack A. Intensity Modulated Radiation Therapy (IMRT) is a Cost-Effective Treatment for Intermediate Risk Prostate Cancer Oral Abstract Presentation at the 46th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Atlanta, GA,, October 4, 2004, International Journal of Radiation Oncology, Physics, Biology, 60 (1) Supp; 2004: S144.

Movsas, B., Konski, A., Pajak, T., Coyne, J., Gwede, C., Garden, A., Spencer, S., Jones, C., Watkins-Bruner, D. Quality of Life (QOL) Variables Influence Local Regional Control in Radiation Therapy Oncology Group (RTOG) Head & Neck Trials (9003 and 9111). Oral Abstract Presentation at the 46th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Atlanta, GA,, October 6, 2004, International Journal of Radiation Oncology, Physics, Biology, 60(1) Supp; 2004:S252.

Konski, A, Pajak, T, Movsas, B, Coyne, J, Harris, J H., Gwede, C., Garden, A., Spencer, S., Jones, C., Watkins-Bruner, D. Socio-demographic variables influence outcome in Radiation Therapy Oncology Group head and neck trials. Poster Presentation at 40th Annual Meeting of the American Society of Clinical Oncology (ASCO), New Orleans LA, June 5-8, 2004. Journal of Clinical Oncology, 22(14S) Supp; 2004:6043.

Kulkarni, S.^, Hanlon, A., Konski, A., Pollack, A., Horwitz, E., Raysor, S., Bruner D.W. Case-Matched Controlled Study Shows Men Prefer Prostate Brachytherapy To Conformal Radiation Therapy. Poster Presentation at International Society for Pharmacoeconomics & Outcomes Research (ISPOR) 9th Annual International Meeting, Arlington, VA. May 16-19, 2004. Value in Health, 7(3):253.

Bruner, DW Page 30 of 57 Watkins Bruner D., Linton, S.^, Mazzoni, S.^, Daly, M., Dewberry-Moore, N., Konski, A., Uzzo, R.

African American Recruitment in Prostate Cancer Research: Unprecedented Success with Relationship Marketing. Plenary Presentation at the 28th Annual Meeting of the American Society of Preventive Oncology (ASPO), Bethesda, MD, March 14-16, 2004. Cancer Epidemiology, Biomarkers & Prevention, 13(2):333. (#40)

Hartsell, W.F., Scott, C., Bruner, D. W., Scarantino, C.W., Ivker, R., Roach, M., Suh, J., Demas, W., Mosvas, B., Petersen, I., Konski, A. Phase III Randomized Trial of 8 Gy in 1 Fraction vs. 30 Gy in 10 Fractions for Palliation of Painful Bone Metastases: Preliminary Results of RTOG 97-14. Accepted for Plenary Presentation at the 45th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Salt Lake City, UT, October 19-23, 2003, International Journal of Radiation Oncology, Physics, Biology, 57(2S):124.

Konksi, A. Bruner, D.W., Monte Carlo Simulation of a Markov Model for a Phase III Clinical Trial Evaluating the Addition of Total Androgen Suppression (TAS) to Radiation Versus Radiation Alone for Locally Advanced Carcinoma of the Prostate (RTOG 86-10). Accepted for Oral Abstract Presentation at the 45th American Society of Therapeutic Radiologists & Oncologists (ASTRO), Salt Lake City, UT, October 19-23, 2003, International Journal of Radiation Oncology, Physics, Biology, 57(2S):215-216.

Bruner, D.W., Barsevick, A., Tian, C., Randall, M., Mannel, R., Cohn, D., Sorosky, J., Spirtos, N. Quality of Life Trade-Off to Incremental Gain in Survival on Gynecologic Oncology Group (GOG) Protocol 122: Whole Abdominal Irradiation (WAI) vs. Doxorubicin-Platinum (AP) Chemotherapy in Advanced Endometrial Cancer. Poster Abstract Presentation at 39th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, IL, May 31-June 3, 2003, Journal of Clinical Oncology, 22; 2003: 449.

Bruner, D.W., Hanlon, A., Kulkarin, S.^, Mazzoni, S.^, Linton, S.^, Konski, A., Pollack, A., Greenberg, R., Beck, J.R. Differences In Husband/Wife Preferences And Utilities For Prostate Cancer Therapies, Poster Abstract Presentation at 8th Meeting of International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Arlington, VA, May 19, 2003, Value in Health, 6(3); 2003: 235-6.

Kulkarni, S.^, Bruner D. W., Babb, J., Uzzo, R., Konski, A., Lai, J. Cella, D. Quality of Life Profile of Men At-Risk for Prostate Cancer: The Fit and the Worried Well. Poster Abstract Presentation at ISPOR 8th Annual International Meeting, Arlington, VA, May 19, 2003, Value in Health, 6(3); 2003:235.

Movsas B., Scott C., Bruner D.W., Pre-Treatment Factors Significantly Influence Quality Of Life In Cancer Patients: A Radiation Therapy Oncology Group (RTOG) Analysis. Oral Abstract Presentation at the 9th Annual Conference of the International Society for Quality of Life Research (ISQOL) Orlando, Fl, October 30 - November 2, 2002, Quality of Life Research, 11 (7); 2002: 623.

Bruner D.W., Hanlon A, Mazzoni S^, Sargent T, Hanks G. Predictors of Preferences, Utilities And Quality Of Life In Men Treated With 3DCRT For Prostate Cancer. Oral Abstract Presentation at the American Society of Therapeutic Radiologists & Oncologists (ASTRO), New Orleans LA, October 2002, International Journal of Radiation Oncology, Physics, Biology, 54(2S); 2002: 47.

Lee, W.L., Scott, C., Lawton, L., Morton, G., Pisansky, T., Baikadi, M., Bruner, D.W., Sandler, H. Health-Related Quality of Life (HRQOL) in Men Treated with Prostate Brachytherapy Alone on Radiation Therapy Group (RTOG) Trail 98-05. Oral Abstract Presentation at the American Society of Therapeutic Radiologists & Oncologists (ASTRO), New Orleans LA, October 2002, International Journal of Radiation Oncology, Physics, Biology, 54(2S); 2002: 47-48.

Bruner, D.W., Hanlon, A., Sargent, T., Mazzoni, S.^, Raysor, S., Hanks, G. Behind The Veil of Ignorance: Assessment of Preferences and Utilities From Men At-Risk For Prostate Cancer. Oral Abstract Presentation at the 7th Annual Meeting of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Arlington, VA, May 2002. Value in Health, 5(3): 2002: 130.

Uzzo, R., Parlanti, A.^, Raysor, S., Horwitz, E., Hanks, G.E., Mirchandani, I., Greenberg, R., Bruner,

Bruner, DW Page 31 of 57 D.W. Prostate Cancer Detection Utilizing Free PSA in a High-Risk Population of Men with

Normal Exams and Total PSA. Oral Abstract Presentation at the 100th Annual Meeting of the American Urological Association (AUA), Orlando, FL, May, 2002. Journal of Urology, 167 (4): 2002: 209. (#30)

Miller, S.M., Sherman, K. A., Rodoletz, Brower, L., Diefenbach, M., Bruner, D.W. Enhancing Participation in and Adaptation to Prostate Cancer Risk Assessment Programs and Screening Adherence. Poster Abstract Presentation at the 2nd Annual Scientific Meeting of the American Academy of Health Behavior, Napa Valley, CA, March, 2002, Annals of Behavioral Medicine, 24, Supplement; 2002: S184.

Parlanti, A.^ Hanlon, A., Raysor, S., Bruner, D.W. Reasons Why Men are Interested in Genetic Testing for Cancer: Comparisons by Age, Race and Family History. Poster Abstract Presentation at the 20th Annual Meeting of the National Society of Genetic Counselors (NSGC), Washington, DC, November 2001. Dec 2001, Journal of Genetic Counseling, 10(6): 433-526.

Bruner, D.W., Parlanti, A.^, Raysor, S., Mazzoni, S.^, Sargent, T. Evaluating Men’s Interest in Interactive Technology Use to Facilitate Prostate Cancer Education and Risk Counseling. Poster Abstract Presentation at the 51st Annual Meeting of the American Society of Human Genetics (ASHG), San Diego, CA, October 2001. American Journal of Human Genetics, 69(4); 2001:380.

Bruner, D.W., Parlanti, A.^, Ross, E., Raysor, S., Mazzoni, S.^, Hanks,G. Categorization Of Risk of Prostate Cancer: Pilot Test of Clinical Outcomes and Risk Perceptions. Poster Abstract Presentation at the 6th Annual Meeting of International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Arlington, VA, May 2001. Value in Health, 4(2): 83.

Scott, C., Stern, J., Asbell, S., Brereton, D., Peer, J., Littman, P., Scarantino, C., Bruner, D.W. Quality of Life of Long-Term Survivors of Head and Neck or Prostate Cancer: Preliminary Results from a Survey of Survivors from Radiation Therapy Oncology Group (RTOG) Clinical Trials. Abstract Presentation at the 7th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Vancouver, Canada, October 2000. Quality of Life Research, 9 (3); 2000: 262.

Bruner, D.W., Determination Of Preferences For The Treatment Of Prostate Cancer. Oral Abstract Presentation at the Oncology Nursing Society (ONS), San Antonio, TX, May 2000. Oncology Nursing Forum, 27(2); 2000: 347.

Bruner, D.W., Baron, J. Validity of the Time-Trade Off Technique in Determining Preferences for the Treatment of Prostate Cancer. Poster Abstract Presentation at 5th Annual Meeting of International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Washington DC, May 2000. Value in Health, 3(2); 2000: 134-135.

Monga, T., Robinson-Whelen, S., Monga, U., Bruner, D. W., & Graves, D. E. Subjective fatigue: A missing piece in the rehabilitation process. Poster Abstract Presentation at the 2nd National Department of Veterans Affairs Rehabilitation Research and Development Conference, Washington, D.C., February, 2000.

Tiwari, S., Movsas, B., Hanks, G., Bruner, D.W., Pinover, W., Horwitz, E., Goosenberg, E., Hanlon, A., Frucht, H. Quality of Life (Fact-C) Scores Remain at Baseline Following Conformal

Radiotherapy for Prostate Cancer: A Prospective Study. Poster Abstract Presentation at the American Society of Therapeutic Radiologists & Oncologists (ASTRO), San Antonio, TX, October 1999. International Journal of Radiation Oncology, Physics, Biology, 45(2) Supplement; 1999: 431.

Bruner, D.W., Ross, E., Raysor, S., Hanlon, A., James. J., Grumet, S.^, Hanks, G. Men Treated With Radiotherapy Have Better Global Quality of Life Outcomes Despite Decrements in Site-Specific Quality-of-Life Domains Than Men at Increased Risk but Without Prostate Cancer. Poster Abstract Presentation at the American Society of Therapeutic Radiologists & Oncologists (ASTRO), San Antonio, TX, October 1999. International Journal of Radiation Oncology, Physics, Biology, 45(2) Supplement; 1999:432. (#20)

Wurzer, J.^, Nicolaou, N.^, Hanlon, A., Bruner, D.W., Hanks, G. Long Term Durability of Potency Preservation in Younger Prostate Cancer Patients Following 3D Conformal Radiation Therapy.

Bruner, DW Page 32 of 57

Oral Abstract Presentation at ASTRO, San Antonio, TX, October 1999. International Journal of Radiation Oncology, Physics, Biology, 45(2) Supplement; 1999: 169.

Pinover, W., Bruner, D., James, J., Grumet, S.^, Greenberg, R., Hanks, G. Screening with Free PSA Benefits Men at High Risk of Developing Prostate Cancer. Oral Abstract Presentation at ASTRO, San Antonio, TX, October 1999. International Journal of Radiation Oncology, Physics, Biology, 45(2) Supplement; 1999: 354.

Hanlon, A.L., Bruner, D.W., Hanks, G.E. Long Term Quality-of-Life Study in Prostate Cancer Patients Treated with Three Dimensional Conformal Radiation Therapy: Bowel and Bladder Quality-of-Life Symptoms are Similar to that of the Normal Population. Oral Abstract Presentation at ASTRO, San Antonio, TX, October 1999. International Journal of Radiation Oncology, Physics, Biology, 45(2) Supplement; 1999: 240. (#20)

Grumet S.C.^, James, J., Bruner, D.W., Raysor, S., Hanks, G.E. Risk Perceptions and Attitudes Regarding Genetic Testing in Men at Risk for Prostate Cancer. Oral Abstract Presentation at the 18th Annual Meeting of the National Society of Genetic Counselors (NSGC), Oakland, CA, October 1999. Journal of Genetic Counseling, 8(6); 1999: 378-9.

Tricoli, J.V., Winter, D.L., Hanlon, A.L., Raysor, S.L., Bruner, D.W., Pinover, W.N. & Hanks, G.E. Racial Differences in Insulin-Like Growth Factor Binding Protein 3 in Men at Increased Risk for Prostate Cancer. Oral Abstract Presentation at the Annual Meeting of the American Association of Cancer Research (AACR), Philadelphia, PA, April 1999. Urology, 54(1); 1999:178-182.

Miller, S.M., Schnoll, R.A., Diefenbach, M.A., Ohls, L.O., Bruner, D.W., Baffoe-Bonnie, A., Hanks, G. & Engstrom, P.F. Genetic Testing for Prostate Cancer: Degree of Willingness and Predictors of Interest. Oral Abstract Presentation at the Annual Meeting of the Society of Behavioral Medicine, San Diego, CA, March 1999. Annals of Behavioral Medicine, 21 Supplement; 1999: 77.

Schnoll, R.A., Diefenbach, M.A., Miller, S.M., Bruner, D.W., Baffoe-Bonnie, A., Hanks, G., Engstrom, P.F. Factors related to screening for prostate cancer. Abstract Presentation at the Annual Meeting of the Society of Behavioral Medicine, San Diego, CA, March 1999. Annals of Behavioral Medicine, 21 Supplement; 1999: 120.

Bruner, D.W., Scott, C., McGowan, D., Lawton, C., Hanks, G., Prestidge, B., Han, S., Gore, E., Asbell, S., Rotman, M. Factors Influencing Sexual Outcomes in Prostate Cancer Patients Enrolled on Radiation Therapy Oncology Group (RTOG) Studies. Oral Abstract Presentation at the 5th Annual Conference of the International Society for Quality of Life Research (ISQOL), Baltimore, MD, November 1998. Quality of Life Research, 7(7); 1998:575-576.

Movsas, B., Hanlon, A., Bruner, D.W., Freedman, G., Pinover, W., Scott, D., Weiner, L., Scher, R., Sigurdson, E., Hoffman, J., Lanciano, R., Coia, L. Prospective QOL (FACT-C) & Sexual Adjustment (SAQ) in Patients with Locally Advanced Rectal Cancer. Presentation at the 5th Annual Conference of the International Society for Quality of Life Research (ISQOL), Baltimore, MD, November 1998. Quality of Life Research, 7(7); 1998: 641.

Bruner, D.W, Scott, C.B., McGowan, D., Lawton, C., Hanks, G., Prestidge, B., Han, S., Gore, E., Asbell, S. The RTOG Modified Sexual Adjustment Questionnaire: Psychometric Testing in the Prostate Cancer Population. Presentation at the American Society for Therapeutic Radiology and Oncology (ASTRO), Phoenix, AZ, October 1998. International Journal of Radiation Oncology, Physics, Biology, 42(1) Supplement; 1998: 202. (#10)

Desobry, G.E., Bruner, D.W., Movsas, B., Schultheiss, T.E. Automated Segmented Field Selection for IMRT Using Utility Based Decision Theory. Abstract Presentation at ASTRO, Phoenix, AZ, October 1998. International Journal of Radiation Oncology, Physics, Biology, 42(1) Supplement; 1998: 206.

Wurzer, J.^, Nicolaou, N.^, Hanlon, A., Bruner, D.W., Hanks, G. Long Term Durability of Potency Preservation in Younger Prostate Cancer Patients Following 3D Conformal Radiation Therapy. Presentation at ASTRO, Phoenix, AZ, October 1998. International Journal of Radiation Oncology, Physics, Biology, 42(1) Supplement; 1998: 206.

Wasserman, T., Scott, C., Bruner, D.W., Fisher, J., Riese, N., Allaster, R., Leonard, B. Quality of Life Research in the Radiation Therapy Oncology Group (RTOG). Oral Abstract Presentation at the

Bruner, DW Page 33 of 57

4th Annual Conference of the International Society for Quality-of-Life Research, (ISOQOL) Vienna, Austria, November 1997. Quality of Life Research, 7(7); 1997: 739-740. (#10)

Barsevick, A., Langer, C., Bruner, D.W., Leighton, J., Luckscherden, C., Bonjo, C., McAleer, C. Correlation of Quality of Life (QOL) with Survival, Treatment, Response, and Anemia in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) treated with carboplatin and paclitaxel. Journal of Clinical Oncology, 16; 1997: 44a.

Bruner, D.W., Hanlon, A., Nicolaou, N.^, Hanks, G. Sexual Function after Radiotherapy + Androgen Deprivation for Clinically Localized Prostate Cancer in Younger Men (age 50-65). Oral Abstract Presentation at the Oncology Nursing Society, New Orleans, LA, May 1997. Oncology Nursing Forum, 24(2); 1997: 327.

Nicolaou, N.^, Bruner, D.W., Hanlon, A., Hanks, G. Preservation of Sexual Function in Younger Prostate Cancer Patients after Radiation Therapy: A Positive Factor in Choice of Treatment Modality. Oral Abstract Presentation at ASTRO, Los Angeles, CA, October 1996. International Journal of Radiation Oncology, Physics, Biology, 36, (1): 1996: 270.

Bruner, D.W., Scott, C., Lawton, C., DelRowe, J., Rotman, M., Buswell, L., Beard, C., Cella, D. RTOG’s first Quality of Life Study - RTOG 9020. Oral Abstract Presentation at ASTRO, San Francisco, CA, October 1994. International Journal of Radiation Oncology, Physics, Biology, 30(S1); 1994: 193.

Bruner, D.W. Research Utilization: The Key to Excellence In Cancer Nursing Practice. Oral Abstract Presentation at the Oncology Nursing Society Annual Congress, Cincinnati, OH, May 1994. Oncology Nursing Forum, 21(2); 1994: 364.

Keegan, M.^, Bruner, D.W., Lanciano, R., Hanks, G. Vaginal Stenosis and Sexual Function Following Intracavitary Radiation for the Treatment of Cervical and Endometrial Carcinoma. Oral Abstract Presentation at ASTRO, San Diego, CA, November 1992. International Journal of Radiation Oncology, Physics, Biology, 24(S1); 1992: 208.

Abstracts in Proceedings or Unpublished (44) Bruner, DW. Vaginal Dilator Adherence and Vaginal Length after Vaginal Brachytherapy for

Endometrial Cancer.” Oral Abstract at the BIT 7th Annual World Cancer Congress, Nanjing China

Tran, L.^, Wells, J.^, Bruner, DW. Poster Abstract “The Relationship between Body Mass Index and Sexual Activity in Women with Endometrial Cancer Prior to Radiation Therapy,” Southern Nursing Research Conference, San Antonio, TX, February 12-15, 2014.

Ong, L.^, Xiao, C.^, Bruner, DW. Poster Abstract “Gender Disparities in NIH Funding of Female vs Male Sexual Function Research,” Southern Nursing Research Conference, San Antonio, TX, February 12-15, 2014.

Yeager, K.^, Bruner, J., Pugh., S., Bruner, D.W. Clinical Trial Participation: Differences in Distance Traveled Across Different Ethnic Groups. Poster Abstract Presentation at Sixth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved. Atlanta, GA., December 6-9, 2013

Bruner, J., Stine, S.H., James, J., Heron, D., Curran, W., Bruner, D.W. Using Cartographic Mapping to Assess and Develop Strategies to Improve Latino Recruitment to Radiation Therapy Oncology Group Clinical Trials. Poster Abstract Presentation at NCI-ASCO Cancer Trial Accrual Symposium, Bethesda, MD., April 29-30, 2010. (#40)

Consoli, S.^, James, ,J., Pisansky, T., Rotman, M., Corbett, T., Speight, J., Byhardt, R., Sandler, H., Kachnic, L., Berk, L., Bruner, D.W. Process and Funding Barriers to Symptom Management Trials Conducted through NCI Cooperative Groups: the Example of RTOG 0215. Using Cartographic Mapping to Assess and Develop Strategies to Improve Latino Recruitment to Radiation Therapy Oncology Group Clinical Trials. Poster Abstract Presentation at NCI-ASCO Cancer Trial Accrual Symposium, Bethesda, MD., April 29-30, 2010.

Ulrich, C.^, James, J., Walker, E., Stine, S.H., Gore, E., Prestidge, B., Michalski, J., Gwede, C., Waite, T., Bruner, D.W. What Is Adequate Knowledge in Communicating Clinical Trials? Poster

Bruner, DW Page 34 of 57

Abstract Presentation at NCI-ASCO Cancer Trial Accrual Symposium, Bethesda, MD., April 29-30, 2010.

Reardon, J.^, James, J., Thomas, T. Leistiko, R., Neading, J., Neimanis, D., Stern, J., Consoli, J., Hanish L., Bruner, D.W. Identification of Patient Level Barriers and Facilitators to RTOG Clinical Trials Recruitment. Poster Abstract Presentation at NCI-ASCO Cancer Trial Accrual Symposium, Bethesda, MD., April 29-30, 2010.

Mao, J.J.^, Gehrman, P.R., Su, I.H., Bruner, D.W., Xie, S.X., El Sehamy, A., DeMichele, A.M. Prevalence and Risk Factors for Insomnia in Breast Cancer Survivors Receiving Aromatase Inhibitors San Antonio Breast Cancer Symposium, San Antonio, TX, December 2009.

Goldhagen, L.^, Consoli, S., Kerrin, K., Bruner, D.W., Study to Assess NCI-designated Comprehensive Cancer Center Resources for Human Subjects Recruitment, Poster Abstract Presentation. 21st Meeting of the Eastern Nursing Research Society, Boston MA, March 19-21, 2009. Awarded the Eastern Nursing Research Society’s First Place Undergraduate Poster Award (#35)

Siddiqui, F., Bae, B, Langer, C., Coyne, J., Gamerman, V., Komaki, R., Choy, H., Curran, W., Watkins-Bruner, D., Movsas, B. The Influence of Gender, Race And Marital Status on Survival in Lung Cancer Patients: Meta-Analysis of Radiation Therapy Oncology Group (RTOG) Trials. EPoster at International Association for the Study of Lung Cancer (IASLC), 13th World Conference on Lung Cancer, San Francisco, CA, July 31-August 4, 2009.

Mao J.J.^, Stricker, C., Bruner, D.W, Farrar, J.T., Bowman, M.A., Xie, S.X., Wolf, J., DeMichele, A. Onset and Risk Factors for Aromatase Inhibitor-Related Arthralgia in Breast Cancer Survivors. San Antonio Breast Cancer Symposium, San Antonio, TX, December 2008.

Mao, J.J.^, Stricker, C., Farrar, J.T., Xie, S.X., Bowman, M.A., Bruner, D.W., Pucci, D., Han, X., DeMichele, A. Feasibility Trial of Electro-Acupuncture for Aromatase Inhibitor Related Arthralgia in Breast Cancer Survivors. San Antonio Breast Cancer Symposium, San Antonio, TX, December 2008.

Wetmore-Arkader, L.^, Bryan, C.^, Calvano, T.^, and Deatrick, J., Giri, V., Bruner, D.W. Adapting Ethnically-Appropriate, Information-Seeking and Recruitment Messages for a Prostate Cancer Screening Program Using Focus Groups. Society for Applied Anthropology, Memphis, TN, March 2008.

Bruner, D.W., Hanlon, A., Trotta, R., Konski, A., Horwitz, E., Kulkarni, S.^, Giri, V. Preferences for Prostate Cancer Screening and Treatment: Assessment of Message Framing and Theoretical Underpinnings, U.S. Department of Defense Prostate Cancer Research Program (PCRP), Innovative Minds in Prostate Cancer Today (IMPaCT) Meeting, Bethesda, MD, September 7, 2007. (#30)

Bruner, DW, Wetmore-Arkader, L^. Recruitment, Retention and Outreach Core (RROC) Facility, University of Pennsylvania, Abramson Cancer Center, Eunice and Irving Leopold Annual Scientific Symposium, March 13, 2006

Wetmore-Arkader, L^, Patterson, F, Kerrin, K, Ware, S, Lerman, C, Bruner, DW. A RROC Outcomes Evaluation of Media Recruitment: The TTURC Experience, University of Pennsylvania, Abramson Cancer Center, Eunice and Irving Leopold Annual Scientific Symposium, March 13, 2006

Bryan, C^, Wetmore-Arkader, L^, Calvano, T^, Bruner, DW. Using Focus Groups to Adapt Ethnically-Appropriate, Information-Seeking and Recruitment Messages for a Prostate Cancer Screening Program, University of Pennsylvania, Abramson Cancer Center, Eunice and Irving Leopold Annual Scientific Symposium, March 13, 2006

Berk, L, Swann, S, Bruner, D.W., Fisher, J, Kachnic, L, Stevens, R, Roach, M, Rabin, A, McCormick, B. Qualitative Comparison of Observer-Reported and Patient-Reported Outcomes in Radiation Therapy Oncology Group Trial 9713, A Randomized Trial of Trolamine for Prevention of Breast Dermatitis. Poster Abstract Presentation at the NIH Patient-Reported Outcomes Assessment in Cancer Trials: Evaluating and Enhancing the Payoff to Decision Making, Bethesda, MD, September 20-21, 2006.

Buzaglo, J., Miller, S., Young, W., Treat, J., Watkins-Bruner, D. Community Tailoring of Prostate Cancer Outreach and Recruitment: Beginning with Focus Groups. Poster Abstract Presentation at

Bruner, DW Page 35 of 57

the First Annual PAC3 Summit, PA Department of Health, Harrisburg, PA, March 11, 2005. (#25)

Konski, A., Feigenberg, S., Eisenberg, Uzzo, R., Watkins-Bruner, D. Black Men with Family History of Prostate Cancer Diagnosed at Younger Age than White Men with Similar Family History Poster Abstract Presentation at the First Annual PAC3 Summit, PA Department of Health, Harrisburg, PA, March 11, 2005.

Konski, A., Feigenberg, S., Bower, A., Raysor, S., Eisenberg, D., Mirchandani, I., Uzzo, R., Greenberg, R., Pollack, A., Hanks, G., Watkins-Bruner, D. African-American Males in a High-Risk Screening Clinic Diagnosed with Prostate Cancer at a Younger Age. Poster Abstract Presentation at the ASCO/AUA Multidisciplinary Prostate Cancer Symposium, Orlando, FL, February 17-19, 2005.

Feigenberg, S., Konski, A., Bower, A., Raysor, S., Eisenberg, D., Mirchandani, I., Uzzo, R., Horowitz, E., Hanks, G., Watkins-Bruner, D. Obesity does not improve prostate cancer detection in a high-risk population. Poster Abstract Presentation at the ASCO/AUA Multidisciplinary Prostate Cancer Symposium, Orlando, FL, February 17-19, 2005.

Freedman, G., Anderson, P., Goldstein, L., Li, J., Hanlon, A., Watkins-Bruner, D., Nicolaou, N., Torosian, M., Sigurdson, E., Hoffman, J., Joseph, N., Morrow, M. A Phase II Clinical Trial of a

Four-Week Course of Radiation For Breast Cancer Using Hypofractionated Intensity Modulated Radiation Therapy (IMRT) With an Incorporated Boost. Poster Abstract Presentation at the 27th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 8 - 11, 2004.

Pajak, TF, Konski, A, Movsas, B, Coyne, J, Harris, J, Gwede, C, Garden, A, Spencer, S, Jones, C, Watkins-Bruner, D. Marital Status and Gender Interaction Affecting Survival in RTOG Head and Neck Trials. 6th International Conference on Head & Neck Cancer. Washington DC, August 7-11, 2004. (#20)

Konski, A, Watkins-Bruner, D., Brereton, & Hanks, G. Long-Term Hormone Therapy in addition to Radiation is Cost-Effective in the Treatment of Patients with Locally Advanced Prostate Cancer: An Economic Analysis of Radiation Therapy Oncology Group (RTOG) protocol 92-02. Oral Abstract Presentation at American Radium Society, Napa Valley, CA, May 1-5, 2004.

Mazzoni, S.^, Bruner, D.W., Raysor, S., Konksi, A. Uzzo, R. An Evaluation of Participant Satisfaction with Services Provided in a Prostate Cancer Risk Assessment Program. Accepted for Oral Abstract Presentation at 131st Annual Meeting of the American Public Health Association (APHA), November 15-19, 2003, San Francisco, CA. (#60)

Konski A., Bruner D. W., Raysor S., Pollack A. Association of Cytokine Levels, Race, And Diabetes Status In A High Risk Prostate Cancer Population. Abstract Accepted for Oral Abstract Presentation at the Second International Conference on Translational Research and Pre-Clinical Strategies in Radiation Oncology, Lugano, Switzerland, March16-19, 2003.

Mazzoni, S.^, Bruner, D.W., Raysor, S. ‘I Forgot’ and Other Reasons Why Men Do Not Show for Their Prostate Cancer Education and Screening Appointment. Oral Abstract Presentation at the 130th Annual American Public Health Association Meeting in Philadelphia, PA, November 12, 2002.

Cornwell, TE, Mazzoni, SE^, and Bruner, D.W. Analysis of Qualitative Data From the Time Trade-Off Technique: Preferences for Prostate Cancer Treatment. Oral Abstract Presentation at the 130th Annual American Public Health Association Meeting in Philadelphia, PA, November 12, 2002.

O’Brien T.G., Parlanti A., Guo Y., Boorman D., Visvanathan K., Helzlsouer K., Bruner D.W. Ornithine Decarboxylase Allele Frequency Distribution in Caucasians and African Americans. Poster Abstract Presentation at the 52nd Annual Meeting of the American Society of Human Genetics (ASHG), Baltimore, MD, October 2002.

Bruner, D.W., Hanlon, A., Raysor, S., Miller, S.M., Diefenbach, M., Horwitz, E., Uzzo, R., Engstrom, P. Predictors of Scheduled Screening Visit Show vs. No-Show Behavior in Men at High-Risk For Prostate Cancer. Poster Abstract Presentation at the 26th Annual Meeting of the American Society of Preventive Oncology (ASPO), Bethesda, MD, March, 2002.

Parlanti, A.^, Moore, D., Hanlon, A., Bruner, D.W. Meta-analysis: Studies of Relative Risk of Prostate Cancer for Men with Affected Relatives. Poster Abstract Presentation at the 26th Annual Meeting of the American Society of Preventive Oncology (ASPO), Bethesda, MD, March, 2002.

Bruner, DW Page 36 of 57 Miller, S.M., Sherman, K.A., Rodoletz, M., Brower, L., Diefenbach, M.A & Bruner, D. W. Prostate

Cancer Risk Assessment: Enhancing Participation and Adaptation. Poster Abstract Presentation at the 26th Annual Meeting of the American Society of Preventive Oncology (ASPO), Bethesda, MD, March, 2002.

Miller, S.M., Sherman, K. A., Rodoletz, Brower, L., Diefenbach, M., Bruner, D.W. Enhancing Adaptation To Prostate Cancer Risk Feedback & Screening Adherence. Oral Abstract Presentation at the Pennsylvania Public Health Association (PPHA) Annual Conference, Philadelphia, PA, November, 2001. (#10)

Mazzoni, S.^, Bruner, D.W., Parlanti, A.^, Raysor, Sargent, T. Pre-Screening Education Improves Knowledge of Prostate Cancer in a Program for At-Risk Men. Oral Abstract Presentation at the Pennsylvania Public Health Association (PPHA) Annual Conference, Philadelphia, PA, November, 2001.

Bruner, D. W., Psychosexual Support for Women with Gynecologic or Breast Cancer: Improving Outcomes. Poster abstract at the Federation of International Gynecology and Obstetrics (FIGO), Washington, D.C. September 2000.

Scott, C., Scarantino, C., Bruner, D. W., Fu, K., Shipley, W. and Cooper, J.: Late Effects of Normal Tissue in Head and Neck and Prostate Cancer Patients Treated with Radiation Therapy. Res Issues in Canc Survivorship (NCI Workshop), Bethesda, MD, 1998.

Miller, S., Diefenbach, M.A., Hanks, G.E., Bruner, D.W., Baffoe-Bonnie, A., O’Donnell, M., Kruus, L. Cognitive-Affective Profiles of Patients at Risk for Prostate Cancer. Presentation at the Annual Meeting of the Society of Behavioral Medicine, New Orleans, LA, March 1998.

Wasserman, T., Scott, C., Bruner, D., Fisher, J., Riese, N., Allaster, R. and Leonard, B.: Quality-of-Life Research in the Radiation Therapy Oncology Group (RTOG). Presentation at Am Radium Soc (ARS), Monte Carlo, Monaco, May 1998. Proceedings Amer Rad Soc, 1998.

Bruner, D.W., Scott, C., Byhardt, R., Coughlin, C., Friedland, J., DelRowe, J. Changes in Urinary Function (CUF): Pilot Data on the Development and Validation of a Measure of the Intrusion on Quality-of-Life caused by changes in urinary function after cancer therapy. (RTOG 9116, 9020). Oral Abstract Presentation at the Drug Information Association 2nd Symposium on Quality of Life Evaluation. Charleston, SC, October 1994.

Scott, C. B., Stetz, J., Bruner, D. W. and Wasserman, T. H.: Design, Analysis, and Data Management Issues in Quality of Life Trials within the Radiation Therapy Oncology Group. Clinical Trials in Oncology: Improving Their Design and Analysis, Toronto, Ontario, 53, 1993.

Bruner, D.W. Quality Assurance in Radiation Oncology Nursing. Oral Abstract Presentation at European Clinical Conference on Cancer, Jerusalem, Israel, November 1993.

Scott, C., Stetz, J., Bruner D.W., Design, Analysis, and Data Management Issues in Quality of Life Trials within the Radiation Therapy Oncology Group. Presentation at the Drug Information Association Quality of Life Symposium, Charleston, SC, April 1993.

Books (5) Bruner, D.W., Haas, M., Goeslin, T. (2004). Manual for Radiation Oncology Nursing Practice and

Education, (3rd ed), Oncology Nursing Press, Pittsburgh. (#5) Bruner, D.W., Moore, G., Haas, M., (Eds). (2001). Outcomes in Radiation Therapy: Multidisciplinary Management. Jones and Bartlett Publishers, Boston. Bruner, D.W., Bucholtz, J., Iwamoto, R., Strohl, R. (1998). Manual for Radiation Oncology Nursing

Practice and Education, 2nd edition, Oncology Nursing Press, Pittsburgh. Bruner, D.W., Slivjak, A. (1994). Documentation Manual for Radiation Oncology Nursing. Fox Chase

Cancer Center Publication, Philadelphia, PA. Bruner D.W., Iwamoto R., Keane K., Strohl R., eds. (1992). Manual for Radiation Oncology Nursing

Practice and Education. Oncology Nursing Society. Chapters in books (11) Bruner, D.W., Berk, L. Design Challenges in Palliative Radiotherapy Clinical Trials, In Lutz, S., Chow,

E., Hoskin, P. (2013). Radiation Therapy in Palliative Cancer Care, Wiley, Hoboken.

Bruner, DW Page 37 of 57 Bruner, D.W. & Hanisch L., Distress/Coping; Bruner, D.W., Sexuality; and Bruner, D.W. & Hollis G.,

Clinical Practicum, In Haas, M., Goeslin, T., Iwamoto, R. (2012). Manual for Radiation Oncology Nursing Practice and Education, (4th ed), Oncology Nursing Press, Pittsburgh.

Lee, W.R., Bruner, D.W. (2004). Health-related quality of life (HRQOL) following prostate brachytherapy. In Dicker, A., Merrick, G. S., Valicenti, R. K., Waterman, F., & Gomella, L. G., (Eds.) Basic and Advanced Techniques in Prostate Brachytherapy. Martin Dunitz, London.

Uzzo, R. G., Watkins-Bruner, D., Horwitz, E.M., Konski, A., Pollack, A., Engstrom, P. F. Kolenko, V. (2003). Prostate cancer prevention: Strategies and realities. In Mydlo, J.H., Godec, C.J., eds. Prostate Cancer:Science and Clinical Practice. Academic Press, Amsterdam; San Diego. pp. 89-99.

Bruner, D.W., Berk, L. Altered Body Image and Sexual Health. (2003). In Cancer Symptom Management, (3rd ed). C. Yarbro, M. Frogge, M. Goodman, (Eds.) Jones and Bartlett Publishers, Boston: pp. 596-603. (#5) Bruner, D.W., Iwamoto, R. (1999). Altered Sexuality. In Cancer Symptom Management: Patient Self-Care Guides (2nd ed). C. Yarbro, M. Frogge, M. Goodman, (Eds.) Jones and Bartlett

Publishers, Boston: pp. 210-226. Bruner, D.W., Iwamoto, R. (1999). Altered Sexuality. In Cancer Symptom Management, (2nd ed). C.

Yarbro, M. Frogge, M. Goodman, (Eds.) Jones and Bartlett Publishers, Boston. Bruner, D. W., Iwamoto, R. (1996). Altered Sexuality. In Cancer Symptom Management. S.

Groenwald, M. Frogge, M. Goodman, C. Yarbro (Eds.) Jones and Bartlett Publishers, Boston: pp. 523-551.

Bruner D.W. (1992). Quality Assurance In Nursing Care In Radiation Oncology. K. Hassey Dow and L. Hilderley (Eds.). W. B. Saunders Co., Philadelphia. pp. 383-387.

Book Reviewer and Advisory Boards 1997-1999 Health Professionals Guides: Advisory Board, Springhouse Corporation, (series of 6 books) 1993 Nursing Care of the Gynecologic Oncology Patient, Moore, G. (Ed.), Reviewer, Jones &

Bartlett Publishers, Inc., Boston 1992 Radiation Therapy - Your Care During Treatment, Reviewer, Krames Communications

Publication Media Coverage and Videos 10/6/16 Medscape “More Evidence: Shorter RT Safe in Low-Risk Prostate Cancer”

http://www.medscape.com/viewarticle/869892 9/30/16 Oncology Nursing News http://nursing.onclive.com/oncnurse-tv/deborah-watkins-bruner- discusses-financial-toxicity 9/26/16 ScienceDaily “Hypofractionated radiation therapy can reduce treatment time by one-third

with comparable QOL for prostate cancer patients” https://www.sciencedaily.com/releases/2016/09/160926143016.htm

5/29/15 Urology Today http://www.urotoday.com/2014-09-18-02-47-34/prostate-cancer/80953-preliminary-patient-reported-outcomes-analysis-of-3-dimensional-radiation-therapy-versus-intensity-modulated-radiation-therapy-on-the-high-dose-arm-of-the-radiation-therapy-oncology-group-rtog-0126-prostate-cancer-trial-abstract.html

5/7/15 Oncology Nursing News http://nursing.onclive.com/oncnurse-tv/Deborah-Watkins-Bruner-Discusses-Physician-and-Patient-Reports-of-Toxicity; https://www.youtube.com/watch?v=8VfaFsamwcw

12/18/13 The Almagest (online journal) “Cognitive function drug proves beneficial for patients with brain cancer” (Results of RTOG memantine study)

3/16/12 A voice for patients. American Journal Constitution http://www.ajc.com/news/business/a-voice-for-patients/nQSFw/

Bruner, DW Page 38 of 57 4/9/10 Filmed CME video entitled, “Focus on Supportive Care for Patients with Cancer” for

National Comprehensive Cancer Network (NCCN) for online publication: http://www.medscape.com/editorial/forums/oncology/

2/13/07 My work with patient-reported outcomes and the RTOG cited in the Wall Street Journal, “FDA and Drug Makers Add Reports From Trial Participants To Traditional Measures Such as Survival, Tumor Shrinkage. By Amy Dockser Marcus, p. D1 and D4.

4/22/05; 6/30/04; 1/21/04; 12/19/03; 10/1/03; 9/23/03; 6/11/03; 1/07/03; 3/06/02; 2/20/02; 6/08/01 Personal appearance, Mary Mason Show, WHAT 1340 AM Radio, Philadelphia. The shows focused African-American men’s risk of prostate cancer and screening and treatment options.

6/20/04; 4/29/02 Personal appearance, Community Action Magazine with Host Tamlin Henry, WDAS 1480 FM Radio, Philadelphia. The shows focus on risk of prostate cancer and screening options.

9/03- 2/04 Newspaper and radio interviews including NPR news, Reuters, LA Times, Cancerpage.com, Reader’s Digest of Canada, and more for publication of “Relative Risk of Prostate Cancer for Men with Affected Relatives: Systematic Review and Meta-analysis” in International Journal of Cancer

2/02 Interview televised on CN8 News Makers with Carla Schoel-Lee. 2001-2002 Appeared in television advertisement for the FCCC Cancer High-Risk Programs, aired on

major Philadelphia Network stations. 6/25/01 President’s Panel on Cancer in Washington, DC, aired on C-SPAN. Testimony focused on

cancer screening and prevention programs reaching the underserved at-risk regardless of ethnicity or culture. http://www.c-span.org/person/?deborahbruner

3/01 Interview published in Men’s Journal, “The Prostate Paradox,” p. 63-8. 9/15/00 Interview published on Internet in www.CancerSource.com, “Dealing with Erectile

Dysfunction” 3/1/99 Prostate Cancer Risk Assessment Program. OncoTherapy Network.

http://www.oncotherapynetwork.com/login?referrer=http%3A//www.oncotherapynetwork.com%2Fprostate-cancer-risk-assessment-program-1

11/1/97 Quality of Life and Cost Effectiveness Outcomes of Androgen Deprivation Therapy for Prostate Cancer. OncoTherapy Network. http://www.oncotherapynetwork.com/login?referrer=http%3A//www.oncotherapynetwork.com%2Fquality-life-and-cost-effectiveness-outcomes-androgen-deprivation-therapy-prostate-cancer

1993 Assisted the RTOG in the development and participated in filming a quality of life video for patients, entitled ‘Quality of Life in Clinical Trials Research.’ Video can be viewed on the web at http://www.rtog.org/regulatory/regs.html (current as of October 2005).

LECTURES BY INVITATION, SPEECHES AND WORKSHOPS Plenary and Keynote Presentations (19) 4/16/16 Health Care Systems Research Network (HCSRN) Precision Medicine and Cancer

Symposium, Keynote Address, “Precision Medicine: Moonshots, Myths and Miracles” Atlanta, GA

5/5/15 American Radium Society 97th Annual Meeting, Keynote Address, “How High-Touch Informs High-Tech Radiation Oncology Research and Practice,” Kauai, Hawaii

4/24/15 40th Annual Oncology Nursing Society (ONS), 2015 Distinguished Researcher Lecture, “Chutes, Ladders and Other Strategies to a Successful Career in Science,” Orlando, FL

11/1/14 Georgia Nursing Leadership Coalition Doctoral Symposium, Opening Plenary, “Getting the most out of mentorship” Georgia Baptist College of Nursing at Mercer

University, GA

Bruner, DW Page 39 of 57 9/7/12 Oncology Nursing Society 2012 Radiation eConference, Keynote Address, “Achieving

Clinical Excellence in Radiation Oncology Nursing through Research and Evidence Based Practice”

4/17/12 Nell Hodgson Woodruff School of Nursing, Emory University, 2012 Nursing Research Symposium, Plenary Session, “Achieving Clinical Excellence through Research and EBP, Atlanta, GA

4/14/12 Abington Memorial Hospital,” Keynote Address, An African-American Women’s Empowerment Summit, Keynote Address, Recruitment of Minorities and Underserved Populations to Cancer Clinical Trials, Abington, PA

1/15/11 Radiation Therapy Oncology Group Plenary Session, “Matching Cancer Control Priorities to Cooperative Group Systems: Dynamic Design in an Equivocal Milieu.” San Diego, CA

2/3/07 Radiation Therapy Oncology Group, Plenary Session: “Predictors of Late Toxicities and Symptom Clusters in Radiation Therapy Oncology Group (RTOG) Prostate Cancer Trials of High Risk Patients: A Meta-analysis of Physician Rated Toxicities.” Tampa, FL. (#10)

9/9/05 Duke Oncology Network Retreat, Keynote Address, “Improving Quality of Life: Assessing and Managing Sexual Health in Oncology Patients” Raleigh-Durham, NC.

5/1/05 Henry Ford Hospital, Department of Radiation Oncology, Visiting Professor, “RTOG Outcomes Model: Combining Clinical, Humanistic and Economic Endpoints” Detroit, MI.

6/26/05 Radiation Therapy Oncology Group, Plenary Session: “Outcomes Associated with Cancer Therapy in Special Populations and Ethnic Minorities at High-Risk for Poor Outcomes: Focus on Head & Neck Cancers” Washington D.C.

3/27-18/04 Mountain Area Health Education Center Conference on Radiation Oncology, Keynote Address, It’s Not All Magic, “Historical Overview and Trends in the Role of the Nurse in Radiation Therapy” Asheville, NC

2/25-26/04 State of the Science Summit II for Pediatric Oncology Nursing Research, Keynote Address, “Nursing research contributions to the adult cooperative groups” Bethesda, MD 6/20/03 Case Western Reserve Univ. & Univ. Hospitals of Cleveland, Radiation Oncology:

Bridging Advanced Technology & Integrated Care, Keynote Address, “Outcomes Research: The Bridge to Improved Patient Care” Cleveland, OH

11/11-12/02 Australian Oncology Nurses Group 25th Anniversary Conference, Keynote Address, “Cost Effectiveness for Nurses,” Plenary Session, “Improving Sexual Outcomes after Cancer Therapy: The Role of the Nurse,” Gold Coast, Queensland Australia

6/01 Fox Chase Cancer Center, 10th Annual Radiation Oncology Nursing Conference, Keynote Address, “Progress, Course and Future of Radiation Oncology” Philadelphia, PA

1/00 Society of Gynecologic Nurse Oncologists (SGNO), Linda Hunter Quality of Life Lecture, “Role of the Nurse in Managing Sexual Dysfunction Following Cancer Therapy” Tampa, FL

Invited Presentations (166) 2/10/17 NRG Scientific Session: NRG Oncology/RTOG 0415, Phase III Non-Inferiority Study

Comparing 2 Fractionation Schedules in Patients with Low-Risk Prostate Cancer: Prostate Specific Quality of Life Results, Houston, TX

2/7/17 Emory University, President’s Inaugural Academic Symposium, “Challenges in Cancer: Moonshots, Miracles and Myths,” Atlanta, GA

11/3/16 Emory University, School of Nursing, Ethics Seminar, “Ethical Issues in Mentoring: Case Studies of Academic Publications,” Atlanta, GA (#165)

10/7/16 Winship Cancer Institute, Emory University, Elkin Lecture, “Gynecologic Cancer and the Vaginal Microbiome,” Atlanta, GA

8/19/16 University of Mississippi Medical Center, ASCO Highlights Symposium, Jackson, MS, “Best of ASCO 2016: Financial Toxicity”

7/23/16 Sigma Theta Tau, International Nursing Honor Society, Special Honoree Session, “Advancing Patient Centered Oncology Practice, Advocacy, and Policy,” Cape Town, South Africa

Bruner, DW Page 40 of 57 2/10/16 Radiation Oncology, Division of Cancer Biology, Research Interest Talks, Emory

University, “Radiation Therapy and the Microbiome,” Atlanta, GA 9/24/15 New York University, “Measuring Clinical Significance in Cancer Research: Value added of

Patient Reported Outcomes,” NY, NY (#160) 8/21/15 University of Mississippi Medical Center, ASCO Highlights Symposium, Jackson, MS,

“Best of ASCO 2015: Patient-Centered Outcomes and Supportive Care” 4/1/15 Winship Cancer Institute, Emory University, Grand Rounds, “Measuring Clinical

Significance in Cancer Research: Value added of Patient Reported Outcomes,” Atlanta, GA 11/19/14 Georgia Core, Annual Meeting, “NRG Oncology NCORP Research Base and Community

Partnerships: A Success Story” 11/14/14 Grand Rapids Clinical Oncology Program’s 2014 Distinguished Lecture Series. “NRG

Oncology NCORP Research Base and Community Partnerships: A Success Story”, Grand Rapids, MI (#155)

8/22/14 University of Mississippi Medical Center, ASCO Highlights Symposium, Jackson, MS, “Best of ASCO 2014: Survivorship”

6/17/14 Radiation Oncology Resident Journal Club, “Patient Reported Outcomes: The Value Added of Hearing the Patient’s Voice.” Emory University, Atlanta, GA

5/15/14 Guest Lecture, Gulou Hospital, Nanjing University, Nanjing, China, “Patient Reported Outcomes in US and International Cancer Clinical Trials”

5/22/14 Guest Lecture, Peking University School of Nursing, Beijing, China, “Patient Reported Outcomes in US and International Cancer Clinical Trials”

2/27/14 Emory University Commission on the Liberal Arts, Panel Presenter, “Mentoring Matters,” Atlanta GA (#150)

12/3/13 National Cancer Institute Symptom Management and Health Related Quality of Life Concept Design Webinar: “Study Design”

10/16/13 Council for the Advancement of Nursing Science’s panel presenter for Special Topics conference Innovative Approaches to Symptom Science: Measurement & Analysis: “The Promise of PROMIS in Cancer Research,” Washington, DC

9/22-25/13 American Society of Therapeutic Radiation and Oncology (ASTRO), Atlanta, GA Panel Presenter: “Patient Reported Outcomes: The Value Added of Hearing the Patient's Voice – “The Why of PROs,” Panel Presenter: Patient Reported Quality of Life Following Radiation Therapy for Prostate Cancer: “The Role of Patient Reported Outcomes and Quality of Life Evaluation of Patients treated for Prostate Cancer with Radiotherapy,” Abstract Discussant, Scientific Session V Patient Reported Outcomes - Pelvic Malignancies(#145)

9/20/13 Panel Presenter; “Symptom Management and Health Related Quality of Life National Clinical Trial Network Working Group Portfolio Evaluation,” CCOP, MBCCOP and Research Base Principal Investigator and Administrators Meeting, Bethesda, MD

4/23/13 Emory University Alumni Association, Panel Discussion, “Superwomen and Sacrifice: The Mind/Body Connection,” Atlanta, GA

4/16/13 Nell Hodgson School of Nursing, Emory University, 2013 Nursing Research Symposium, Panel Session, “Achieving Clinical Excellence through Research & Evidence-Based Practice,” Atlanta, GA

3/13-14/13 New York University, Visiting Professor, “Patient Reported Outcomes as Clinical Research Endpoints: Validation, Use, and National Recommendations,” New York, NY

2/19/13 Emory University, T32 Training Grant Lecture, “Symptom Management Evaluation in Chronic Illness Research: Use of the Patient Reported Outcomes (PROs)”

12/8/09 National Cancer Institute, Grand Rounds “NCI Translational Working Group Pathways: Application in Symptom Management” 2nd presentation, “Patient-reported Outcomes in Clinical Research” and Visiting Scholar, Bethesda, MD (#140)

10/22/12 American Society of Therapeutic Radiation and Oncology (ASTRO), Panel Presenter: Patient Reported Outcomes: The Value Added of Hearing the Patient's Voice – “The Why of PROs,” Boston, MA

Bruner, DW Page 41 of 57 6/13/12 Grady Hospital, Nursing Grand Rounds, “Nursing Management of Sexual Health in

Patients Treated for Cancer,” Atlanta, GA 6/4/12 American Society Clinical Oncology (ASCO) Annual Meeting, Educational Session,

"Capturing Patient Perspective: Patient-Reported Outcomes As Endpoints," Chicago, IL 3/13/12 Winship Cancer Institute, Emory University, Prostate Cancer Program Meeting,

“Comparative Effectiveness Implications of Patient-Reported and Clinician-Reported Toxicity Data: Preliminary Analysis of 3DCRT vs IMRT on RTOG 0126 Prostate Cancer Trial High Dose Arm," Atlanta, GA

1/21/11 Radiation Therapy Oncology Group, Publications Session, “ Preliminary Analysis of 3DCRT vs IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial: Patient Reported Outcomes,” Atlanta, GA (#135)

12/3/11 Cleveland Clinic, Grand Rounds, “RTOG Toxicity/Symptom Mitigation and Outcomes: Comprehensive Models for Cooperative Group Research,” Cleveland, OH

10/20/11 Winship Cancer Institute, Emory University, Cancer Control Program, "Sexual function after pelvic cancers treated with radiotherapy: Interventions and Knowledge Gaps," Atlanta, GA

4/1/11 Cancer Center, University of Virginia, Grand Rounds, “Symptom Management: Intersection of NCI Cooperative Group Research with the NCI Translational Pathway Model,” Charlottesville, VA

6/30/10 Winship Cancer Institute, Emory University, Grand Rounds, “Symptom Management, Quality of Life and Translational Research: Intersection of NCI Cooperative Group and Translational Working Group Models,” Atlanta, GA

3/13/10 NCI Fatigue State-of-the-Science Conference, “The Cooperative Group Perspective,” Bethesda, MD (#130)

3/10/10 Guest Lecturer, “Patient Reported Outcomes—Rationale, Selection, Implementation and Interpretation,” University of Jordan, Amman

1/25/10 NCI-NIAID Sponsored Meeting on Advanced Radiation Therapeutics (ART) / Radiation Injury Mitigation (RIM), “Designing Phase II or III Clinical Trials to Demonstrate RT Mitigation: The RTOG Example,” Bethesda, MD

1/15/10 Radiation Therapy Oncology Group Symposium, Moving Away from Survival - Novel Clinical Trial Endpoints for Radiation Oncology Research, “The New Patient Reported Outcomes- Common Toxicity Criteria for Adverse Events (PRO-CTCAE) Reporting System,” Tampa, FL

12/18/09 Radiation Oncology, University of Pennsylvania, “RTOG Health Services Research and Outcomes (HSRO) Committee and the RTOG Community Clinical Oncology Program (CCOP)”, Philadelphia, PA

11/10/09 Provost Symposium, University of Pennsylvania, School of Nursing, Integrated, Multi-disciplinary Translational Research Across a Disease Spectrum Using the NCI TRWG Pathways Model, “NCI Translational Working Group Pathways: Application in Symptom Management,” Philadelphia, PA (#125)

10/29/09 Chair, Oral Session: Methods for Preference-Based Measurement, Part 1, 16th Annual Conference of the International Society for Quality of Life Research (ISOQOL), New Orleans, LA

10/2/09 5th Annual Chicago Supportive Oncology Conference “Helping Patients with Radiation-Induced Sexual Dysfunction,” Chicago, IL

9/30/09 23rd Annual Meeting of the Canadian Association of Radiation Oncology, “Use of Patient-Reported Outcomes (PROs) to Assess Palliative Care Endpoints in Clinical Trials: The Bone Metastasis Exemplar RTOG 9714.” Quebec City, Quebec

9/3/09 Lilly, Inc. ROUND TABLE: How to Increase the Enrollment of Minority Patients in Oncology Clinical Trials? Addressing Disparities in Cancer Treatment and Outcomes. Indianapolis, IN

Bruner, DW Page 42 of 57 3/28/09 AWARE for All, CISCRP, 3rd Annual Philadelphia Clinical Research Education Day, “The

Role of Women and Minorities as Clinical Research Participants,” Drexel University, Philadelphia, PA (#120)

3/22/09 NCI Symptom Management and Health Related Quality of Life Steering Committee Meeting, “Translational Research Working Group: Pathway and Funding Update,” Bethesda, MD.

3/2/09 Community Clinical Oncology Program CCOP/MBCCOP and Research Base Meeting, PI and Administrator Meeting, “SxQOL Committee,” Bethesda, MD

3/2/09 Community Clinical Oncology Program CCOP/MBCCOP and Research Base Meeting, PI and Administrator Meeting, “Translational Working Group,” Bethesda, MD

2/7/09 NCI Community Clinical Oncology Program (CCOP) Meeting, “Translational Research Working Group: Pathway Update,” Bethesda, MD.

11/7-9/08 NCI Translational Science Meeting, Poster Discussion Session Co-chair, “Biobehavioral Mechanisms in Cancer Progression and Control,” Washington, DC (#115)

6/20/08 Radiation Therapy Oncology Group Symposium, Proton Therapy in the Cooperative Group Setting, “Quality of Life Assessments in Proton Therapy,” Philadelphia, PA

6/2/08 American Society of Clinical Oncology, Meet the Professor Session, “Optimizing Your Clinical Trials Program,” Chicago, IL

5/21/08 Center for Business Intelligence, Patient Reported Outcomes Conference, “Designing a Measurement Strategy Panel,” Philadelphia, PA

1/18/08 Radiation Therapy Oncology Group (RTOG), “Sexual Function after Gynecologic Cancer Therapy,” San Diego, CA

1/10/08 Summit Series on Cancer Clinical Trials, Panel Presenter, Baltimore, MD (#110) 11/29/07 University of Pennsylvania, Center for Public Health Initiatives 2007 Retreat, “Health

Disparities,” Philadelphia, PA 10/28/07 American Society of Therapeutic Radiation and Oncology (ASTRO), Panel Moderator and

Presenter: Sexual Function after Pelvic Radiotherapy, Los Angeles, CA 4/25/07 Washington University School of Medicine, Department of Radiation Oncology, “The

RTOG Outcomes Model: Exploring the Value Added of Combining Traditionally Disparate Endpoints,” St. Louis, MO

3/14/07 University of Pennsylvania, Human Subjects Workshop, “Improving Recruitment Strategies for Clinical Trials,” Philadelphia, PA

2/4/07 Radiation Therapy Oncology Group, Winter Symposium: “Radiation Therapy Oncology Group (RTOG) Recruitment to Clinical Trials,” Tampa, FL. (#105)

9/20/06 NIH Patient-Reported Outcomes Assessment in Cancer Trials: Evaluating and Enhancing the Payoff to Decision Making, “Issues and Challenges with Integrating PROs in Clinical Trials supported by NCI- Sponsored Clinical Trials Networks,” Bethesda, MD

9/15/06 American Society of Therapeutic Radiation and Oncology (ASTRO), Health Services Outcomes Research in Radiation Oncology Symposium, “Developments in Patient Reported Outcomes,” San Diego, CA

8/15/06 Radiation Therapy Oncology Group (RTOG) Study Chair Workshop, “Patient Recruitment Efforts in Clinical Trials,” Philadelphia, PA

6/8/06 5th Annual University of Pennsylvania School of Nursing/UPHS Oncology Nursing Research Symposium, “Improving Patient Access to Health Systems, Clinical Trials and Effective Cancer Therapy: A Way to Reduce Cancer Disparities for Minorities,” Philadelphia, PA

5/4/06 Oncology Nursing Society (ONS) Educational Session on Research Opportunities in the Cooperative Groups, “The Radiation Therapy Oncology Group: Exploring Nursing Leadership in Clinical Trials,” Boston, MA. (#100)

10/24/05 National Cancer Institute Symposium, Assessing Quality of Life (QOL) in Cancer Symptom Management Trials Workshop, Presenter, “Outcomes Research in Cancer Symptom Management Trials: The Radiation Therapy Oncology Group (RTOG) Conceptual Model,” Bethesda, MD.

Bruner, DW Page 43 of 57 10/20/05 American Society of Therapeutic Radiation and Oncology (ASTRO), 47th Annual Meeting,

Panel Presenter, “Developments in Quality of Life (QOL) and Patient Reported Outcome (PRO) Reporting in Oncology Clinical Trials” Denver, CO.

9/15/05 Columbia University/Presbyterian Hospital Hem/Onc Grand Rounds, “Benefits of Conducting Clinical Trials through the Community CCOP,” New York, NY.

9/12/05 Roswell Park Cancer Prevention Grand Rounds, “Benefits of Conducting Clinical Trials through the Community CCOP,” Buffalo, NY.

3/16/05 Second Annual National Comprehensive Cancer Network (NCCN) Nursing Program: Role of the Advanced Practice Nurse in Quality Oncology Care, “Quality of Life: Sexuality Issues for Cancer Patients,” Hollywood, FL.

2/17/05 School of Nursing, University of Pennsylvania, Guest Lecturer, “Multisite Research: Conceptual Frameworks and Nurse Scientist Opportunities,” Philadelphia, PA.

2/15/05 Howard University, Cancer Control Lecture Series, “Multisite Research: Conceptual Frameworks and Opportunities,” Washington, DC.

10/3-7/05 American Society of Therapeutic Radiation and Oncology (ASTRO), 46th Annual Meeting, Panel Presenter and Co-Moderator, “Sexual Function after Pelvic Radiation Therapy” Atlanta, GA. 10/22/03 American Society of Therapeutic Radiation and Oncology (ASTRO), 45th Annual Meeting, Panel Moderator, “Quality of Life” Salt Lake City, UT. 9/22/03 Fox Chase Cancer Center, Familial Cancer Risk Counseling: A Basic Cancer Genetic

Program for Nurses, “Medical Management of Individuals at Risk for Prostate Cancer,” Philadelphia, PA (#90)

4/9/03 Delaware Valley National Association of Clinical Nurse Specialists Networking Group, “Outcomes Measurement for Advance Practice Nurses,” Virtua Health, Voorhees, NJ.

3/28/03 Robert H. Lurie Comprehensive Cancer Center of Northwestern University’s Integrating Economic Analyses in Cancer Clinical Trials. “The Radiation Therapy Oncology Group

Outcomes Model: Economic Endpoints and Measures,” Chicago, IL. 3/1/03 The 37th Annual San Francisco Conference: Radiation Oncology, Assessing Quality of Life

in Radiation Therapy Clinical Trials: The RTOG Experience,” San Francisco, CA. 2/6/03 Thomas Jefferson University, Guest Lecturer, Principles of Pharmacoeconomics Graduate

Class, “Cost-Utility Analysis,” Philadelphia, PA. 1/24/03 Radiation Therapy Oncology Group (RTOG) Research Associates Meeting, “Framework

and Methods for Assessing Quality of Life in Clinical Trials,” Houston, TX. 11/11-12/02 Australian Oncology Nurses Group 25th Anniversary Conference, Panel Presentation,

“Quality of Life Issues in Prostate Cancer” Gold Coast, Queensland Australia. 9/11/02 Thomas Jefferson University’s Health Policy Forum, “The Impact of the Prostate Cancer

Risk Assessment Program” Philadelphia, PA. 6/13/02 Cooperative Group Cancer Nursing Research Summit, “Nursing Research in the Radiation

Therapy Oncology Group (RTOG)” Washington, DC. 6/12/02 Fox Chase Cancer Center, Advanced Nurses Cancer Genetic Risk Counseling Course,

“Prostate Cancer Risk Assessment” Philadelphia, PA. 11/01 American Society of Therapeutic Radiation and Oncology (ASTRO), 43rd Annual Meeting,

Panel Moderator, “Quality of Life” San Francisco, CA. (#80) 7/20/01 Gynecologic Oncology Group, Semi-annual Cooperative Group Meeting, Workshop

Coordinator and Presenter, “Vaginal Length and Sexual Function in Women Treated with Intracavitary for Cervical Carcinoma” Cincinnati, OH.

6/01 American Society of Therapeutic Radiation and Oncology (ASTRO) Outcomes Conference, “Measuring Outcomes: Assessing Cost-Effectiveness within Clinical Trials” Toronto, Canada

5/01 Presidents Panel on Cancer, “The Prostate Cancer Risk Assessment Program: Successful Strategies for African-American Recruitment” Washington, DC.

11/00 Irish Gynaecology Oncology Society, “Psychosexual Sequelae following Gynaecological Cancer” Galway, Ireland.

Bruner, DW Page 44 of 57 11/00 Oncology Nursing Society Institute of Learning, “Ways to Incorporate Sexuality into Your

Nursing Practice,” Charlotte, NC. 10/00 International Bone Metastases Consensus Meeting on Endpoint Measurements for Future

Clinical Trials, “Measuring Quality of Life: The RTOG Outcomes Model” Boston, MA. 10/00 American Society of Therapeutic Radiation and Oncology (ASTRO), 42nd Annual Meeting,

Panel Presenter, “Quality of Life and 3D CRT” Boston, MA. 9/00 Federation of International Gynecology & Obstetrics (FIGO), “Psychosexual Support for

Women with Gynecological or Breast Cancer: Improving Outcomes” Washington, DC. 5/00 Fox Chase Cancer Center, 9th Annual Radiation Oncology Nursing Conference, “Patterns of Care Studies: Past, Present & Future,” and “Improving Sexual Outcomes After Cancer Therapy: The Role of the Nurse” Philadelphia, PA (#70-71)

6/99 2nd Sonoma Conference on Prostate Cancer, “Quality of Life Outcomes after PSA Failures in Men Treated with Radiotherapy” Sonoma, CA.

5/99 Association of Cancer Executives (ACE), “Cancer Program Growth: Identifying & Developing New Revenue Streams – Prostate Cancer Screening” San Diego, CA.

5/99 Fox Chase Cancer Center, 8th Annual Radiation Oncology Nursing Conference “Role of the Nurse in Managing Sexual Dysfunction Following Cancer Therapy,” and “Role of the Radiation Nurse: Administration and Research” Philadelphia, PA.

4/99 Oncology Nursing Society, 24th Annual Congress, “The Role of Outcomes in Health Systems Management” Atlanta, GA.

4/99 Ireland Cancer Center, Frontiers in Cancer Care, “The Silent Sorrow: Sexual Dysfunction Following Cancer Therapy” Cleveland, OH.

11/98 American College of Oncology Administrators (ACOA), 7th Annual National Symposium “Quality of Life and Cancer Care: Or What Do Issues Like Sex Have to do with Reimbursement?” Dallas, TX.

9/98 Stevens Cancer Center – Scripps Memorial Hospital Cancer Symposium, “Controversies in Prostate Cancer Screening” San Diego, CA.

9/98 Vanderbilt University Medical Center, Oncology Nurse Practitioner Symposium, “The Silent Sorrow: Sexual Dysfunction Following Cancer Therapy” Nashville, TN.

5/98 Fox Chase Cancer Center, 7th Annual Radiation Oncology Nursing Conference, “Sexuality and the Cancer Patient” Philadelphia, PA. (#60)

4/98 American Cancer Society, Genetics and Cancer Conference, “Genetic Testing and Informed Consent,” and “Gene Therapy and Treatment Protocols: Roles of Providers and Patients” Utica, NY.

11/97 American College of Oncology Administrators, “Cancer Screening and Genetic Risk Assessment Programs: Administrative Issues and Logistical Tips” Orlando, FL

11/97 Dr. Robert W. McCullough Memorial Symposium, “Cost Effectiveness and Palliative Care” Port Jervis, NY.

6/97 1st Sonoma Conference on Prostate Cancer, “Quality of Life and Cost-Effectiveness Outcomes of Androgen Deprivation Therapy for Prostate Cancer,” Sonoma, CA. Report published in Oncology News International, Supplement 3, 6(11); 1997: 22-24.

5/97 Fox Chase Cancer Center, 2nd Annual Multidisciplinary Radiation Oncology Conference and 6th Annual Radiation Oncology Nursing Conference, “Are Current Therapies for Non-small Cell Lung Cancer Cost Effective? Should They Be?” and “Cancer Screening and Genetic Risk Assessment Programs: Administrative Issues and Logistical Tips” Washington, DC.

5/97 Oncology Nursing Society, 22nd Annual Congress, Panel Presenter, “Cost Effectiveness 101,” and Dinner Symposium sponsored by Amgen, “Translating Advanced Practice Nursing into Dollars and Sense: Cost Effectiveness and Quality Adjusted Life Years” New Orleans, LA.

4/97 American Association of Cancer Research (AACR), Panel Presenter, “Redirecting Research in the African American Population: Focus Group Utilization” San Diego, CA. (#50)

2/97 Radiation Therapy Oncology Group (RTOG), Semi-annual Meeting, “What Quality of Life Research Will Unfold” Houston, TX.

Bruner, DW Page 45 of 57 9/96 Contemporary Forums Conference, Cancer Nursing, “Integrated Care of the Gyn Radiation

Oncology Patient: A Case Study Approach” and “The Role of the Advanced Practice Nurse in Radiation Oncology - Collaborative Practice” Washington, DC.

5/96 Fox Chase Cancer Center, 1st Annual Multidisciplinary Radiation Oncology Conference and 5th Annual Radiation Oncology Nursing Conference, “Quality Improvement” and “Sexuality and the Gyn Cancer Patient” Philadelphia, PA.

10/95 American Society of Therapeutic Radiation and Oncology (ASTRO), Panel Presenter and Co-Moderator, “Introduction to Quality of Life and Sexual Functioning Issues in Men Treated for Prostate Cancer: OR What Does Sex Have to do With Reimbursement?” Abstract Session Co-Moderator, “Quality of Life” Miami Beach, FL.

9/95 Contemporary Forums Conference, Trends in Gynecology Oncology: A Nursing Perspective, “Sexuality” Ft. Worth, TX.

5/95 Fox Chase Cancer Center, 4th Annual Radiation Oncology Nursing Conference, “Prostate Cancer Screening” and “Quality Improvement and Documentation” Philadelphia, PA. (#40-41)

4/94 Fox Chase Cancer Center, 3rd Annual Radiation Oncology Nursing Course, “Documentation and Quality Improvement” and “Role of the Nurse in Advanced Practice” Philadelphia, PA.

10/93 American Society of Therapeutic Radiation and Oncology (ASTRO), Panel Moderator, “Quality of Life: A New Clinical Trials Endpoint” New Orleans, LA.

9/93 Fox Chase Cancer Center, Nursing Grand Rounds, “Changes in Documentation: Sexuality and Sexual Assessment” Philadelphia, PA.

4/93 American Cancer Society, Philadelphia Division Student Nurse Conference, “Demystifying Radiation Therapy” King of Prussia, PA.

3/93 American Cancer Society, Philadelphia Division Annual LPN Conference, “Breast Cancer: Sexuality and Fertility Issues” Philadelphia, PA.

4/93 Fox Chase Cancer Center, 2nd Annual Radiation Oncology Nursing Course, “Sexuality Issues and the Radiation Patient” and “Documentation and Quality Assurance” Philadelphia, PA.

11/92 American Society of Therapeutic Radiation and Oncology (ASTRO) Moderator – Presenter, “Sexuality and the Patient Receiving Radiation Therapy” San Diego, CA.

10/92 Oncology Nursing Society - Fall Institute, “Nursing Management of the Patient Receiving Brachytherapy” Minneapolis, MN. (#30)

5/92 Fox Chase Cancer Center, “Sexuality and the Cancer Patient” Philadelphia, PA. 3/92 Fox Chase Cancer Center, 1st Annual Radiation Oncology Nursing Course, “Quality Assurance

in Radiation Oncology Nursing” and “Intra-operative Radiation Therapy” and “Radiation Oncology Nursing Update” Philadelphia, PA.

3/92 Pottstown Memorial Hospital, Guest Lecturer, "Sexuality and the Cancer Patient" Pottstown, PA 2/92 Oncology Nursing Society, Philadelphia Area Chapter, "Nursing Care of the Patient Receiving

Radiation Therapy" Philadelphia, PA. 10/91 Fox Chase Cancer Center, "Case Management in Radiation Oncology” Philadelphia, PA 10/91 American Cancer Society, Philadelphia Division "Sexuality and Fertility Issues in Breast Cancer"

Philadelphia, PA. 7/91 Radiation Therapy Oncology Group, Semi-annual Meeting, "Sexual Assessment of the Patient

with Prostate Cancer" Philadelphia, PA. 5/91 Oncology Nursing Society, South Jersey Chapter, "Sexuality and the Gynecologic Cancer

Patient" NJ. 4/91 Crozer-Chester Medical Center, Guest Lecturer, "Nursing Care of the Patient Receiving

Radiation Therapy" Chester, PA.(#20) 4/91 Fox Chase Cancer Center, Radiation Technologist Annual Conference, "Sexuality and the Cancer

Patient" Philadelphia, PA. 4/91 American Cancer Society, Philadelphia Division, "Sexuality for Health Care Professionals"

Philadelphia, PA. 3/91 Fox Chase Cancer Center, "Nursing Care of the Patient Receiving Radiation Therapy"

Philadelphia, PA.

Bruner, DW Page 46 of 57 2/91 Graduate Hospital, Guest Lecturer, "Nursing Care of the Patient Receiving Radiation Therapy"

Philadelphia, PA. 11/90 American Cancer Society Lecture, Thomas Jefferson University Hospital Resident Program

"Sexual Issues in Cancer Rehabilitation" Philadelphia, PA. 10/90 Oncology Nursing Society, Fall Institute, "Quality Assurance in Radiation Oncology Chicago, IL 9/90 American Cancer Society Lecture, Germantown Hospital, "Radiation Therapy: Symptom

Management" Philadelphia, PA. 8/90 Fox Chase Cancer Center, "Nursing Care of the Patient Receiving Radiation Therapy"

Philadelphia, PA. 2/90 Widener University, Guest Lecturer for Oncology Graduate Program, "Sexuality and the Cancer

Patient" Chester, PA. 2/90 Medical College of Pennsylvania, Conference on Women's Health in the 90's, "Treatment of the Abnormal Pap" and "Sexuality after Radical Surgery" and "Osteoporosis and Estrogen

Replacement Therapy" Orlando, FL. (#10) 11/89 Lehigh Valley Hospital Center, Oncology Nursing Course Update: 1989, “Gynecologic

Oncology: Pelvic Radiation Therapy" Allentown, PA. 10/89 American Society of Therapeutic Radiology and Oncology (ASTRO) - ACR/CARROS Socio-

Economic Program, "A Model Quality Assurance Program for Radiation Oncology Nursing." San Francisco, CA.

10/89 Fox Chase Cancer Center, Women's Issues in Cancer, "Intracavitary Radiation Therapy" Philadelphia, PA.

5/89 American Cancer Society Conference, Co-chairperson and speaker Philadelphia Division RN Update: Gynecologic Cancer, "Patient Education...resources, techniques and literature" Philadelphia, PA.

3/89 Oncology Nursing Society, Philadelphia Area Chapter, Current Trends in Cancer Nursing Conference, "Sexuality in the Patient with Cancer," Thomas Jefferson University Hospital, Philadelphia, PA.

5/88 American Cancer Society, Philadelphia Division Annual Cancer Nursing Conference for L.P.N.'s, "Symptom Management" Philadelphia, PA.

1/88 American Cancer Society, Co-chairperson and speaker Philadelphia Division, Cancer: Impact on Sexual Health A Workshop for the Health Care Professional, "Gynecologic Cancer" Philadelphia, PA.

5/87 American Cancer Society, Philadelphia Division Annual Cancer Nursing Conference for L.P.N.'s, “Sexuality and the Breast Cancer Patient” Philadelphia, PA.

MEETING/CONFERENCE/ WEBINAR ORGANIZING ROLES 12-3-13 Member, National Cancer Institute (NCI) Webinar, NCI Symptom Management and

Health Related Quality of Life Concept Design Webinar 6-18-10 Co-Chair, Radiation Therapy Oncology Group (RTOG) Summer Symposium,

“Comparative Effectiveness in Clinical Trials,” Philadelphia, PA. 2-2-07 Chair, Radiation Therapy Oncology Group (RTOG) Winter Symposium, “Benchmarking

Your RTOG Accrual: Where Your Institution Stands And Strategies For Improvement”, Tampa, FL.

2001 Chair, Quality of Life and Economic Outcomes in Localized Prostate Cancer: Consensus Conference, San Francisco 1992-2001 Chair, Fox Chase Cancer Center Radiation Oncology Conference, Philadelphia, PA

(Developed and coordinated the first annual conference in the country to prepare nurses for their role in radiation oncology. Approximately 1,700 nurses from 49 states and 12 countries attended in first 10 years of operation under my management. The conference still continues to be held annually.)

MEMBERSHIPS IN PROFESSIONAL & SCIENTIFIC SOCIETIES & OFFICES HELD Institute of Medicine

Bruner, DW Page 47 of 57 2016-present Member 2014 Reviewer: Graduate Medical Education That Meets the Nation's Health Needs 2013 Reviewer: Delivering High-Quality Cancer Care: Charting a New Course for a System

in Crisis 2013-present Southern Nursing Research Society 2000 - 2005 American Society of Preventive Oncology 2001 - 2004 Executive Board of Directors 1991 - present American Society of Therapeutic Radiologists, Oncologists 2009 - 2011 Member, Bone Metastasis Guideline Group 2007- 2009 Member, Evidence-Based Clinical Practice Guideline: Role of Post-

Operative Radiotherapy for Radical Prostatectomy Panel 2005 - 2006 Member, Scientific Planning Committee, ASTRO Outcomes Workshop

(September 14-15, 2006, Westin- Hortin Plaza, San Diego, CA) 2005 - 2006 Abstract Reviewer, Annual Scientific Meeting 2004 - 2008 Member, Steering Committee of the Research Council 2001 - 2007 Member, Health Services Research Committee 1992 - 1996 Chairperson, Quality of Life Committee 1987 - 2007 American Cancer Society (ACS), Philadelphia Division 2005 Chair- 10th Annual Prostate Cancer Conference 11/9/04 Presenter, Regional Volunteer Forum, Southeast Region 2004 Chair- 9th Annual Prostate Cancer Conference 2003 Chair- 8th Annual Prostate Cancer Conference 2001 - 2007 Board of Directors, Southeast Region 1993 - 1994 Co-chair Extramural Nursing Experience 1988 - 1995 Member - Nurses Education Committee 1988 - 1994 Member - Gyn Committee 1988 - 1990 Chairperson - Gyn Nurses’ Speakers Bureau 1988 - 1989 Co-chair, Annual Nursing Conference Delaware County Division 2006 - 2009 Relay for Life Strathhaven High School Team Chaperone 1997 to 2000 Relay for Life Team Member 1996 Relay for Life Team Captain 1984 to present Oncology Nursing Society (ONS), National March 20- 21, 2017 Invitation only, Research Think Tank 2005-6 Member, Scientific Planning Committee, Multi-site Research Training

Workshop (October 19-21, 2006, Arlington, VA) 2006 to 2007 Member - Multi-site Research Advisory Panel 2005 Member - Multi-site Research Project Team 1994 to present Member - Advanced Nursing Research SIG 1993 to 1994 Liaison to Government Relations Committee, Radiation SIG 1992 to 1995 Member - Quality Assurance Work Group, Radiation SIG 1990 to 2004 Chairperson - Guidelines Work Group, Radiation SIG 1990 to present Member - Radiation Special Interest Group (SIG) 2012-present Metro-Atlanta Area Chapter, Local 1988 to 2000 ONS Philadelphia Area Chapter, Local

Bruner, DW Page 48 of 57 1993 to 1995 Director-at-Large 1993 to 1994 Liaison to Government Relations Committee 1988 to 1990 Chairperson - Program Committee 2000 to2008 International Society for Pharmacoeconomic & Outcomes Research 1995 to present International Society for Quality of Life Research 2010 Member - Annual Meeting Planning Committee, Social Activities and

Charity Subcommittees, London, UK 2009 Member - Annual Meeting Planning Committee, New Orleans, LA Chair – Social Activities subcommittee 2006 Member - Annual Meeting Planning Committee, Lisbon Portugal 1994 to present American Nurses Association 1997 to 1999 Chair - Expert Task Force on Prostate Cancer Education 1988 to 1996 Society of Gynecologic Nurse Oncologists NATIONAL CANCER RESEARCH COOPERATIVES - RESPONSIBILITIES National Cancer Institute 2015-2020 Presidential Appointment, National Cancer Advisory Board 2014-present Member, Cancer Care Delivery Coordination Committee 2013 Member, Working Group on PROs/HRQOL in NCTN and NCORP clinical

trials 2012 to 2013 Member, NCI National Clinical Trials Network (NCTN) Working Group 2010 Member, Community Clinical Oncology Program (CCOP) Advisory

Committee on Strategic Planning 2007 to 2011 Member, Clinical Trials and Translation Research Advisory Committee

(CTAC) 2010-2011 Member, Clinical Trials Working Group (CTWG) Evaluation Working

Group 2009-2010 Member, Process to Accelerate Translational Science (PATS) Working

Group 2007 to 2010 Co-Chair, Symptom Management and Health-Related Quality Life Steering Re-elected to 2013 Committee 2007-present Member, Symptom Management and Health-Related Quality Life Steering Committee 2007 Consultant, Office of Communication and Education RE: Improving

Clinical Trials Recruitment 2001 to 2007 Member, Cooperative Group Health Related Quality of Life Ad Hoc

Committee 2011 to present NRG Oncology 2013 to present Deputy Chair for Publications Member, Executive Committee 2011 to 2013 Member, Scientific Advisory Working Group 2011 to 2013 Member, Grant Writing Working Group 2011 to 2013 Convener and Tri-chair, Outcomes Working Group 1991 to present Radiation Therapy Oncology Group (RTOG) 2013-2017 Member- Board of Directors, RTOG Foundation 2014-present Member, Advisory Board, RTOG Foundation 2010-2015 PI- CCOP 2007-2010 Co-PI- CCOP

Bruner, DW Page 49 of 57 2005 to 2007 Founding Chair – Recruitment Committee 2004 to 2013 Group Vice-Chair for Outcomes - RTOG 2000 to 2013 Founding Chair- Health Services Research and Outcomes Committee 2001 to 2013 Member- Publications Committee 2001 to 2013 Member- Translational Research Committee 1999-2000 Chair - Quality of Life Committee 1994-1998 Co-chair - Quality of Life Committee 1994 to 2010 Member - Economic Impact Committee 1994 to 2013 QOL liaison, Genitourinary Committee 1991 to 2013 Founding Member - Quality of Life Committee

1993 to 2009 Gynecology Oncology Group (GOG) 1993 to 2009 Founding Member, Quality of Life Committee 2004 to 2009 North Central Cancer Therapy Group (NCCTG) Consultant, Community Clinical Oncology Program RESEARCH REVIEW PANELS AND COMMITTEES NIH June 2013-2015 Permanent Member, NCI Scientific Review Group Subcommittee J Career

Development 4/21-22/14 NCI National Clinical Oncology Research Program (NCORP) Study Section 5/22-24/13 Clinical and Translational Science Award (CTSA) Program Study Section 11/1/12; 3/5-6/13 NCI Scientific Review Group Subcommittee J Career Development 2/22-23/10 Clinical and Translational Science Award (CTSA) Program Study Section 7/09 ARRA Challenge Grants Review Panel 2/19-21/08 MD Anderson Cancer Center Core Grant Review Panel 2/10/05 Minority Biomedical Research Support (MBRS) Program Behavioral Science Research Panel 11/19/03, 11/16-17/04 CCOP Review Panel Department of Defense

4/7-8/05; 6/8-10/03; Prostate Cancer Behavioral Science/ Epidemiology Section Review Panel 7/8-10/02 7/14-15/04; 8/15-7/01 Breast Cancer Behavioral/Social Sciences- Clinical Health Services Review

Panel 3/11 Dutch Cancer Society (KWF Kankerbestrijding) Nursing Research Committees Fox Chase Cancer Center, Phila., PA 9/93-6/95 Chairperson 10/92-9/93 Co-chair 9/89-6/95 Member Albert Einstein Medical Center, Phila., PA 9/86-7/89 Member Crozer Chester Medical Center, Chester, PA 6/83-7/84 Member Ad Hoc Task Force/Committees/Consensus Panels/ Invitation only Meetings 6-29-16 Cancer Moonshot Summit, Howard University, Washington, D.C. 10-19-15 ARRO Poster Walk with a Professor, American Society for Radiation Oncology (ASTRO)

57th Annual Meeting, San Antonio, TX October 18-21, 2015.

Bruner, DW Page 50 of 57 9-28-15 Created a dialogue with NCI to hold and participated in a Special Invitation Only Meeting

“Patient Reported Outcomes (PROs) in Precision Medicine Clinical Trials” National Cancer Institute, Bethesda, MD

2012 Member, CONSORT Consensus Meeting on Patient Reported Outcomes, January 16-17, 2012, London, England

2011 Co-Chair, NCI Symptom Management & Quality of Life Clinical Trials Planning Meeting on Building Bridges: the Identification of Core Symptom and Health-Related Quality of Life Domains for use in Cancer Research (September 22-23, 2011), Bethesda, MD

2010 Invitee, Methods and Issues for Adaptive Trial Designs in Radiation Therapy (Invitation only) (September 7-8, 2010) Bethesda, MD

2009-10 Member, Scientific Planning Committee, NCI Fatigue Clinical Trials Planning Conference (April 13-14, 2010), Bethesda, MD

2009-10 Member, American Society for Radiation Oncology (ASTRO) International Bone Metastasis Treatment Guidelines Panel

2005-6 Member, Scientific Planning Committee, NIH Patient-Reported Outcomes Assessment in Cancer Trials: Evaluating and Enhancing the Payoff to Decision Making, (September 21, 2006), Bethesda, MD

2004 Member, NIH State-of-the-Science Conference on Improving End-of-Life Care, Bethesda, MD 2004 Host, Cooperative Group Cancer Nursing Research Summit II, New Orleans, LA 2003 Member, Work-group on improving minority recruitment in cancer prevention and screening,

Maya Angelou Research Center on Minority Health, Wake Forest University 2002-05 Member, Pennsylvania Cancer Control Consortium (PAC3), Developed PAs first Cancer Plan 2002 Member, Cooperative Group Cancer Nursing Research Summit, Washington, DC 2002 Member, Lent IV Late Effects Workshop: Incorporation into the NCI-CTC, St. Petersburg, FL 2001 Chair, Quality of Life and Economic Outcomes in Localized Prostate Cancer: Consensus Conference, San Francisco 2000 Member, International Bone Metastases Consensus Meeting on Endpoint Measurements for

Future Clinical Trials, Boston, MA. Meeting report: “International Bone Metastases Consensus on Endpoint Measurements for Future Clinical Trials Proceedings of the First Survey and Meeting (Work in Progress) International Bone Metastases Consensus Working Party,” Clinical Oncology, 13;82-84, 2001.

1995 Member, NCI Workshop on Quality of Life in Clinical Trials, Bethesda, MD. Meeting report: “Quality of Life in Clinical Cancer Trials,” Monographs Journal of the National Cancer Institute, 20, 1996.

1992 Member, RTOG/EORTC Late Effects Working Group: Late Effects of Normal Tissues (LENT) Consensus Conference, San Francisco, CA. Meeting report: Late Effects of Normal Tissues (LENT) Consensus Conference: RTOG/EORTC SOMA Scales,” International Journal of Radiation Oncology, Biology Physics, 31(5): Special Issue, 1995.

1990 Chair, American College of Radiology, Radiation Oncology Nursing Task Force on Standards Development, Philadelphia, PA. Meeting report: “Report of the Radiation Oncology Nursing Subcommittee of the American College of Radiology Task Force On Standards Development,” Oncology, 4 (8):80-81.

SELECTED PROFESSIONAL ACTIVITIES Patient Centered Outcomes Institute (PCORI) 2015-present Member, Advisory Panel on Clinical Trials Subcommittee on Recruitment, Accrual, and

Retention (RAR) Editorial Service Journals 2017 JAMA: Reviewer 2016 JAMA Oncology: Reviewer

Bruner, DW Page 51 of 57 2015 British Journal of Cancer: Reviewer 2015 Radiotherapy & Oncology: Reviewer 2014 Brachytherapy: Reviewer 2013 Expert Review of Pharmacoeconomics & Outcomes Research, Reviewer 2012 Current Opinion in Supportive and Palliative Care: Challenges in conducting

clinic al trials in supportive and palliative care. Guest Editor 2011 Gynecologic Oncology: Reviewer 2010 Pharmacoeconomics and Outcomes Research: Reviewer 2009 Journal of Supportive Oncology: Reviewer 2005 Journal of Clinical Oncology: Reviewer 2004 Medical Decision Making: Reviewer 2002 Cancer: Reviewer 2002 Pharmacy and Therapeutics: Reviewer 2002; 2008; 2017 Journal of the National Cancer Institute: Reviewer 2002 to 2003 Clinical Prostate Cancer: Reviewer 2001 to 2003 Cancer Nursing: Editorial Board 2001 to 2003 Pharmacoeconomics: Reviewer 1992-1996, 2004-05 International Journal of Radiation Oncology Biology Physics: Reviewer SERVICE ACTIVITIES AT CURRENT PLACE OF EMPLOYMENT Emorv University School of Nursing Task Forces/Committees 2016-present Chair, Advisory Committee on PhD Partnership Program in Nursing with Addis Ababa

University, Ethiopia 2015-2016 Ad hoc Committee on development of a PhD Program in Nursing with Addis Ababa

University, Ethiopia 2015 Faculty participant, Nell Hodgson Woodruff School of Nursing external review meeting 2013-present Graduate Progressions Committee 2013-present P30 Cognition Advisory Board 2012-present Faculty Academic Promotions and Tenure Committee 2012-present PhD curriculum 2012-present T32 Symptoms and Chronic Illness Advisory Board 2011-present Grad Group 2011-2013 Search Committee Emory University Task Forces/Committees 2016-present Executive Advisory Board, Office of the Vice Provost Strategic Research Initiatives 2016-2017 Chair, Ad Hoc Implementation Committee of Tenure Promotion and Appointment

Committee (TPAC) 2016 Member, University Ad Hoc Faculty Case Review Panel 2016-2017 Member, Faculty Council Research Administrative Services (RAS) Task Force 2015-2018 Elected Member, University Senate and Faculty Council 2015-2016 Co-chair, University Faculty Council Tenure, Promotions, and Appointments Writing

Committee 2015 Member, Executive Vice President, Woodruff Health Sciences, Search Committee 2015 Co-chair, Emory Ebola Faculty and Community Forum 2014-2015 Member, Emory Ebola Advisory Task Force 2014-2015 Member, Task Force on Shared Faculty Governance Membership 2012-2014 Commission on Rethinking Liberal Arts Education for the 21st Century

2014-2015 Advisory council, member 2013-2014 Vice-Chair 2013-2014 Executive Committee 2012-2014 Steering Committee 2012 Co-leader Research Working Group, Liberal Arts Commission

Bruner, DW Page 52 of 57 2013-2016 Faculty Counselor to the Emory Development and Communications Committee of

the Board of Trustees 2013-2016 Ex officio member, University Senate and Faculty Council

2013 Invitation only, member of Brazil Academic Learning Community Emory University Winship Cancer Institute 2016-present Member, Scientific Research Council 2016-present Co-chair, Faculty and Trainee Development Committee 2015-present Associate Director for Mentorship, Training and Education 2015 Member, Strategic Planning Executive Committee 2015 Leader, Survivorship/Supportive Oncology/Palliative Care Strategic Plan 2015 Member, CPC Data Management Task Force 2014-2016 Member, ACS Institutional Research Grant Executive Committee 2014-2015 New Research Initiatives, Facilitator and Chair, Pilot Grant Reviews 2012-2015 Member, Academic Development & Promotions Committee 2014 Member, Task Force to Review Grant Review procedures 2013 Leader, Winship Task Force for Dashboard Metrics 2012 Chair, Kennedy Survivorship Grant Review Panel, Winship Cancer Institute 2012 Member, ACS Pilot Grant Review Panel, Winship Cancer Institute 2011-present Member Winship Cancer Institute, Executive Committee 2011-2015 Associate Director for Outcomes Research 2011-present Member Winship Cancer Institute (Emory Led) Atlanta Clinical & Translational Science Institute (ACTSI) 2016 Reviewer, Emory-Georgia Tech Healthcare Innovation Program, inaugural student seed

grants program 2015- 2017 Planning Committee for the Collaboration and Multi-Disciplinary Team Science

Function 2015-present ACTSI Nursing Research Committee 2012; 2015 Member, Healthcare Innovation Program-Atlanta Clinical & Translational Science

Institute (ACTSI) Faculty Seed Grant Review Panel 2012-2013 Member, ACTSI Community Engagement Research Program Steering Board University of Pennsylvania School of Nursing Task Forces/Committees 2010-2011 Director Biobehavioral Research Center 2010-2011 Chair, Personnel Committee 2010-2011 Chair, Task Force on Developing Data Systems 2010 Member, Search Committee for Biobehavioral and Health Sciences Division Chair 2010 Chair, Claire Fagin Research Award Nomination Committee 2009-2010 Member, Dean’s Advisory Group 2009-2010 Chair, Joint Research Resources Working Group 2009 Member, Biobehavioral and Health Sciences Division Strategic Planning Committee 2009 Member, Associate Dean for Research Advisory Taskforce 2009 Member, Endowed Chair Review Taskforce 2008 Member, Curriculum Review of Oncology NP Program 2007-2009 Member, Research Committee

2008-2009 Chair of Research Committee 2007 Member, Task Force to IT for the 21st Century 2006 Member, Task Force on Diversity 2006-2011 Member, Personnel Committee 2006-2011 Member, Grad Group University of Pennsylvania Task Forces/Committees

Bruner, DW Page 53 of 57 2011 Abramson Cancer Center, Recruitment, Outcomes and Assessment Resource (ROAR),

Internal Advisory Board 2009-2010 Reviewer, University Research Funds 2009-2011 Penn’s Center for Health Behavior Research (KGlanz, Center Director), Internal

Advisory Panel 2009-2010 Vice Provost for Research’s Research Council 2008 Center for Public Health Initiatives Community-Academic Partnership Symposium

Planning Committee 2008-2011 Abramson Cancer Center Program Leaders Committee 2007-2009 Medical Oncology EMR Governance Committee 2007 Abramson Cancer Center Strategic Planning Committee Co-Leader, Cancer Prevention Work Group 2007 HUP/Abramson Cancer Center Oncology Governance Committee 2007-08;11 Abramson Cancer Center American Cancer Society Institutional Pilot Funds Research

Review Panel 2006 Abramson Cancer Center Ad Hoc Committee on IT Fox Chase Cancer Center Community Cancer Screening and Outreach 1990, 1992-1995 Prostate Cancer Screening Coordinator, screened over 200 men 1994-1995 Breast Cancer Survivors Celebration - Co-Coordinator, Fox Chase Cancer Center DOCTORAL DISSERTATION COMMITTEES Emory University Dissertation Committees 2016-present Chair, Gaea Daniels 2013-2015 Advisor, Tommy Flynn 2012 Reader, Jessica Holmes Emory-Addis Ababa University Dissertation Committees 2016-present Chair, Semarya Lemlem University of Pennsylvania Dissertation Committees 2009-2011 Chair, Canhua Xiao May 2009-Sept 2011 Member, Catherine Harris General Examinations 5/10 Chair, Jessica Reardon Qualifying Examinations 5/7/09 Committee Member, Catherine Harris Fall 2008 Committee Member, Canhua Xiao Spring 2007 Committee Member, Rebecca Trotta 9/5/06 Reader, Christopher Lee Other Dissertation Committees Fall 2014 PhD thesis reviewer, Fran Lubotzky, University of Sydney, Australia Fall 2011-Fall 2015 Member, Laura Beamer, University of Utah Fall 2006-Spring 2009 Member, Jeffrey Albaugh, University of Illinois FACULTY MENTORSHIP 2015-present Janice Withycombe, RN, PhD, Assistant Professor Primary Mentor 2015-2016 Nadine Matthie, RN, PhD, Research Assistant Professor Primary Mentor 2014-present Jessica Holmes Wells, RN, PhD, Research Assistant Professor, promoted to Assistant

Professor, Tenure Track, Emory SON 2015

Bruner, DW Page 54 of 57

Co-investigator and Mentor, Winship Cancer Institute, American Cancer Society Institutional Research Grant, Exploring the Anal Microbiome and Anal Cancer Risk in HIV-Infected and Uninfected Women (1/1/16 to 12/31/16) Primary Mentor on NIH Loan Repayment Award, 7/1/2015-6/30/2017 Primary Mentor, SON, K01NR015733-01A1 “Multilevel Predictors of Follow-up after Anal Cancer Screening in HIV-infected Individuals” (09/25/2015 – 07/31/2018), $88,884

2015-present Canhua Xiao, RN, PhD, promoted to Assistant Professor, Tenure Track, Emory SON 2015

2013-present Primary Mentor, 1K99NR014587-01 Fatigue in Head and Neck Cancer: Role of pro- and anti-inflammatory signaling (09/27/2013 - 06/30/2018) $924,891 Oncology Nursing Society, Victoria Mock New Investigator Award, May 2015, Dr. Bruner primary nominator

2012- present Kate Yeager, RN, PhD, Research Assistant Professor, promoted to Assistant Professor,

Tenure Track, Emory SON 2014 Primary Mentor, 1K01NR014673-01Adherence in African Americans Being Treated for Cancer Pain (09/27/2013 - 07/31/2016) $275,283 Primary Mentor, “African American Caregivers’ Influence on Adherence to Cancer Pain Treatment” (PI, Kate Yeager, PhD) Funded through Winship American Cancer Society Institutional Research Pilot Grant Program (6/1/15 to 5/31/16) $30,000

2011- 2014 Tami Thomas, RN, PhD, Assistant Professor, SON, Emory University, Atlanta , Chair,

Mentorship Committee, Primary Mentor on NIH Loan Repayment Award, in 2015. Dr. Thomas became Associate Professor and Associate Dean for Academic Affairs at Florida International University in Miami, FL.

2011- 2014 Carolyn Reilly, RN, PhD, Assistant Professor, SON, Emory University, Atlanta GA,

Member, Mentorship Committee 2010-2011 Mary Ersek, RN, PhD, Associate Professor, SON, University of Pennsylvania, Philadelphia Chair, Mentorship Committee 2010-2011 Yvonne Paterson, PhD, Associate Dean for Research, SON, University of Pennsylvania, New Faculty Mentor 2009-2010 Ann Rogers, RN, PhD, Associate Professor, SON, University of Pennsylvania, Philadelphia,

Appointed and Promoted to Professor, SON, Emory University 2010 Chair, Mentorship Committee, in 2012, Dr. Rogers became the Edith F. Honeycutt Chair in

Nursing and Professor and Director of Graduate Studies, Nell Hodgson Woodruff School of Nursing Emory University

2007-2011 Jun Mao, MD, SOM, Associate Professor, University of Pennsylvania, Philadelphia,

Appointed, Chief of the Integrative Medicine Service at Memorial Sloan Kettering Cancer Center in New York, 2015. Primary Mentor: Abramson Cancer Center American Cancer Society Institutional Research Grant #78-002-29, Acupuncture and Aromatase Inhibitor related Arthralgia (1/1/07 to 12/21/07) $30,000 Primary Mentor: ACS Career Development Award, Acupuncture for Hot Flashes Among Breast Cancer Survivors #10963 (7/01/08 to 6/30/11) $300,000 Mentor, PA K23 (AT004112) - Career Development Award (estimated total costs $673,492)

Bruner, DW Page 55 of 57 2007-2011 Salimah Meghani, RN, PhD, SON, University of Pennsylvania, Philadelphia, promoted to

Associate Professor with tenure in 2012 Primary Mentor: 1K01NR010886 -01. – Career Development Award, Disparities in Analgesic Preference for Cancer Pain: A Conjoint Analysis Study (7/1/08 to 6/30/09- converted to an ARRA Challenger R01 7/09) $254,250 (direct costs) Primary Mentor: Abramson Cancer Center American Cancer Society Institutional Research Grant #IRG 78-002-29, Developing and field-testing a choice-based conjoint survey to elicit differences in analgesic preference for cancer pain between African Americans and Whites, (1/1/08 to 12/21/08) $30,000

2007-2008 Connie Ulrich, RN, PhD, SON, University of Pennsylvania, Philadelphia

Mentor and Co-I, Factors Associated with Retention in Radiation Therapy Oncology Trials: A 20 year review, Funded through the Radiation Therapy Oncology Group/Pennsylvania Health Research Formula Funds Research Grant (1/1/07 - 12/31/08) $30,000

2007-2010 Giang T. Nguyen, MD, SOM, University of Pennsylvania, Philadelphia

Mentor and Co-PI, Research Recruitment, HPV, and Cervical Cancer Prevention in Asian American Women, Funded through the Abramson Cancer Center’s Strategic Planning Pilot Project and the Pennsylvania Commonwealth Universal Research Enhancement (C.U.R.E.) Program ME-02-149 (1/1/08 - 12/31/10) $200,000

GRADUATE MENTORSHIP 2016- Jingbing Bai, RN, PhD, Postdoctoral Fellow

2017 Primary Mentor, “Gut Microbiome in Children with Sarcoma Following Chemotherapy: A Case-Control Study,” funded by the Alpha Epsilon Chapter of Sigma Theta Tau. $1500 2017 Congress Conference Scholarship funded by ONS Foundation Endowment. $1,200

2014-2015 Mei Bai, RN, PhD, Postdoctoral Fellow 2011-2016 NINR T32 Interdisciplinary Training for Nurse Scientists in Improving Outcomes in Chronic

Conditions (PI, Sandra Dunbar, RN, PhD) Faculty and Executive Committee Member 2012-2015 Jessica Holmes, RN, PhD, Postdoctoral Fellow, Primary Mentor, SON, Emory University,

Atlanta GA, Dr. Holmes promoted to Assistant Professor, Research Track, Emory SON 2015 2015-18 Primary Mentor, 1K01NR015733-01A1 Multilevel Predictors of Follow-up after Anal Cancer Screening in HIV-infected Individuals 09/25/2015 – 07/31/2016, $88,884

2011-2014 Canhua Xiao, RN, PhD, Postdoctoral Fellow, Primary Mentor, SON, Emory University, Atlanta GA, Dr. Xiao promoted to Assistant Professor, Tenure Track, Emory SON 2015 2013-present Primary Mentor, 1K99NR014587-01 Fatigue in Head and Neck Cancer: Role of pro- and anti-inflammatory signaling (09/27/2013 - 06/30/2018) $924,891 2013-2015 Primary Mentor/Co-I, ONS Foundation. Fatigue and NF-kB Related Inflammatory Mediators in Patients with Head and Neck Cancer. (1/15/13-1-15-15) $25,000 Emory IRB #00033273. 2012-2013 Primary Mentor, Sigma Theta Tau Alpha Epsilon Chapter Research Scholarship Award, “Fatigue and NF-kB Related Inflammatory Mediators in Patients with Head and Neck Cancer Undergoing Chemoradiotherapy” $1000 2010-2011 Primary Mentor, American Nurse’s Foundation, “Identifying Symptom Clusters in Patient with Head and Neck Cancer Post Radiation Therapy” $3,500 2010-2011 Canhua Xiao, RN, PhDC, Doctoral Candidate, SON, University of Pennsylvania, Philadelphia Primary Mentor: Mentored Research Award, SON, The Comparison of Missing Data Handling Techniques on Factor Analysis $5000

2008-2010 Laura Hanisch, PhD, Psychologist, Postdoctoral Fellow, University of Pennsylvania, Took a position as a Medical Writer/Patient Information Specialist at the National Comprehensive Cancer Network

2006-2008 Charlene Bryan, PhD, Epidemiology, Postdoctoral Fellow, University of Pennsylvania, Took a position with Novartis. Deceased.

Bruner, DW Page 56 of 57 UNDERGRADUATE MENTORSHIP 2015 Special Advisor to Fatu Kekula, Liberian Student from Cuttington University, http://www.cnn.com/2015/04/10/health/fatu-kekula-nursing-emory/ Honors Seminar (Emory University) 2015-16 Mentor, Julie Lemen

2016 Student Alumni Board 100 Senior Honorary, an award that distinguishes the 100 most outstanding members of the senior class, nominated by Dr. Bruner Mentor and Senior Author for ePoster Abstract, Lemen, J., etal, Characterizing the Vaginal Microbiome of Gynecologic Cancer Patients: An Integrative Review. ONS, April 28–May 1, 2016.

2015-16 Mentor, Rubi Garcia Mentor and Senior Author for Oral Abstract, Garcia, R., etal, Exploring the Relationship Between Pre-Treatment BMI and Post-Treatment Sexual Function in Women with Endometrial Cancer treated with Vaginal Brachytherapy, ONS, April 28–May 1, 2016.

2014 Mentor, Deanna Gutierrez Mentor, Deirdre Horvath

2013 Mentor, Lynn Tran Mentor and Senior Author for Poster Abstract “The Relationship between Body Mass

Index and Sexual Activity in Women with Endometrial Cancer Prior to Radiation Therapy,” Southern Nursing Research Conference, San Antonio, TX, February 12-15, 2014.

Senior Inquiry (University of Pennsylvania) Spring 2011 Courtney Horn, “Fatigue and Exercise in Cancer Patients” Fall 2006 Renee Ferrari, “Breast Cancer and Pregnancy: Exploring Available Treatment

Modalities”

Undergraduate Research Assistants 2017-18 Marissa Bergh, SON, Emory University 2017-18 Melissa Mickiewicz, Emory College, Emory University 2016-18 Colin McNamara, SON, Emory University 2016-17 Clara Reddick, Rollins School of Public Health, Emory University 2016-17 Rosalyn Thomas, SON, Emory University

Mentor and Senior Author for Poster Abstract “Quality Assurance of the Vaginal Microbiome Collection Protocol in Women with Gynecologic Cancers,” Southern Nursing Research Conference, Dallas, TX, February 22-25, 2017; same poster presented at Emory SON Scholarship Day April 10, 2017, Won 2nd Place for Best Poster

2015-16 Julie Lemen, SON, Emory University (see achievements under honors seminar) 2015-16 Rubi Garcia, SON, Emory University (see achievements under honors seminar) 2012-2013 Luke Ong, Emory College, Emory University Mentor and Senior Author for Poster Abstract “Gender Disparities in NIH Funding of

Female vs Male Sexual Function Research,” Southern Nursing Research Conference, San Antonio, TX, February 12-15, 2014.

2010-2012 Janan McCormick, SON, University of Pennsylvania Mentor and Co-PI, “Development of normative vaginal length data with the vaginal sound.” (6/1/11- 5/31/12) $10,000

2009 Lindsey Goldhagen, SON, University of Pennsylvania Mentor and Senior Author of her Eastern Nursing Research Society’s First Place Undergraduate Poster Award in 2009, “Study to Assess NCI-designated Comprehensive Cancer Center Resources for Human Subjects Recruitment.”

Bruner, DW Page 57 of 57 Emory University SON Mentorship Lectures 3/29/17 H-Index and Alternative Metrics of Scholarship 11/3/14 Ethical Issues in Mentoring: Case Studies in Academic Publications 11/3/16 Crucial Accountability Role Play 10/5/16 Crucial Accountability Book Review Facilitator 1/25/16 Practice Your Scholarship Impact Narrative: Drafting before you need it helps guide your

next steps at all ranks 10/28/15 Crucial Conversations 10/5/15 Assistant Professors Tea and Career Development 9/15/15 A New Mentorship Pathway 2/19/15 Scientific Evidence for How We Dress Is Related to Success 11/20/14 Ethical Issues in Mentoring: Case Studies in Academic Publications 11/3/14 H-Index and Alternative Metrics of Scholarship 3/21/14 Shakespeare’s Guide to Mentorship: It is not in the stars to hold our destiny but in

ourselves 3/20/14 Lunch and Learn - Metrics for Impact of Scholarship: H-Index 2/3/14 Shakespeare’s Guide to Mentorship: Be great in act, as you have been in thought 12/2/13 Shakespeare’s Guide to Mentorship: To be, or not to be [a mentor] 10/7/13 Shakespeare’s Guide to Mentorship: Double, double toil and trouble….